Collected Works of Daniel Catovsky

Introduction

Dr. Daniel Catovsky has been recognized for his work on the morphology of CLL, the Medical Research Council (MRC) Trials and the differential diagnosis of CLL. He was one of the first to recognize the prolymphocytoid transformation of CLL. Careful observation of the UK MRC trials revealed that the treatment of the early stages of CLL were not associated with overall survival, and there was no survival benefit with immediate versus deferred chemotherapy. Dr. Catovsky was instrumental in bringing CLL, the most common adult leukemia, to the attention of the research community, and his work in hairy cell leukemia has helped to transform the prognosis for patients with this disease.

Dr. Daniel Catovsky obtained his medical degree in Buenos Aires in 1961 and worked for some years at the Hammersmith Hospital in London before becoming Head of Haematology at the Royal Marsden Hospital and Institute of Cancer Research in 1988. He has also served as a member of the small lymphocytic leukemia sub-committee WHO classification project.

Collected Works

1963

• Catovsky D, Rymar J, Criscaut JJ. Estudios citoquímicos en un caso de síndrome de Di Guglielmo. Sangre (Barc). 1963;87:387-98.
• Grignaschi VJ, Sperperato AM, Catovsky D, Farinati SA. La reacción de fosfatasa alcalina en los leucocitos neutrófilos de la sangre humana. Prensa Med Argent. 1963 Sep 27;50:2567-71.

1965

• Catovsky D, Rymar J, Criscaut JJ. Determinación citoquímica de fosfatasa alcalina, fosfatasa ácida, arilsulfatasa y peroxidasas. Sangre (Barc). 1965;10:71-6.
• Catovsky D. Localización de la fosfatasa acida en las células tejido hemolinfopoyetico y de exudados inflamatorios, a pH 5 y 6,3. Arch Histol Norm Patol. 1965 Jun 1;9(1):97-103.

1967

• Catovsky D. Fagocitosis in vivo con el método de la ventana cutánea. Observaciones en el ser humano normal y en hemopatías. Arch Fund Roux Ocefa. 1967 Apr-Jun;1(2):113-24.
• Catovsky D, Sforza MB. Phytohaemagglutinin in aplastic anaemia. Lancet. 1967 Nov 4;2(7523):991-2. 

1969

• Catovsky D, Holt PJ, Galton DA. Lymphocyte cultures in multiple myeloma and other paraproteinaemias. Br J Haematol. 1969 Dec;17(6):608-9. 

1970

• Catovsky D, Holt PJ. Lymphocyte survival and macrophage growth in long term in vitro leucocyte cultures. Experientia. 1970;26(7):783-4.
• Catovsky D, Holt PJ. Long-term in vitro lymphocyte culture. Clin Sci. 1970 Jan;38(1):3P.
• Catovsky D, Ikoku NB, Pitney WR, Galton DA. Thromboembolic complications in myelomatosis. Br Med J. 1970 Aug 22;3(5720):438-9. 

1971

• Catovsky D, Galton DA. Myelomonocytic leukaemia supervening on chronic lymphocytic leukaemia. Lancet. 1971 Mar 6;1(7697):478-9. 
• Catovsky D, Shaw MT, Hoffbrand AV, Dacie JV. Sideroblastic anaemia and its association with leukaemia and myelomatosis: a report of five cases. Br J Haematol. 1971 Apr;20(4):385-93. 
• Catovsky D, Holt PJ. T or B lymphocytes in chronic lymphocytic leukaemia. Lancet. 1971 Oct 30;2(7731):976-7. 
• Catovsky D, Lewis SM, Sherman D. Erythrocyte sensitivity to in-vitro lysis in leukaemia. Br J Haematol. 1971 Nov;21(5):541-50. 
• Catovsky D, Galton DA, Griffin C. The significance of lysozyme estimations in acute myeloid and chronic monocytic leukaemia. Br J Haematol. 1971 Nov;21(5):565-80. 
• Catovsky D, Galton DA, Griffin C, Hoffbrand AV, Szur L. Serum lysozyme and vitamin B12 binding capacity in myeloproliferative disorders. Br J Haematol. 1971 Dec;21(6):661-72. 

1972

• Catovsky D, Galton DA, Robinson J. Myeloperoxidase-deficient neutrophils in acute myeloid leukaemia. Scand J Haematol. 1972;9(2):142-8. 
• Holt PJ, Pal SG, Catovsky D, Lewis SM. Surface structure of normal and leukaemic lymphocytes. I. Effect of mitogens. Clin Exp Immunol. 1972 Apr;10(4):555-70. 
• Catovsky D, Tripp E, Hoffbrand AV. Response to phytohaemagglutinin and pokeweed mitogen in chronic lymphocytic leukaemia. Lancet. 1972 Apr 8;1(7754):794-5. 
• Catovsky D, Tripp E, Hoffbrand AV, König E, Cohnen G, Brittinger G, Douglas SD, Fröland SS, Stavem P. Response to phytohaemagglutinin and pokeweed mitogen in chronic lymphocytic leukaemia. Lancet. 1972 Apr 8;1(7754):794-6. 
• Catovsky D, Galton DA. Cytochemical demonstration of lysozyme and nitroblue tetrazolium reduction in leukaemia monocytes. Br J Haematol. 1972 May;22(5):634-5.
• Catovsky D, Holt PJ, Galton DA. Binucleated blast-cells in lymphocyte cultures from myelomatosis. Immunology. 1972 Jun;22(6):1103-9. 
• Catovsky D, Holt PJ, Galton DA. Lymphocyte transformation in immunoproliferative disorders. Br J Cancer. 1972 Jun;26(3):154-63. 
• Goldman JM, Catovsky D. The function of the phagocytic leucocytes in leukaemia. Br J Haematol. 1972 Sep;23:Suppl:223-30. 
• Kaur J, Catovsky D, Valdimarsson H, Jensson O, Spiers AS. Familial acute myeloid leukaemia with acquired Pelger-Huet anomaly and aneuploidy of C group. Br Med J. 1972 Nov 11;4(5836):327-31. 
• Hill RS, Catovsky D, Lewis SM. Paroxysmal nocturnal haemoglobinuria-like red cell abnormality in patient with lymphoproliferative disease. Br Med J. 1972 Dec 16;4(5841):649-50. 

1973

• Catovsky D, Galton DA. Lysozyme activity and nitroblue-tetrazolium reduction in leukaemic cells. J Clin Pathol. 1973 Jan;26(1):60-9. 
• Catovsky D, Pettit JE, Galton DA. Diagnostic features of leukaemic reticuloendotheliosis. Br J Haematol. 1973 Aug;25(2):278-9. 
• Catovsky D, Galetto J, Okos A, Galton DA, Wiltshaw E, Stathopoulos G. Prolymphocytic leukaemia of B and T cell type. Lancet. 1973 Aug 4;2(7823):232-4. 
• Pickering TG, Catovsky D. Hypokalaemia and raised lysozyme levels in acute myeloid leukaemia. Q J Med. 1973 Oct;42(168):677-82.
• Hoffbrand V, Tripp E, Catovsky D, Das KC. Transport of methotrexate into normal haemopoietic cells and into leukaemic cells and its effects on DNA synthesis. Br J Haematol. 1973 Oct;25(4):497-511. 

1974

• Catovsky D, Pettit JE, Galton DA, Spiers AS, Harrison CV. Leukaemic reticuloendotheliosis (‘Hairy’ cell leukaemia): a distinct clinico-pathological entity. Br J Haematol. 1974 Jan;26(1):9-27. 
• Catovsky D, Pettit JE, Galetto J, Okos A, Galton DA. The B-lymphocyte nature of the hairy cell of leukaemic reticuloendotheliosis. Br J Haematol. 1974 Jan;26(1):29-37. 
• Galton DA, Goldman JM, Wiltshaw E, Catovsky D, Henry K, Goldenberg GJ. Prolymphocytic leukaemia. Br J Haematol. 1974 May;27(1):7-23. 
• Kaur J, Catovsky D, Spiers AS, Galton DA. Increase of T lymphocytes in the spleen in chronic granulocytic leukaemia. Lancet. 1974 May 4;1(7862):834-6. 
• Catovsky D, Goldman JM, Okos A, Frisch B, Galton DA. T-lymphoblastic leukaemia: a distinct variant of acute leukaemia. Br Med J. 1974 Jun 22;2(5920):643-6. 
• Spiers AD, Costello C, Catovsky D, Galton DA, Goldman JM. Chronic granulocytic leukaemia: multiple-drug chemotherapy for acute transformation. Br Med J. 1974 Jul 13;3(5923):77-80. 
• Viza D, Catovsky D, Trejdosiewicz L, Phillips J, Collard AJ. Détection d’antigènes viraux dans les leucémies humaines. C R Acad Hebd Seances Acad Sci D. 1974 Aug 5;279(6):531-4.
• Catovsky D, Miliani E, Okos A, Galton DA. Clinical significance of T-cells in chronic lymphocytic leukaemia. Lancet. 1974 Sep 28;2(7883):751-2. 
• Catovsky D, Galetto J, Okos A, Miliani E, Galton DA. Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia. J Clin Pathol. 1974 Oct;27(10):767-71. 
• Kaur J, Spiers AS, Catovsky D, Galton DA. Increase of T lymphocytes in the spleen in Hodgkin’s disease. Lancet. 1974 Oct 5;2(7884):800-2. 
• Stathopoulos G, Papamichail M, Sheldon P, Catovsky D, Davies AJ, Holborow EJ, Wiltshaw E. Immunological studies in a case of T-cell leukaemia. J Clin Pathol. 1974 Nov;27(11):851-9. 

1975

• Catovsky D. Blood cell cytochemistry and supplementary techniques. In Dacie JV, Lewis SM, Eds. Practical Haematology. 5th edition. Edinburgh: Churchill Livingstone; 1975:120-149.
• Spiers AS, Baikie AF, Galton DA, Richards HG, Wiltshaw E, Goldman JM, Catovsky D, Spencer J, Peto R. Chronic granulocytic leukaemia: effect of elective splenectomy on the course of disease. Br Med J. 1975 Jan 25;1(5951):175-9. 
• Catovsky D, Frisch B, Okos A, Van Noorden S. Scanning electron microscopy and the nature of the hairy cell. Lancet. 1975 Feb 22;1(7904):462-3. 
• Catovsky D, Papamichail M, Okos A, Miliani E, Holborow EJ. Formation of mouse red cell rosettes by “hairy” cells. Biomedicine. 1975 Apr 10;23(3):81-4.
• Geary CG, Catovsky D, Wiltshaw E, Milner GR, Scholes MC, Van Noorden S, Wadsworth LD, Muldal S, MacIver JE, Galton DA. Chronic myelomonocytic leukaemia. Br J Haematol. 1975 Jul;30(3):289-302. 
• Catovsky D. Methods for the study and cell differentiation in acute leukaemia. Br J Cancer. 1975 Aug;32(2):282-3. 
• Catovsky D. T-cell origin of acid-phosphatase-positive lymphoblasts. Lancet. 1975 Aug 16;2(7929):327-8. 
• Catovsky D. Cytochemistry of leucocytes. J Clin Pathol. 1975 Sep;28(9):759-60. 
• Spiers AS, Baikie AG, Galton DA, Kaur J, Catovsky D, Goldman JM, Wiltshaw E, Lowenthal RM, Buskard NA. Splenectomy for complications of chronic granulocytic leukaemia. Lancet. 1975 Oct 4;2(7936):627-30. 

1976

• Buskard NA, Catovsky D, Okos A, Goldman JM, Galton DA. Prolymphocytic leukaemia: cell studies and treatment by leucapheresis. Hamatol Bluttransfus. 1976;18:237-50.
• Greaves M, Capellaro D, Brown G, Revesz T, Janossy G, Lister TA, Beard M, Rapson N, Catovsky D. Analysis of human leukaemic cells using cell surface binding probes and the fluorescent activated cell sorter. Hamatol Bluttransfus. 1976;19:243-60. 
• Catovsky D. Morphological recognition of lymphocytes and macrophages. Recent Results Cancer Res. 1976;(56):1-7. 
• Goldman JM, Th’ng KH, Catovsky D, Galton DA. Production of colony‑stimulating factor by leukemic leucocytes. Blood. 1976 Mar;47(3):381-8. 
• Catovsky D, Cherchi M, Okos A, Hegde U, Galton DA. Mouse red-cell rosettes in B-lymphoproliferative disorders. Br J Haematol. 1976 Jun;33(2):173-7. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451-8. 
• Beard MD, Durrant J, Catovsky D, Wiltshaw E, Amess JL, Brearley RL, Kirk B, Wrigley PF, Janossy G, Greaves MF, Galton DA. Blast crisis of chronic myeloid leukaemia (CML). I. Presentation simulating acute lymphoid leukaemia (ALL). Br J Haematol. 1976 Oct;34(2):167-78. 
• Janossy G, Greaves MF, Revesz T, Lister TA, Roberts M, Durrant J, Kirk B, Catovsky D, Beard ME. Blast crisis of chronic myeloid leukaemia (CML). II. Cell surface marker analysis of “lymphoid” and myeloid cases. Br J Haematol. 1976 Oct;34(2):179-92. 
• Kramers MT, Catovsky D, Foa R, Cherchi M, Galton DA. 5′ nucleotidase activity in leukaemic lymphocytes. Biomedicine. 1976 Dec 30;25(10):363-5.

1977

• Catovsky D. Cell markers in acute lymphoblastic leukaemia and lymphoproliferative disorders. In Hoffbrand AV, Brain MC, Hirsh J, Eds. Recent Advances in Haematology. Edinburgh: Churchill Livingstone; 1977: 201‑217.
• Catovsky D, Okos A, Fuentez‑Castellano J, García Talavera J, Luquetti A. The nature of the hairy cell. In Seno S, Takaku F, Irino S, Eds. Topics in hematology: proceedings of the 16th International Congress of Hematology, Kyoto, September 5-11, 1976. Amsterdam: Exerpta Medica; 1977:879‑881.
• Catovsky D, Galton DA. Cell markers and the classification of acute leukaemia. Haematol Blood Transfus. 1977;20:25-31. 
• Greaves MF, Janossy G, Roberts M, Rapson NT, Ellis RB, Chessels J, Lister TA, Catovsky D. Membrane phenotyping: diagnosis, monitoring and classification of acute ‘lymphoid’ leukaemias. Haematol Blood Transfus. 1977;20:61-75. 
• Kramers MTC, Catovsky D, Cherchi M, Galton DAG. 5′nucleotidase in cord blood lymphocytes. Leuk Res. 1977;1(4):279-281. 
• Catovsky D. Hairy-cell leukaemia and prolymphocytic leukaemia. Clin Haematol. 1977 Feb;6(1):245-68.
• Bain B, Catovsky D, O’Brien M, Spiers AS, Richards GH. Megakaryoblastic transformation of chronic granulocytic leukaemia: an electron microscopy and cytochemical study. J Clin Pathol. 1977 Mar;30(3):235-42. 
• Lewis SM, Catovsky D, Hows JM, Ardalan B. Splenic red cell pooling in hairy cell leukaemia. Br J Haematol. 1977 Mar;35(3):351-7. 
• Catovsky D, Enno A. Morphological and cytochemical identification of lymphoid cells. Lymphology. 1977 Jun;10(2):77-84.
• Spiers AS, Goldman JM, Catovsky D, Costello C, Buskard NA, Galton DA. Multiple-drug chemotherapy for acute leukemia The TRAMPCOL regimen: results in 86 patients. Cancer. 1977 Jul;40(1):20-9. 
• Catovsky D, Sperandio P, O’Brien M, Cherchi M, Galton DA. Phagocytic potential of leukaemic B-lymphocytes. Scand J Haematol. 1977 Aug;19(2):211-6. 
• Spiers AS, Goldman JM, Catovsky D, Costello C, Galton DA, Pitcher CS. Prolonged remission maintenance in acute myeloid leukaemia. Br Med J. 1977 Aug 27;2(6086):544-7. 
• Hoffbrand AV, Ganeshaguru K, Janossy G, Greaves MF, Catovsky D, Woodruff RK. Terminal deoxynucleotidyl-transferase levels and membrane phenotypes in diagnosis of acute leukaemia. Lancet. 1977 Sep 10;2(8037):520-3. 
• Catovsky D, Pittman S, Lewis D, Pearse E. Marker chromosome 14q+ in follicular lymphoma in transformation. Lancet. 1977 Oct 29;2(8044):934. 
• Gralnick HR, Galton DAG, Catovsky D, Bennett JM, Sultan C. Classification of acute leukemia. Ann Intern Med. 1977 Dec 1;87(6):740-753. 

1978

• Catovsky D, Cherchi M, Galton DA, Hoffbrand AV, Ganeshaguru K. Cell differentiation in B and T‑lympho proliferative disorders. In Clarkson B, Marks PA, Till JE, Eds. Differentiation of Normal and Neoplastic Hematopoietic Cells. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1978: 811‑822.
• Catovsky D, O’Brien M, Cherchi M. Cytochemistry: an aid to the diagnosis and classification of the acute leukemias. Recent Results Cancer Res. 1978;64:108-12. 
• Catovsky D, Sperandio P, O’Brien M. Facultative phagocytosis by leukemic B-lymphocytes: further proof of the B-cell nature of hairy cells. Recent Results Cancer Res. 1978;64:208-12. 
• García-Talavera J, Catovsky D, Fuentes Castellano J. Receptores de Membrana en la leucemia monoctica aguda. Sangre (Barc). 1978;23(3):282-90.
• Catovsky D, Goldman JM, Galton DA. Survival after relapse in acute myeloid leukaemia. Lancet. 1978 Feb 4;1(8058):266-7. 
• Goldman JM, Catovsky D, Galton DA. Reversal of blast-cell crisis in C.G.L. by transfusion of stored autologous buffy-coat cells. Lancet. 1978 Feb 25;1(8061):437-8. 
• Kramers MT, Catovsky D. Cell membrane enzymes: L-gamma-glutamyl transpeptidase, leucine aminopeptidase, maltase and trehalase in normal and leukaemic lymphocytes. Br J Haematol. 1978 Apr;38(4):453-61. 
• Catovsky D, Cherchi M, Greaves MF, Janossy G, Pain C, Kay HE. Acid-phosphatase reaction in acute lymphoblastic leukaemia. Lancet. 1978 Apr 8;1(8067):749-51. 
• Janossy G, Woodruff RK, Paxton A, Greaves MF, Capellaro D, Kirk B, Innes EM, Eden OB, Lewis C, Catovsky D, Hoffbrand AV. Membrane marker and cell separation studies in Ph1-positive leukemia. Blood. 1978 May;51(5):861-77. 
• van den Berghe H, Borgstrom GH, Brandt L, Catovsky D, de la Chapelle A, Golomb HM, Hossfeld DK, Lawler S, Lindsten J, Louvagie A, Mitelman F, Reeves BR, Rowley JD, Sandberg AA, Teerenhovi L, Vuopio P. Chromosomes in Ph1-positive chronic granulocytic leukemia. First International Workshop on Chromosomes in Leukaemia. Br J Haematol. 1978 Jul;39(3):305-9. 
• van den Berghe H, Borgstrom GH, Brandt L, Catovsky D, de la Chapelle A, Golomb HM, Hossfeld DK, Lawler S, Lindsten J, Louvagie A, Mitelman F, Reeves BR, Rowley JD, Sandberg AA. Chromosomes in acute non-lymphocytic leukaemia. First International Workshop on Chromosomes in Leukaemia. Br J Haematol. 1978 Jul;39(3):311-6. 
• Catovsky D, O’Brien M, Cherchi M, Benavides I. Ultrastructural, cytochemical and surface marker analysis of cells during blast crisis of chronic granulocytic leukaemia. Boll Ist Sieroter Milan. 1978 Jul 31;57(3):344-54.
• Galton DA, Catovsky D, Wiltshaw E. Clinical spectrum of lymphoproliferative diseases. Cancer. 1978 Aug;42(2 Suppl):901-10. 
• Enno A, Catovsky D, Darrell J, Goldman JM, Hows J, Galton DA. Co-trimoxazole for prevention of infection in acute leukaemia. Lancet. 1978 Aug 19;2(8086):395-7. 
• Lampert IA, Catovsky D, Bergier N. Malignant histiocytosis: a clinico-pathological study of 12 cases. Br J Haematol. 1978 Sep;40(1):65-77. 
• Kramers MT, Catovsky D, Foa R. Cell membrane enzymes. II. Alkaline phosphatase and alkaline phosphodiesterase I in normal and leukaemic lymphocytes. Br J Haematol. 1978 Sep;40(1):111-8. 
• Bentley SA, Catovsky D, Lewis SM, Wardle JM. Study of the peripheral blood leucocyte population by Fourier analysis of the cell volume histogram. Acta Cytol. 1978 Sep-Oct;22(5):377-81.
• Frisch B, Lewis SM, Catovsky D. Ultrastructural study of normal and leukaemic leucocyte processes. Biomedicine. 1978 Oct;28(5):264-70.
• Benavides I, Catovsky D. Myeloperoxidase cytochemistry using 2, 7-fluorenediamine. J Clin Pathol. 1978 Nov;31(11):1114-6. 
• Golomb HM, Catovsky D, Golde DW. Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med. 1978 Nov;89(5 Pt 1):677-83. 
• McCarthy D, Catovsky D. Response to doxorubicin in hairy cell leukaemia. Scand J Haematol. 1978 Nov;21(5):445-7. 

1979

• Catovsky D, Costello C. Cytochemistry of normal and leukaemic lymphocytes: a review. Basic Appl Histochem. 1979;23(4):255-70.
• Catovsky D, Costello C, O’Brien M, Cherchi M. Ultrastructure and cell marker studies in lymphoproliferative disorders. Haematol Blood Transfus. 1979;23:107-13. https://doi.org/10.1007/978-3-642-67057-2_13
• Mayans J, Catovsky D, Marty ML. Síntesis de inmunoglobulinas “in vitro” en la leucemia prolinfocitica. Sangre (Barc). 1979;24(1):27-31.
• Enno A, Catovsky D, O’Brien M, Cherchi M, Kumaran TO, Galton DA. ‘Prolymphocytoid’ transformation of chronic lymphocytic leukaemia. Br J Haematol. 1979 Jan;41(1):9-18. 
• Foa R, Kramers MT, Catovsky D. Alkaline phosphatase in human lymphocyte subpopulations. Experientia. 1979 Feb 15;35(2):269-70. 
• McCarthy D, Holland I, Lavender JP, Catovsky D. Pneumatosis coli in adult acute myeloid leukaemia. Clin Radiol. 1979 Mar;30(2):175-8. 
• Hughes GR, Elkon KB, Spiller R, Catovsky D, Jamieson I. Polyarteritis nodosa and hairy-cell leukaemia. Lancet. 1979 Mar 24;1(8117):678. 
• Vicariot M, Goldman JM, Catovsky D, Galton DA. Treatment of chronic granulocytic leukaemia with repeated single doses of busulphan. Eur J Cancer. 1979 Apr;15(4):559-63. 
• Islam A, Catovsky D, Goldman JM, Galton DA. Value of long-core biopsy in detection of discrete bone-marrow lesions. Lancet. 1979 Apr 21;1(8121):878. 
• Pittman S, Catovsky D, Morilla R. Unusual translocations in Ph1-positive acute lymphoblastic leukaemia. Lancet. 1979 May 5;1(8123):986. 
• Goldman JM, Catovsky D, Hows J, Spiers AS, Galton DA. Cryopreserved peripheral blood cells functioning as autografts in patients with chronic granulocytic leukaemia in transformation. Br Med J. 1979 May 19;1(6174):1310-3. 
• Foa R, Catovsky D. T-lymphocyte colonies in normal blood, bone marrow and lymphoproliferative disorders. Clin Exp Immunol. 1979 Jun;36(3):488-95. 
• McLean A, Woods RL, Catovsky D, Farmer P. Pharmacokinetics and metabolism of chlorambucil in patients with malignant disease. Cancer Treat Rev. 1979 Jun;6 Suppl:33-42. 
• Sibbald R, Catovsky D. Complete remission in prolymphocytic leukaemia with the combination chemotherapy—CHOP. Br J Haematol. 1979 Jul;42(3):488-90. 
• Mitelman F, Andersson-Anvret M, Brandt L, Catovsky D, Klein G, Manolov G, Manolova Y, Mark-Vendel E, Nilsson PG. Reciprocal 8;14 translocation in EBV-negative B-cell acute lymphocytic leukemia with Burkitt-type cells. Int J Cancer. 1979 Jul 15;24(1):27-33. 
• Catovsky D. Ph1-positive acute leukaemia and chronic granulocytic leukaemia: one or two diseases? Br J Haematol. 1979 Aug;42(4):493-8. 
• Foa R, Catovsky D, Brozovic M, Marsh G, Ooyirilangkumaran T, Cherchi M, Galton DA. Clinical staging and immunological findings in chronic lymphocytic leukemia. Cancer. 1979 Aug;44(2):483-7. 
• Elkon KB, Hughes GR, Catovsky D, Clauvel JP, Dumont J, Seligmann M, Tannenbaum H, Esdaile J. Hairy-cell leukaemia with polyarteritis nodosa. Lancet. 1979 Aug 11;2(8137):280-2. 
• Catovsky D, Pittman S, O’Brien M, Cherchi M, Costello C, Foa R, Pearce E, Hoffbrand AV, Janossy G, Ganeshaguru K, Greaves MF. Multiparameter studies in lymphoid leukemias. Am J Clin Pathol. 1979 Oct;72(4 Suppl):736-45.
• Hillyard CJ, Oscier DG, Foa R, Catovsky D, Goldman JM. Immunoreactive calcitonin in leukaemia. Br Med J. 1979 Dec 1;2(6202):1392-3. 

1980

• Catovsky D. Leucocyte enzymes in leukaemia. In Roath S, Ed. Topical Reviews in Haematology. Bristol, UK: Wright; 1980: 157‑185.
• Costello C, Catovsky D, O’Brien M, Morilla R, Varadi S. Chronic T-cell leukemias. I. Morphology, cytochemistry and ultrastructure. Leuk Res. 1980;4(5):463-76. 
• Suri R, Goldman JM, Catovsky D, Johnson SA, Wiltshaw E, Galton DA. Priapism complicating chronic granulocytic leukemia. Am J Hematol. 1980;9(3):295-9. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. A variant form of hypergranular promyelocytic leukaemia (M3). Br J Haematol. 1980 Jan;44(1):169-70. 
• Lampert I, Catovsky D, Marsh GW, Child JA, Galton DA. The histopathology of prolymphocytic leukaemia with particular reference to the spleen: a comparison with chronic lymphocytic leukaemia. Histopathology. 1980 Jan;4(1):3-19. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. A variant form of hypergranular promyelocytic leukemia (M3). Ann Intern Med. 1980 Feb;92(2 Pt 1):261. 
• Cherchi M, Catovsky D. Mouse RBC rosettes in chronic lymphocytic leukaemia: different expression in blood and tissues. Clin Exp Immunol. 1980 Feb;39(2):411-5. 
• Lauria F, Foa R, Catovsky D. Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. Scand J Haematol. 1980 Feb;24(2):187-90. 
• Costello C, Catovsky D, O’Brien M, Galton DA. Prolymphocytic leukaemia: an ultrastructural study of 22 cases. Br J Haematol. 1980 Mar;44(3):389-94. 
• Manoharan A, Catovsky D, Goldman JM, Lauria F, Lampert IA, Galton DA. Significance of splenomegaly in childhood acute lymphoblastic leukaemia in remission. Lancet. 1980 Mar 1;1(8166):449-52. 
• Foa R, Catovsky D, Cherchi M, Benavides I, Ganeshaguru K, Hoffbrand AV. Cell surface and enzyme markers of cord blood lymphocytes. Br J Haematol. 1980 Apr;44(4):583-92. 
• Lauria F, Catovsky D. Increased proportion of Fc gamma and Fc mu positive T-lymphocytes following treatment with neuraminidase. Boll Ist Sieroter Milan. 1980 May 31;59(2):143-6.
• O’Brien M, Catovsky D, Costello C. Ultrastructural cytochemistry of leukaemic cells: characterization of the early small granules of monoblasts. Br J Haematol. 1980 Jun;45(2):201-8. 
• Costello C, Wardle J, Catovsky D, Lewis SM. Cell volume studies in B-cell leukaemia. Br J Haematol. 1980 Jun;45(2):209-14.
• Goldman JM, Johnson SA, Islam A, Catovsky D, Galton DA. Haematological reconstitution after autografting for chronic granulocytic leukaemia in transformation: the influence of previous splenectomy. Br J Haematol. 1980 Jun;45(2):223-31. 
• Catovsky D, Bernasconi C, Verdonck PJ, Postma A, Hows J, van der Does-van den Berg A, Rees JK, Castelli G, Morra E, Galton DA. The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients. Br J Haematol. 1980 Aug;45(4):523-34. 
• Islam A, Catovsky D, Galton DA. Histological study of bone marrow regeneration following chemotherapy for acute myeloid leukaemia and chronic granulocytic leukaemia in blast transformation. Br J Haematol. 1980 Aug;45(4):535-40. 
• Foa R, Zafar MN, Catovsky D. Inhibition of T-lymphocyte colony formation by inhibitors of mitochondrial protein synthesis. Immunology. 1980 Sep;41(1):55-8. 
• Foa R, Catovsky D, Lauria F. T-lymphocyte colonies in human cord blood. Exp Hematol. 1980 Oct;8(9):1139-45.
• Foa R, Lauria F, Catovsky D. Evidence that T colony formation is a property of T mu (helper) lymphocytes. Clin Exp Immunol. 1980 Oct;42(1):152-5. 
• Foa R, Catovsky D, Lauria F, Galton DA. Reduced T-colony forming capacity by T-lymphocytes from B-chronic lymphocyte leukaemia. Br J Haematol. 1980 Dec;46(4):623-5. 

1981

• Catovsky D. Acute leukaemias. In Hoffbrand AV, Lewis SM, Eds. Postgraduate Haematology. New York, NY: Appleton-Century-Crofts; 1981:431‑477.
• Catovsky D. Overview. In Catovsky D, Ed. The Leukemic Cell. Edinburgh, UK: Churchill Livingstone; 1981:1‑28.
• Catovsky D, Crockard A, Matutes E, O’Brien M. Cytochemistry of leukaemic cells. In Stoward PJ, Polak JM, Eds. Histochemistry: the widening horizons of its applications in the biomedical sciences. Chichester, UK: Wiley; 1981:67‑87.
• Goldman JM, Johnson SA, Starke ID, Wareham NJ, Catovsky D, Galton DA. Autografting for patients with chronic granulocytic leukaemia in transformation. In Touraine JL, Gluckman E, Griscelli C, Eds. Bone Marrow Transplantation in Europe II. Proceedings of the Fifth European Symposium on Bone Marrow Transplantation, Courchevel, Savoie, France, March 16-18, 1981. Amsterdam, Netherlands: Excerpta Medica; 1981:58‑62.
• Catovsky D, O’Brien M. Lysosomal granules in leukemic monocytes and their relation to maturation stages. Haematol Blood Transfus. 1981;27:167-73. 
• Manoharan A, Catovsky D. Histiocytic medullary reticulosis re-visited. Haematol Blood Transfus. 1981;27:205-10. 
• Ganeshaguru K, Lee N, Llewellin P, Prentice HG, Hoffbrand AV, Catovsky D, Habeshaw JA, Robinson J, Greaves MF. Adenosine deaminase concentrations in leukaemia and lymphoma: relation to cell phenotypes. Leuk Res. 1981;5(3):215-22. 
• Greaves MF, Rao J, Hariri G, Verbi W, Catovsky D, Kung P, Goldstein G. Phenotypic heterogeneity and cellular origins of T cell malignancies. Leuk Res. 1981;5(4-5):281-99. 
• Hughes RG, Islam A, Lewis SM, Catovsky D. Spontaneous remission following bone marrow necrosis in chronic lymphocytic leukaemia. Clin Lab Haematol. 1981;3(2):173-83. 
• Manoharan A, Catovsky D, Lampert IA, Al-Mashadhani, Gordon-Smith EC, Galton DA. Histiocytic medullary reticulosis complicating chronic lymphocytic leukaemia: malignant or reactive? Scand J Haematol. 1981 Jan;26(1):5-13. 
• de Salvo Cardullo L, Morilla R, Catovsky D. Significance of Phi bodies in acute leukaemia. J Clin Pathol. 1981 Feb;34(2):153-7. 
• Foa R, Catovsky D, Lauria F, Zafar MN, Galton DA. T-lymphocytes in B-cell chronic lymphocytic leukaemia. Haematologica. 1981 Feb;66(1):105-16.
• Goldman JM, Johnson SA, Catovsky D, Agnarsdottir G, Goolden AW, Galton DA. Identical twin marrow transplantation for patients with leukemia and lymphoma. Transplantation. 1981 Feb;31(2):140-1. 
• Lauria F, Mantovani V, Catovsky D, Guarini A, Gobbi M, Gugliotta L, Mirone E, Tura S. T gamma cell deficiency in idiopathic thrombocytopenic purpura (ITP). Scand J Haematol. 1981 Feb;26(2):156-60. 
• Goldman JM, Catovsky D, Goolden AW, Johnson SA, Galton DA. Buffy coat autografts for patients with chronic granulocytic leukaemia in transformation. Blut. 1981 Mar;42(3):149-55. 
• Catovsky D, Costello C, Loukopoulos D, Fessas PR, Foxley JM, Traub NE, Mills MJ, O’Brien M. Hairy cell leukemia and myelomatosis: chance association or clinical manifestations of the same B-cell disease spectrum. Blood. 1981 Apr;57(4):758-63. 
• Catovsky D, Lauria F, Matutes E, Foa R, Mantovani V, Tura S, Galton DA. Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia. Br J Haematol. 1981 Apr;47(4):539-44. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol. 1981 Apr;47(4):553-61. 
• Zafar MN, Pittman S, Cherchi M, Catovsky D. Stimulation of chronic lymphatic leukaemia cells by pokeweed mitogen after treatment with neuraminidase-galactose oxidase. Clin Exp Immunol. 1981 Apr;44(1):124-8. 
• Manoharan A, Catovsky D, Clein P, Traub NE, Costello C, O’Brien M, Boralessa H, Galton DA. Simultaneous or spontaneous occurrence of lympho- and myeloproliferative disorders: a report of four cases. Br J Haematol. 1981 May;48(1):111-6. 
• Catovsky D. Prognosis in acute myeloid leukaemia. Br Med J (Clin Res Ed). 1981 Jun 27;282(6282):2134. 
• Binet JL, Catovsky D, Chandra P, Dighiero G, Montserrat E, Rai KR, Sawitsky A. Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system. Report from the International Workshop on CLL. Br J Haematol. 1981 Jul;48(3):365-7. 
• Islam A, Catovsky D, Goldman JM, Galton DA. Histological study of the bone marrow in chronic granulocytic leukaemia in blast transformation. I. Serial observations before and after autografting. Histopathology. 1981 Jul;5(4):339-51. 
• Bain BJ, Catovsky D, O’Brien M, Prentice HG, Lawlor E, Kumaran TO, McCann SR, Matutes E, Galton DA. Megakaryoblastic leukemia presenting as acute myelofibrosis — a study of four cases with the platelet-peroxidase reaction. Blood. 1981 Aug;58(2):206-13. 
• Catovsky D, Cherchi M, Brookss D, Bradely J, Zola H. Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7. Blood. 1981 Aug;58(2):406-8. 
• Catovsky D, Wechsler A, Cherchi M. Characterization of B-cell leukemias: a tentative immunomorphological scheme. Blood. 1981 Aug;58(2):410-1. 
• Foa R, Catovsky D. Inhibitory effect of cyclosporin A on peripheral blood and bone marrow T lymphocyte colony formation. Clin Exp Immunol. 1981 Aug;45(2):371-5. 
• Oscier DG, Catovsky D, Errington RD, Goolden AW, Roberts PD, Galton DA. Splenic irradiation in B-prolymphocytic leukaemia. Br J Haematol. 1981 Aug;48(4):577-84. 
• Islam A, Catovsky D, Goldman JM, Galton DA. Histological study of the bone marrow in chronic granulocytic leukaemia in blast transformation. II. Bone marrow fibre content before and after autografting. Histopathology. 1981 Sep;5(5):491-8. 
• Goldman JM, Johnson SA, Catovsky D, Wareham NJ, Galton DA. Autografting for chronic granulocytic leukemia. N Engl J Med. 1981 Sep 17;305(12):700. 
• Costello C, Catovsky D, O’Brien M. Cytoplasmic inclusions in a case of prolymphocytic leukemia. Am J Clin Pathol. 1981 Oct;76(4):499-501. 
• Catovsky D, de Salvo Cardullo L, O’Brien M, Morilla R, Costello C, Galton D, Ganeshaguru K, Hoffbrand V. Cytochemical markers of differentiation in acute leukemia. Cancer Res. 1981 Nov;41(11 Pt 2):4824-32. 
• Ingoldby CJ, Ackroyd N, Catovsky D, Spencer J. Splenectomy for hairy cell leukaemia. Clin Oncol. 1981 Dec;7(4):325-31.
• Matutes E, Wechsler A, Gomez R, Cherchi M, Catovsky D. Unusual T-cell phenotype in advanced B-chronic lymphocytic leukaemia. Br J Haematol. 1981 Dec;49(4):635-42. 

1982

• Catovsky D. Prolymphocytic and hairy cell leukemias. In Dameshek W, Gunz FW, Henderson ES, Eds. Leukemia. 4th edition. New York, NY: Grune & Stratton; 1982:759‑781.
• Catovsky D. Prolymphocytic leukaemia. Nouv Rev Fr Hematol. 1982;24(6):343-7.
• Catovsky D, Garcia-Talavera J. Enfermedades malignas del sistema fagocítico mononuclear. Sangre (Barc). 1982;27(4-C):819-30.
• Pittman S, Morilla R, Catovsky D. Chronic T-cell leukemias. II. Cytogenetic studies. Leuk Res. 1982;6(1):33-42. 
• Foa R, Lauria F, Catovsky D, Galton DA. Reduced T-colony forming capacity in B-chronic lymphocytic leukaemia.–II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia. Leuk Res. 1982;6(3):329-33. 
• Foa R, Catovsky D, Incarbone E, Cherchi M, Wechsler A, Lusso P, Fierro MT, Giubellino MC, Bernengo MG, Semenzato G. Chronic T-cell leukaemias. III. T-colonies, PHA response and correlation with membrane phenotype. Leuk Res. 1982;6(6):809-14. 
• Starke ID, Donnelly P, Catovsky D, Darrell J, Johnson SA, Goldman JM, Galton DA. Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia. Lancet. 1982 Jan 2;1(8262):5-6. 
• Foa R, Lauria F, Catovsky D. On the causes of hypogammaglobulinaemia in B-CLL. Haematologica. 1982 Feb;67(1):145.
• Thien SL, Catovsky D, Oscier D, Goldman JM, van der Reijden HJ, Melief CJ, Rümke HC, Ten Berge RJ, von dem Borne AE. T-chronic lymphocytic leukaemia presenting as primary hypogammaglobulinaemia–evidence of a proliferation of T-suppressor cells. Clin Exp Immunol. 1982 Mar;47(3):670-6. 
• Catovsky D, Greaves MF, Rose M, Galton DA, Goolden AW, McCluskey DR, White JM, Lampert I, Bourikas G, Ireland R, Brownell AI, Bridges JM, Blattner WA, Gallo RC. Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet. 1982 Mar 20;1(8273):639-43. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982 Jun;51(2):189-99. 
• Catovsky D. Symposium: classification of leukemia. 1. The classification of acute leukemia. Pathology. 1982 Jul;14(3):277-81. 
• Blattner WA, Kalyanaraman VS, Robert-Guroff M, Lister TA, Galton DA, Sarin PS, Crawford MH, Catovsky D, Greaves M, Gallo RC. The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer. 1982 Sep 15;30(3):257-64. 
• Goldman JM, Baughan AS, McCarthy DM, Worsley AM, Hows JM, Gordon-Smith EC, Catovsky D, Batchelor JR, Goolden AW, Galton DA. Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia. Lancet. 1982 Sep 18;2(8299):623-5.
• Catovsky D, Linch DC, Beverley PC. T cell disorders in haematological diseases. Clin Haematol. 1982 Oct;11(3):661-95.
• Crockard A, Chalmers D, Matutes E, Catovsky D. Cytochemistry of acid hydrolases in chronic B- and T-cell leukemias. Am J Clin Pathol. 1982 Oct;78(4):437-44. 
• Liu Yin JA, Catovsky D. Histiocytic medullary reticulosis and acute lymphoblastic leukemia. Lancet. 1982 Oct 9;2(8302):818. 
• Lauria F, Foà R, Gobbi M, Matutes E, Mantovani W, Incarbone E, Tura S, Catovsky D. T lymphocyte subsets and colony growth in hairy-cell leukemia. Ric Clin Lab. 1982 Oct-Dec;12(4):567-72. 
• Catovsky D, Wechsler A, Matutes E, Gomez R, Bourikas G, Cherchi M, Pepys EO, Pepys MB, Kitani T, Hoffbrand AV, Greaves MF. The membrane phenotype of T-prolymphocytic leukaemia. Scand J Haematol. 1982 Nov;29(5):398-404. 
• Matutes E, Catovsky D. The fine structure of normal lymphocyte subpopulations–a study with monoclonal antibodies and the immunogold technique. Clin Exp Immunol. 1982 Nov;50(2):416-25. 
• Zafar MN, O’Brien M, Catovsky D. Similarities in mitochondrial ultrastructure of leukemic cells and ethidium-bromide-treated normal cells. J Ultrastruct Res. 1982 Nov;81(2):133-8. 

1983

• Catovsky D. Leukemia and myeloma. In Pinedo HM, Chabner BA, Eds. Cancer Chemotherapy. Annual 5. Oxford, UK: Elsevier; 1983:217‑247.
• Galton DA, Goldman JM, Catovsky D. The treatment of chronic granulocytic leukaemia. In Hollán SR, Ed. Recent advances in haematology, immunology, and blood transfusion: proceedings of the plenary sessions of the joint meeting of the 19th congress of the International Society of Haematology and the 17th congress of the International Society of Blood Transfusion, Budapest, August 1982. Chichester, UK: Wiley; 1983:197‑209.
• Catovsky D, San Miguel JF, Soler J, Matutes E, Melo JV, Bourikas G, Haynes BF. T cell leukaemias. Immunologic and clinical aspects. J Exp Clin Cancer Res. 1983;2:229‑233.
• Crockard AD, O’Brien M, Robinson D, Tavares de Castro J, Matutes E, Catovsky D. Morphological and cytochemical features of adult T-cell lymphoma-leukaemia. Haematol Blood Transfus. 1983;28:131-4. 
• McCarthy DM, San Miguel JF, Freake HC, Green PM, Zola H, Catovsky D, Goldman JM. 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk Res. 1983;7(1):51-5. 
• Matutes E, Robinson D, O’Brien M, Haynes BF, Zola H, Catovsky D. Candidate counterparts of Sézary cells and adult T-cell lymphoma-leukaemia cells in normal peripheral blood: an ultrastructural study with the immunogold method and monoclonal antibodies. Leuk Res. 1983;7(6):787-801. 
• Mehta AB, Catovsky D, O’Brien CJ, Lott M, Bowley N, Hemmingway A. Massive retroperitoneal lymphadenopathy as a terminal event in hairy cell leukaemia. Clin Lab Haematol. 1983;5(3):259-63. 
• Robert-Guroff M, Kalyanaraman VS, Blattner WA, Popovic M, Sarngadharan MG, Maeda M, Blayney D, Catovsky D, Bunn PA, Shibata A, Nakao Y, Ito Y, Aoki T, Gallo RC. Evidence for human T cell lymphoma-leukemia virus infection of family members of human T cell lymphoma-leukemia virus positive T cell leukemia-lymphoma patients. J Exp Med. 1983 Jan 1;157(1):248-58. 
• Yin JA, Kumaran TO, Marsh GW, Rossiter M, Catovsky D. Complete recovery of histiocytic medullary reticulosis-like syndrome in a child with acute lymphoblastic leukemia. Cancer. 1983 Jan 15;51(2):200-2. 
• Bloomfield CD, Rowley JD, Goldman AI, Lawler SD, Secker LM, Walker M, Mitelman F, Alimena G, Berger R, Borgstrom GH, Brandt L, Catovsky D, de la Chapelle A, Dewald GW, Garson OM, Garwicz S, Golomb HM, Hossfeld DK, Nilsson P, Pierre RJ, Philip P, Prigogina E, Sakurai M, Sandberg AA, Tricot G, Van Den Berghe H, Van Orshoven A, Vuopio P, Whang-Peng J. Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Third International Workshop on Chromosomes in Leukemia. Cancer Res. 1983 Feb;43(2):868-73. 
• Crockard AD, Macfarlane E, Jess H, Catovsky D. Correlation of lymphocyte beta-glucuronidase and N-acetyl-beta-glucosaminidase with E-rosette formation. Histochem J. 1983 Feb;15(2):179-83. 
• Mehta AB, Baughan AS, Catovsky D, Goldman JM, Johnson SA, Galton DA. Reversal of marrow fibrosis in acute megakaryoblastic leukaemia after remission-induction and consolidation chemotherapy followed by bone marrow transplantation. Br J Haematol. 1983 Mar;53(3):445-9. 
• Matutes E, San Miguel JF, Catovsky D. Marcadores de membrana en las enfermedades linfoproliferativas crónicas. Med Clin (Barc). 1983 Mar 5;80(7):334-50.
• Goolden AW, Goldman JM, Kam KC, Dunn PA, Baughan AS, McCarthy DM, Worsley AM, Gordon-Smith EC, Samson D, Catovsky D, Galton DA. Fractionation of whole body irradiation before bone marrow transplantation for patients with leukaemia. Br J Radiol. 1983 Apr;56(664):245-50. 
• Bain B, Manoharan A, Lampert I, McKenzie C, Catovsky D. Lymphoma-like presentation of acute monocytic leukaemia. J Clin Pathol. 1983 May;36(5):559-65. 
• Crockard A, Catovsky D. Cytochemistry of normal lymphocyte subsets defined by monoclonal antibodies and immunocolloidal gold. Scand J Haematol. 1983 May;30(5):433-43. 
• O’Brien C, Lampert IA, Catovsky D. The histopathology of adult T-cell lymphoma/leukaemia in blacks from the Caribbean. Histopathology. 1983 May;7(3):349-64. 
• Njoku OS, Lewis SM, Catovsky D, Gordon-Smith EC. Anaemia in myelofibrosis: its value in prognosis. Br J Haematol. 1983 May;54(1):79-89. 
• Lauria F, Foa R, Mantovani V, Fierro MT, Catovsky D, Tura S. T-cell functional abnormality in B-chronic lymphocytic leukaemia: evidence of a defect of the T-helper subset. Br J Haematol. 1983 Jun;54(2):277-83. 
• Gallo RC, Kalyanaraman VS, Sarngadharan MG, Sliski A, Vonderheid EC, Maeda M, Nakao Y, Yamada K, Ito Y, Gutensohn N, Murphy S, Bunn PA Jr, Catovsky D, Greaves MF, Blayney DW, Blattner W, Jarrett WF, zur Hausen H, Seligmann M, Brouet JC, Haynes BF, Jegasothy BV, Jaffe E, Cossman J, Broder S, Fisher RI, Golde DW, Robert-Guroff M. Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res. 1983 Aug;43(8):3892-9. 
• Pittman S, Catovsky D. Chromosome abnormalities in B-cell prolymphocytic leukemia: a study of nine cases. Cancer Genet Cytogenet. 1983 Aug;9(4):355-65. 
• Matutes E, Carrington D, Hegde U, Catovsky D. C-type particles in cells from T-cell lymphoma/leukaemia after 5-7 days culture. Lancet. 1983 Aug 6;2(8345):335-6. 
• Matutes E, Crockard AD, O’Brien M, Catovsky D. Ultrastructural cytochemistry of chronic T-cell leukaemias. A study with four acid hydrolases. Histochem J. 1983 Sep;15(9):895-909. 
• Foa R, Lauria F, Raspadori D, Lusso P, Ferrando ML, Fierro MT, Giubellino MC, Catovsky D. Normal helper T-cell function in hairy-cell leukaemia. Scand J Haematol. 1983 Oct;31(4):322-8. 
• Golomb HM, Catovsky D, Golde DW. Hairy cell leukemia: a five-year update on seventy-one patients. Ann Intern Med. 1983 Oct;99(4):485-6. 
• Matutes E, Crockard AD, Catovsky D. The ultrastructural morphology of T lymphocytes in B-chronic lymphocytic leukaemia: a study with monoclonal antibodies and the immunogold technique. Br J Haematol. 1983 Oct;55(2):273-83. 
• Catovsky D, Tavares de Castro J. The classification of acute leukaemia (AL) and its clinical significance. Schweiz Med Wochenschr. 1983 Oct 8;113(40):1434-7.
• Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DA. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet. 1983 Dec 24-31;2(8365-66):1452-4. 

1984

• Catovsky D. Blood cell cytochemistry and supplementary techniques. In Dacie JV, Lewis SM, Eds. Practical Haematology. 6th edition. Edinburgh, UK: Churchill Livingstone; 1984:84‑116.
• Catovsky D. Chronic lymphocytic, prolymphocytic and hairy cell leukaemias. In Goldman JM, Preisler HD, Eds. Leukemias. London, UK: Butterworths; 1984:266‑298.
• Catovsky D. Leukemia and myeloma. In Pinedo HM, Chabner BA, Eds. Cancer Chemotherapy. Annual 6. Amsterdam, Netherlands: Elsevier; 1984:200‑231.
• Catovsky D, O’Brien C, Lampert I, Crockard AD, Johnson SAN, Francis GE, Sharp J, Galton DAG. Diagnostic features of adult T‑cell lymphoma‑leukemia. In Magrath IT, O’Connor GT, Ramot B. Pathogenesis of Leukemias and Lymphomas: Environmental Influences. New York, NY: Raven Press; 1984:105‑117.
• Catovsky D, Matutes E, Crockard AD, O’Brien M, Costello C. Prolymphocytic leukemia of B and T cell types. Morphological differences by light and electron microscopy. In Polliack A, Ed. Human Leukemias: Cytochemical and Ultrastructural Techniques in Diagnosis and Research. Boston, MA: Nijhoff; 1984:251‑259.
• Matutes E, Robinson D, Catovsky D. Ultrastructural analysis of normal B and T lymphocyte subsets with the immunogold technique. In Polliack A, Ed. Human Leukemias: Cytochemical and Ultrastructural Techniques in Diagnosis and Research. Boston, MA: Nijhoff; 1984:261‑270.
• Goldman JM, Wyatt SE, Baughan ASJ, Cranfield T, McCarthy DM, Worsley AM, Yin J, Reid CD, Catovsky D, Gordon‑Smith EC, Galton DA. Allogeneic bone marrow transplantation (BMT) for chronic granulocytic leukaemia (CGL). Exp Hematol. 1984;12(Suppl 15):34‑35.
• Islam A, Catovsky D, Goldman JM, Galton DA. Studies on cellular interactions between stromal and haemopoietic stem cells in normal and leukaemic bone marrows. Bibl Haematol. 1984;(50):17-30. 
• Matutes E, Brito-Babapulle V, Catovsky D. Clinical, immunological, ultrastructural, and cytogenetic studies in black patients with adult T-cell leukemia/lymphoma. Princess Takamatsu Symp. 1984;15:59-70.
• Amaki I, Hattori K, Bennett JM, Yoshida T, Tomonaga M, Ogawa T, Catovsky D, Shimoyama M, Ohshima T, Fujimoto T, Kamada N. Proceedings of the international round table conference: FAB classification of acute leukemias correlating with response to chemotherapy. Nihon Ketsueki Gakkai Zasshi. 1984 Feb;47(1):206-38.
• Foroni L, Catovsky D, Rabbitts TH, Luzzatto L. DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies. Mol Biol Med. 1984 Feb;2(1):63-79.
• Miedema F, Terpstra FG, Smit JW, Daenen S, Gerrits W, Hegde U, Matutes E, Catovsky D, Greaves MF, Melief CJ. Functional properties of neoplastic T cells in adult T cell lymphoma/leukemia patients from the Caribbean. Blood. 1984 Feb;63(2):477-81. 
• Baughan AS, Worsley AM, McCarthy DM, Hows JM, Catovsky D, Gordon-Smith EC, Galton DA, Goldman JM. Haematological reconstitution and severity of graft-versus-host disease after bone marrow transplantation for chronic granulocytic leukaemia: the influence of previous splenectomy. Br J Haematol. 1984 Mar;56(3):445-54. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Myelodysplastic syndromes: is another classification necessary? Br J Haematol. 1984 Mar;56(3):515-7. 
• Donnelly JP, Starke ID, Galton DA, Catovsky D, Goldman JM, Darrell JH. Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia. J Hosp Infect. 1984 Mar;5(1):83-91. 
• Islam A, Catovsky D, Goldman JM, Galton DA. Histomorphological study of cellular interactions between stromal and haemopoietic stem cells in normal and leukaemic bone marrow. Histopathology. 1984 Mar;8(2):293-313. 
• Rowe IF, Worsley AM, Donnelly P, Catovsky D, Goldman JM, Galton D, Pepys MB. Measurement of serum C reactive protein concentration after bone marrow transplantation for leukaemia. J Clin Pathol. 1984 Mar;37(3):263-6. 
• Starke ID, de Beer FC, Donnelly JP, Catovsky D, Goldman JM, Galton DA, Pepys MB. Serum C-reactive protein levels in the management of infection in acute leukaemia. Eur J Cancer Clin Oncol. 1984 Mar;20(3):319-25. 
• Vardiman J, Catovsky D, Flandrin GR, Pierre R. Fourth International Workshop on Chromosomes in Leukemia 1982: Correlation between morphology and karyotype. Cancer Genet Cytogenet. 1984 Mar;11(3):275-81. 
• Matutes E, Catovsky D. Retrovirus y leucemia. Med Clin (Barc). 1984 Mar 17;82(10):448-50.
• Marcus RE, Catovsky D, Goldman JM, Worsley AM, Galton DA. Maintenance and consolidation therapy in AML. Lancet. 1984 Mar 24;1(8378):686-7. 
• Melo JV, Catovsky D, Bodger M. Reactivity of the monoclonal antibody RFB1 in chronic B-cell leukaemias. Scand J Haematol. 1984 Apr;32(4):417-22. 
• Robinson D, Tavares de Castro J, Polli N, O’Brien M, Catovsky D. Simultaneous demonstration of membrane antigens and cytochemistry at ultrastructural level: a study with the immunogold method, acid phosphatase and myeloperoxidase. Br J Haematol. 1984 Apr;56(4):617-31. 
• Tavares de Castro J, San Miguel JF, Soler J, Catovsky D. Method for the simultaneous labelling of terminal deoxynucleotidyl transferase (TdT) and membrane antigens. J Clin Pathol. 1984 Jun;37(6):628-32. 
• Worsley AM, Catovsky D, Goldman JM, Galton DA. New combination chemotherapy for relapsed acute myeloid leukaemia. Lancet. 1984 Jun 2;1(8388):1232. 
• McCarthy D, Hibbin J, Matutes E, Daniel P, Catovsky D, Goldman JM. 1,25-Dihydroxyvitamin D3 and myelofibrosis. Lancet. 1984 Jun 9;1(8389):1298. 
• McCarthy D, Hibbin J, San Miguel JF, Freake H, Rodrigues B, Andrews C, Pinching A, Catovsky D, Goldman JM. The effect of vitamin D3 metabolites on normal and leukemic bone marrow cells in vitro. Int J Cell Cloning. 1984 Jul;2(4):227-42. 
• Brito-Babapulle V, Matutes E, Hegde U, Catovsky D. Adult T-cell lymphoma/leukemia in a Caribbean patient: cytogenetic, immunologic, and ultrastructural findings. Cancer Genet Cytogenet. 1984 Aug;12(4):343-57. 
• Polliack A, Leizerowitz R, Berrebi A, Gamliel H, Galili N, Gurfel D, Catovsky D. Prolymphocytic leukaemia: surface morphology in 21 cases as seen by scanning electron microscopy and comparison with B-type CLL and CLL in ‘prolymphocytoid’ transformation. Br J Haematol. 1984 Aug;57(4):577-84. 
• Crockard AD, MacFarlane E, Andrews C, Bridges JM, Catovsky D. Dipeptidylaminopeptidase IV activity in normal and leukemic T-cell subpopulations. Am J Clin Pathol. 1984 Sep;82(3):294-9. 
• Skinnider L, Catovsky D, Incarbone E. The effect of tetradecanoyl-12, 13-phorbol acetate on ‘hairy’ cells. Scand J Haematol. 1984 Sep;33(3):301-8. 
• Goldman JM, Gordon-Smith EC, Catovsky D, Galton D, Reid C. Timing of transplant for CML patients. Blood. 1984 Oct;64(4):945-6. https://doi.org/10.1182/blood.V64.4.945.945
• Polli N, Zola H, Catovsky D. Characterization by ultrastructural cytochemistry of normal and leukemic myeloid cells reacting with monoclonal antibodies. Am J Clin Pathol. 1984 Oct;82(4):389-95. 
• Stewart JS, Matutes E, Lampert IA, Goolden AW, Catovsky D. HTLV-I-positive T-cell lymphoma/leukaemia in an African resident in UK. Lancet. 1984 Oct 27;2(8409):984-5. 
• Islam A, Catovsky D, Goldman JM, Galton DA. Bone marrow fibre content in acute myeloid leukaemia before and after treatment. J Clin Pathol. 1984 Nov;37(11):1259-63. 
• Newland AC, Catovsky D, Linch D, Cawley JC, Beverley P, San Miguel JF, Gordon-Smith EC, Blecher TE, Shahriari S, Varadi S. Chronic T cell lymphocytosis: a review of 21 cases. Br J Haematol. 1984 Nov;58(3):433-46. 
• San Miguel JF, McCarthy DM, Rodriques B, Freake HC, Zola H, Goldman JM, Catovsky D. Changes in surface antigens of HL-60 cells during differentiation in vitro. Blut. 1984 Nov;49(5):369-73. 
• Catovsky D, O’Brien M, Melo JV, Wardle J, Brozovic M. Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemia. Semin Oncol. 1984 Dec;11(4):362-9.
• Melo JV, San Miguel JF, Moss VE, Catovsky D. The membrane phenotype of hairy cell leukemia: a study with monoclonal antibodies. Semin Oncol. 1984 Dec;11(4):381-5.
• Pittman S, Catovsky D. Prognostic significance of chromosome abnormalities in chronic lymphocytic leukaemia. Br J Haematol. 1984 Dec;58(4):649-60. 
• Haines ME, Goldman JM, Worsley AM, McCarthy DM, Wyatt SE, Dowding C, Kearney L, Th’ng KH, Wareham NJ, Pollock A, Galvin MC, Samson D, Geary CG, Catovsky D, Galton DA. Chemotherapy and autografting for chronic granulocytic leukaemia in transformation: probable prolongation of survival for some patients. Br J Haematol. 1984 Dec;58(4):711-21. 
• Wyatt SE, Nunn P, Hows JM, Yin J, Hayes MC, Catovsky D, Gordon-Smith EC, Hughes JM, Goldman JM, Galton D. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax. 1984 Dec;39(12):887-94. 
• Brito-Babapulle V, Melo JV, Foroni L, Robinson D, Parreira L, Brozovic M, Catovsky D. Neoplastic kappa and lambda cells in a B-PLL with chromosome translocations of both light chain gene regions. Int J Cancer. 1984 Dec 15;34(6):769-73. 

1985

• Catovsky D. Leukemia and myeloma. In Pinedo HM, Chabner BA, Eds. Cancer Chemotherapy. Annual 7. Amsterdam, Netherlands: Elsevier; 1985:209‑236.
• Catovsky D, Melo JV, Matutes E. Biological markers in lymphoproliferative disorders. In Bloomfield CD, Ed. Chronic and Acute Leukemias in Adults. Boston, MA: Martinus Nijhoff; 1985:69‑112. https://www.springer.com/us/book/9780898387025
• Matutes E, Brito-Babapulle V, Catovsky D. Clinical, immunological, ultrastructural, and cytogenetic studies in black patients with adult T-cell leukemia/lymphoma. In Miwa M, Sugano H, Sugimura T, Weiss RA, Eds. Retroviruses in Human Lymphoma/Leukemia. Tokyo, Japan: Japan Scientific Societies Press; 1985:59-70.
• Tavares de Castro J, Robinson D, Stein H, Catovsky D. Normal counterparts of Hodgkin’s disease and lymphoid malignancies studied with the immunogold method. In Grignani F, Martelli MF, Mason DY, Eds. Monoclonal Antibodies in Haematopathology. New York, NY: Raven Press; 1985:319‑328.
• Matutes E, Catovsky D. Ultrastructural analysis of normal and leukaemic cells by the immunogold method and monoclonal antibodies. Haematol Blood Transfus. 1985;29:174-9. 
• Shibata A, Bennett JM, Castoldi GL, Catovsky D, Flandrin G, Jaffe ES, Katayama I, Nanba K, Schmalzl F, Yam LT, Lewis SM. Recommended methods for cytological procedures in haematology. International Committee for Standardization in Haematology (ICSH). Clin Lab Haematol. 1985;7(1):55-74. 
• Keidan AJ, Catovsky D, Tavares de Castro J, Spry CJ. Hypereosinophilic syndrome preceding T cell lymphoblastic lymphoma. Clin Lab Haematol. 1985;7(1):83-8. 
• Pereira AM, Tavares de Castro J, Santos EG, Perloiro MC, Catovsky D. T lymphoblastic transformation of refractory anaemia with excess of blasts. Clin Lab Haematol. 1985;7(1):89-95. 
• Mehta AB, Tavares De Castro J, San Miguel JF, Yin JA, O’Brien M, Kearney L, Catovsky D. Osteolytic lesion as the presenting feature of chronic granulocytic leukaemia. Clin Lab Haematol. 1985;7(2):105-12. 
• Andrews C, Crockard AD, San Miguel JF, Catovsky D. Dipeptidylaminopeptidase IV (DAP IV) in B- and T-cell leukaemias. Clin Lab Haematol. 1985;7(4):359-68. 
• Tindle RW, Nichols RA, Chan L, Campana D, Catovsky D, Birnie GD. A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res. 1985;9(1):1-9. 
• Polli N, O’Brien M, Tavares de Castro J, Rodriguez B, McCarthy D, Catovsky D. Monocytic differentiation induced by 1,25 dihydroxyvitamin D3 in myeloid cells: an ultrastructural immunocytochemical study. Leuk Res. 1985;9(2):259-70. 
• Robinson DS, Posnett DN, Zola H, Catovsky D. Normal counterparts of hairy cells and B-prolymphocytes in the peripheral blood. An ultrastructural study with monoclonal antibodies and the immunogold method. Leuk Res. 1985;9(3):335-48. 
• Woods GM, Sawyer PJ, Kirov SM, Lowenthal RM, Jupe DM, Catovsky D. Functional and phenotypic analysis of a T cell prolymphocytic leukemia. Leuk Res. 1985;9(5):587-96.
• Polli N, O’Brien M, Tavares de Castro J, Matutes E, San Miguel JF, Catovsky D. Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia. I. Ultrastructural morphology and cytochemistry. Br J Haematol. 1985 Feb;59(2):277-96. 
• San Miguel JF, Tavares de Castro J, Matutes E, Rodriguez B, Polli N, Zola H, McMichael AJ, Bollum FJ, Thompson DS, Goldman JM, Catovsky D. Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia. II. Studies with monoclonal antibodies and terminal transferase. Br J Haematol. 1985 Feb;59(2):297-309. 
• Soler J, O’Brien M, de Castro JT, Miguel JF, Kearney L, Goldman JM, Catovsky D. Blast crisis of chronic granulocytic leukemia with mast cell and basophilic precursors. Am J Clin Pathol. 1985 Feb;83(2):254-9. 
• Dharmasena FM, Davies GS, Catovsky D. Paecilomyces varioti pneumonia complicating hairy cell leukaemia. Br Med J (Clin Res Ed). 1985 Mar 30;290(6473):967-8. 
• Morgan MA, Scott CS, Tavares de Castro J, Limbert HJ, Polli N, Catovsky D, Pyrah RD, Roberts BE. Biphenotypic leukaemia: a case of mixed T lymphoblastic and myeloblastic leukaemia. J Clin Pathol. 1985 May;38(5):575-81. 
• Apostolov K, Barker W, Catovsky D, Goldman J, Matutes E. Reduction in the stearic to oleic acid ratio in leukaemic cells–a possible chemical marker of malignancy. Blut. 1985 Jun;50(6):349-54. 
• Marcus RE, Catovsky D, Goldman JM, Galton DA, Newland AC, Slocombe G, Hegde U. Mitozantrone and high-dose cytarabine in adult acute myeloid leukaemia. Lancet. 1985 Jun 15;1(8442):1384. 
• Zola H, Moore HA, Hunter IK, Hohmann A, McNamara PJ, Bradley J, Muir P, Morley A, Melo JV, Catovsky D. The human leucocyte P30 antigen: properties and assessment of value as a clonal marker. Tissue Antigens. 1985 Jul;26(1):60-70. 
• Matutes E, Rodriguez B, Polli N, Tavares de Castro J, Parreira A, Andrews C, Griffin JD, Tindle RW, Catovsky D. Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9. Hematol Oncol. 1985 Jul-Sep;3(3):179-86.
• Melo JV, Foroni L, Brito Babapulle V, Lewis DS, Bennett M, Robinson D, Parreira L, Luzzatto L, Catovsky D. Prolymphocytic leukemia of B cell type: rearranged immunoglobulin (Ig) genes with defective Ig production. Blood. 1985 Aug;66(2):391-8. 
• Robinson DS, Melo JV, Andrews C, Schey SA, Catovsky D. Intracytoplasmic inclusions in B prolymphocytic leukaemia: ultrastructural, cytochemical, and immunological studies. J Clin Pathol. 1985 Aug;38(8):897-903. 
• Worman CP, Catovsky D, Bevan PC, Camba L, Joyner M, Green PJ, Williams HJ, Bottomley JM, Gordon-Smith EC, Cawley JC. Interferon is effective in hairy-cell leukaemia. Br J Haematol. 1985 Aug;60(4):759-63. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med. 1985 Sep;103(3):460-2.
• Islam A, Catovsky D, Goldman JM, Galton DA. Bone marrow biopsy changes in acute myeloid leukaemia. I: Observations before chemotherapy. Histopathology. 1985 Sep;9(9):939-57. 
• Marcus RE, Matutes E, Drysdale H, Catovsky D. Phenotypic conversion of TdT+ adult AML to CALLA+ ALL. Scand J Haematol. 1985 Sep;35(3):343-7. 
• Rabbitts TH, Stinson A, Forster A, Foroni L, Luzzatto L, Catovsky D, Hammarström L, Smith CI, Jones D, Karpas A, Minowada J, Taylor AMR. Heterogeneity of T-cell beta-chain gene rearrangements in human leukaemias and lymphomas. EMBO J. 1985 Sep;4(9):2217-24. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985 Oct;103(4):620-5. 
• Catovsky D, Matutes E, Moss V, Brito-Babapulle V. T-cell leukaemias with “helper” phenotype in adults. Lancet. 1985 Oct 26;2(8461):945-6. 
• Donnelly JP, Marcus RE, Goldman JM, Cohen J, Worsley AM, Catovsky D, Darrell JH, Want SV, Galton DA. Ceftazidime as first-line therapy for fever in acute leukaemia. J Infect. 1985 Nov;11(3):205-15. 
• Parreira A, Robinson DS, Melo JV, Ayliffe M, Ball S, Hegde U, Baughan A, Fairhead S, Talavera JG, Katzmann JA, Catovsky D. Primary plasma cell leukaemia: immunological and ultrastructural studies in 6 cases. Scand J Haematol. 1985 Nov;35(5):570-8. 
• Matutes E, Parreira A, Foa R, Catovsky D. Monoclonal antibody OKT17 recognizes most cases of T-cell malignancy. Br J Haematol. 1985 Dec;61(4):649-56. 
• Miedema F, van Oostveen JW, Terpstra FG, van den Wall Bake AW, Willemze R, Rauws EA, Bieger R, van ‘t Veer MB, Catovsky D, Melief CJ. Analysis of helper activity on pokeweed mitogen- and interleukin 2-driven immunoglobulin synthesis by neoplastic T4+ cells. J Clin Invest. 1985 Dec;76(6):2139-43. 
• Parreira L, Matutes E, Marcus RE, Brito-Babapulle V, Parreira A, Goldman JM, Galton DA, Catovsky D. Atypical promyelocytic leukemia (M3) with immature primary granules and t(15;17). Cancer Genet Cytogenet. 1985 Dec;18(4):315-24. 

1986

• Catovsky D. Leukaemia and myeloma. In Pinedo HM, Chabner BA, Eds. Cancer Chemotherapy. Annual 8. Amsterdam, Netherlands: Elsevier; 1986:224‑261.
• Brito-Babapulle V, Pittman S, Melo JV, Parreira L, Catovsky D. The 14q+ marker in hairy cell leukaemia. A cytogenetic study of 15 cases. Leuk Res. 1986;10(2):131-8. 
• Dharmasena F, Littlewood T, Gordon-Smith EC, Catovsky D, Galton DA. Adult acute lymphoblastic leukaemia presenting with bone marrow aplasia. Clin Lab Haematol. 1986;8(4):361-4. 
• Haines ME, Catovsky D, Galton DA. Remission of the nephrotic syndrome associated with chronic lymphocytic leukaemia. Clin Lab Haematol. 1986;8(4):366-8. 
• Goldman JM, Apperley JF, Jones L, Marcus R, Goolden AWG, Batchelor R, Hale G, Waldmann H, Reid CD, Hows J, Gordon‑Smith E, Catovsky D, Galton DAG. Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med. 1986 Jan 23;314(4):202‑7. 
• Bloomfield CD, Goldman AI, Alimena G, Berger R, Borgström GH, Brandt L, Catovsky D, de la Chapelle A, Dewald GW, Garson OM, Garwicz S, Golomb HM, Hossfeld DK, Lawler SD, Mitelman F, Nilsson P, Pierre RV, Philip P, Prigogina E, Rowley JD, Sakurai M, Sandberg AA, Secker Walker LM, Tricot G, Van Den Berghe H, Van Orshoven A, Vuopio P, Whang‑Peng J. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood. 1986 Feb;67(2):415-20. 
• Brito-Babapulle V, Matutes E, Parreira L, Catovsky D. Abnormalities of chromosome 7q and Tac expression in T cell leukemias. Blood. 1986 Feb;67(2):516-21. 
• Marcus RE, Catovsky D, Johnson SA, Gregory WM, Talavera JG, Goldman JM, Galton DA. Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten year period. Br J Cancer. 1986 Feb;53(2):175-80. 
• Matutes E, Brito-Babapulle V, Foroni L, Catovsky D. The nature of T-chronic lymphocytic leukaemia. Br J Haematol. 1986 Feb;62(2):402-3. 
• Moss VE, Miedema F, Matutes E, Terpstra F, Brownell A, Brozovic M, Catovsky D. An unusual variant of T-CLL: evidence for the existence of a hitherto unrecognized T cell subset. Clin Exp Immunol. 1986 Feb;63(2):303-11. 
• Catovsky D. Hairy cell leukemia: 1986. Br Med J (Clin Res Ed). 1986 Mar 22;292(6523):786. 
• Parreira L, Tavares de Castro J, Hibbin JA, Marsh JC, Marcus RE, Babapulle VB, Spry CJ, Goldman JM, Catovsky D. Chromosome and cell culture studies in eosinophilic leukaemia. Br J Haematol. 1986 Apr;62(4):659-69. 
• Apperley JF, Jones L, Hale G, Waldmann H, Hows J, Rombos Y, Tsatalas C, Marcus RE, Goolden AW, Gordon-Smith EC, Catovsky D, Galton DAG, Goldman JM. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant. 1986 May;1(1):53-66.
• Parreira L, Kearney L, Rassool F, Babapulle VB, Matutes E, Parreira A, Tavares de Castro J, Goldman JM, Catovsky D. Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGL. Cancer Genet Cytogenet. 1986 May;22(1):29-34.
• Zwi LJ, Evans DJ, Wechsler AL, Catovsky D. Splenic angiosarcoma following chemotherapy for follicular lymphoma. Hum Pathol. 1986 May;17(5):528-30. 
• Melo JV, Catovsky D, Galton DA. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol. 1986 Jun;63(2):377-87. 
• San Miguel JF, Foroni L, González M, del Cañizo MC, Salazar J, Rios A, Matutes E, Catovsky D. Coexpression of T- and B-markers in a lymphoproliferative disorder. Scand J Haematol. 1986 Jul;37(1):10-7. 
• Matutes E, Dalgleish AG, Weiss RA, Joseph AP, Catovsky D. Studies in healthy human T-cell-leukemia lymphoma virus (HTLV-I) carriers from the Caribbean. Int J Cancer. 1986 Jul 15;38(1):41-5. 
• Melo JV, Catovsky D, Galton DA. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of ‘prolymphocytoid’ transformation. Br J Haematol. 1986 Sep;64(1):77-86. 
• Matutes E, Garcia Talavera J, O’Brien M, Catovsky D. The morphological spectrum of T-prolymphocytic leukaemia. Br J Haematol. 1986 Sep;64(1):111-24. 
• Laffan MA, Talavera JG, Catovsky D. Hypercalcaemia in T cell acute lymphoblastic leukaemia: report of two cases. J Clin Pathol. 1986 Oct;39(10):1143-6. 
• Melo JV, Brito-Babapulle V, Foroni L, Robinson DS, Luzzatto L, Catovsky D. Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. Int J Cancer. 1986 Oct 15;38(4):531-8. 
• Pombo de Oliveira MS, Awad el Seed FE, Foroni L, Matutes E, Morilla R, Luzzatto L, Catovsky D. Lymphoblastic leukaemia in Siamese twins: evidence for identity. Lancet. 1986 Oct 25;2(8513):969-70. 
• Bennett JM, Berger R, Catovsky D, Chan L, Flandrin G, Minowada J, Mitelman F, Preud’homme J-L, Sandberg AA, Van den Berghe H, Williams D. Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Report of the workshop held in Leuven, Belgium, April 22-23, 1985. First MIC Cooperative Study Group. Cancer Genet Cytogenet. 1986 Nov;23(3):189-97. 
• Dharmasena F, Englert H, Catovsky D, Galton DA, Drysdale HC. Incomplete Reiter’s syndrome following chemotherapy of acute myeloid leukaemia. Postgrad Med J. 1986 Nov;62(733):1045-6. 
• Melo JV, Wardle J, Chetty M, England J, Lewis SM, Galton DA, Catovsky D. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. III. Evaluation of cell size by morphology and volume measurements. Br J Haematol. 1986 Nov;64(3):469-78. 
• Daly P, Brito-Babapulle V, Lawlor E, Blaney C, Parreira A, Catovsky D. Variant translocation t(8;22) and abnormalities of chromosome 15(q22) and 17(q12-21) in a Burkitt’s lymphoma/leukaemia with disseminated intravascular coagulation. Br J Haematol. 1986 Nov;64(3):561-9. 
• Dharmasena F, Wickham N, McHugh PJ, Catovsky D, Galton DA. Osteolytic tumors in acute megakaryoblastic leukemia. Cancer. 1986 Nov 15;58(10):2273-7. 

1987

• Catovsky D, Matutes E. The classification of T‑cell leukemias. In Rai KR, Gale RP, eds. Chronic Lymphocytic Leukemia: Recent Progress and Future Direction. UCLA Symposium on Molecular and Cellular Biology, New Series, vol. 59. New York, NY: Alan R. Liss; 1987:163‑176.
• Brito-Babapulle V, Pittman S, Melo JV, Pomfret M, Catovsky D. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia. Hematol Pathol. 1987;1(1):27-33.
• Catovsky D. Leukemia and myelomatosis. Cancer Chemother Biol Response Modif. 1987;9:134-64.
• Gallhofer G, Melo JV, Spencer J, Catovsky D. Splenectomy in advanced chronic lymphocytic leukaemia. Acta Haematol. 1987;77(2):78-82. 
• Ganeshaguru K, Ho AD, Piga A, Catovsky D, Hoffbrand AV. Biochemical mechanisms of deoxycoformycin toxicity in chronic leukemias. Leuk Res. 1987;11(10):941-5. 
• Marcus RE, Catovsky D, Prentice HG, Newland AC, Chessells JM, Stevens RF, Hann IM, Goldman JM, Hoffbrand AV, Galton DA. Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985. Haematol Blood Transfus. 1987;30:346-51. 
• Melo JV, Catovsky D, Galton DA. Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal. Blood Cells. 1987;12(2):339-53.
• Stünkel KG, Thiel E, Opitz HG, Schlumberger HD, Opitz U, Catovsky D, Klimetzek V. Monoclonal antibodies detecting plasminogen activators on the membrane of leukemic lymphoid cells of T-cell origin. Cancer Detect Prev Suppl. 1987;1:269-77.
• Melo JV, Catovsky D, Gregory WM, Galton DA. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features. Br J Haematol. 1987 Jan;65(1):23-9. 
• Parreira A, Smith J, Hows JM, Smithers SA, Apperley J, Rombos Y, Goldman JM, Gordon-Smith EC, Catovsky D. Immunological reconstitution after bone marrow transplant with Campath-1 treated bone marrow. Clin Exp Immunol. 1987 Jan;67(1):142-50. 
• Th’ng KH, Garewal G, Kearney L, Rassool F, Melo JV, White H, Catovsky D, Foroni L, Luzzatto L, Goldman JM. Establishment and characterization of three new malignant lymphoid cell lines. Int J Cancer. 1987 Jan 15;39(1):89-93. 
• Brito-Babapulle F, Catovsky D, Slocombe G, Newland AC, Marcus RE, Goldman JM, Galton DA. Phase II study of mitoxantrone and cytarabine in acute myeloid leukemia. Cancer Treat Rep. 1987 Feb;71(2):161-3.
• Matutes E, Foroni L, Amin S, de Oliveira MP, Brito-Babapulle V, Luzzatto L, Catovsky D. ‘Pseudo-lymphoid’ leukaemia with unusual features: ultrastructural, immunological, cytogenetic and molecular studies. Eur J Haematol. 1987 Apr;38(4):303-9. 
• Melo JV, Robinson DS, Gregory C, Catovsky D. Splenic B cell lymphoma with “villous” lymphocytes in the peripheral blood: a disorder distinct from hairy cell leukemia. Leukemia. 1987 Apr;1(4):294-8.
• Worman CP, Catovsky D, Cawley JC, Bevan PC, Bottomley JM, Nethersell AB. The U.K. experience with human lymphoblastoid interferon in HCL: a report of the first 50 cases. Leukemia. 1987 Apr;1(4):320-2.
• Foroni L, Catovsky D, Luzzatto L. Immunoglobulin gene rearrangements in hairy cell leukemia and other chronic B cell lymphoproliferative disorders. Leukemia. 1987 Apr;1(4):389-92.
• Catovsky D, Quesada JR, Golomb HM. Guidelines for the treatment of hairy cell leukemia. Leukemia. 1987 Apr;1(4):405-6.
• Haralambidou S, Melo JV, Catovsky D. Different reactivity of monoclonal antibodies against common acute lymphoblastic leukaemia antigen (CD10). J Clin Pathol. 1987 May;40(5):490-3. 
• Polli N, Matutes E, Robinson D, Catovsky D. Morphological heterogeneity of Leu7, Leu11 and OKM1 positive lymphocyte subsets: an ultrastructural study with the immunogold method. Clin Exp Immunol. 1987 May;68(2):331-9. 
• Brito-Babapulle F, Catovsky D, Newland AC, Goldman JM, Galton DA. Treatment of acute myeloid leukemia with intermediate-dose cytosine arabinoside and mitoxantrone. Semin Oncol. 1987 Jun;14(2 Suppl 1):51-2.
• Melo JV, Hegde U, Parreira A, Thompson I, Lampert IA, Catovsky D. Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. J Clin Pathol. 1987 Jun;40(6):642-51. 
• Pombo De Oliveira MS, Gregory C, Matutes E, Parreira A, Catovsky D. Cytochemical profile of megakaryoblastic leukaemia: a study with cytochemical methods, monoclonal antibodies, and ultrastructural cytochemistry. J Clin Pathol. 1987 Jun;40(6):663-9. 
• Yamaguchi K, Matutes E, Catovsky D, Galton DA, Nakada K, Takatsuki K. Strongyloides stercoralis as candidate co-factor for HTLV-I-induced leukaemogenesis. Lancet. 1987 Jul 11;2(8550):94-5. 
• Brito-Babapulle F, Catovsky D, Galton DA. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia. Br J Haematol. 1987 Aug;66(4):445-50. 
• Jones L, Thein SL, Jeffreys AJ, Apperley JF, Catovsky D, Goldman JM. Identical twin marrow transplantation for 5 patients with chronic myeloid leukaemia: role of DNA finger-printing to confirm monozygosity in 3 cases. Eur J Haematol. 1987 Aug;39(2):144-7. 
• Nakada K, Yamaguchi K, Furugen S, Nakasone T, Nakasone K, Oshiro Y, Kohakura M, Hinuma Y, Seiki M, Yoshida M, Matutes E, Catovsky D, Ishii T, Takatsuki K. Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. Int J Cancer. 1987 Aug 15;40(2):145-8. 
• Brito-Babapulle V, Pomfret M, Matutes E, Catovsky D. Cytogenetic studies on prolymphocytic leukemia. II. T cell prolymphocytic leukemia. Blood. 1987 Oct;70(4):926-31. 
• Ng JP, Hogg RB, Cumming RL, McCallion J, Catovsky D. Primary splenic hairy cell leukaemia: a case report and review of the literature. Eur J Haematol. 1987 Oct;39(4):349-52. 
• Dearden CE, Matutes E, Hoffbrand AV, Ganeshaguru K, Brozovic M, Williams HJ, Traub N, Mills M, Linch DC, Catovsky D. Membrane phenotype and response to deoxycoformycin in mature T cell malignancies. Br Med J (Clin Res Ed). 1987 Oct 10;295(6603):873-5.
• Foroni L, Foldi J, Matutes E, Catovsky D, O’Connor NJ, Baer R, Forster A, Rabbitts TH, Luzzatto L. α, β and γ T-cell receptor genes: rearrangements correlate with haematological phenotype in T cell leukaemias. Br J Haematol. 1987 Nov;67(3):307-18. 
• Brito-Babapulle V, Matutes E, Foroni L, Pomfret M, Catovsky D. A t(8;14)(q24;q32) in a T-lymphoma/leukemia of CD8+ large granular lymphocytes. Leukemia. 1987 Dec;1(12):789-94.
• Zola H, Neoh SH, Potter A, Melo JV, De Oliveria MS, Catovsky D. Markers of differentiated B cell leukaemia: CD22 antibodies and FMC7 react with different molecules. Dis Markers. 1987 Dec;5(4):227-35.

1988

• Melo JV, Robinson DSF, Catovsky D. The differential diagnosis between chronic lymphocytic leukaemia and other B‑cell lymphoproliferative disorders: morphological and immunological studies. In Polliack A, Catovsky D, Eds. Chronic Lymphocytic Leukemia. Chur, Switzerland: Harwood Academic Publishers; 1988: 85-103.
• Foa R, Matutes E, Brito‑Babapulle V, Foroni L, Catovsky D. T‑cell chronic lymphocytic leukaemia; a proliferation of large granular lymphocytes. Immunological, clinical, ultrastructural and molecular studies. In Polliack A, Catovsky D, Eds. Chronic Lymphocytic Leukemia. Chur, Switzerland: Harwood Academic Publishers; 1988: 369‑381.
• Pombo de Oliveira MS, Matutes E, Rani S, Morilla R, Catovsky D. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia. Acta Haematol. 1988;80(2):61-4. 
• Rabbitts PH, Douglas J, Fischer P, Nacheva E, Karpas A, Catovsky D, Melo JV, Baer R, Stinson MA, Rabbitts TH. Chromosome abnormalities at 11q13 in B cell tumours. Oncogene. 1988;3:99‑103.
• Rani S, De Oliveira MS, Catovsky D. Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides. Hematol Pathol. 1988;2(2):73-8.
• Matutes E, Brito-Babapulle V, Worner I, Sainati L, Foroni L, Catovsky D. T-cell chronic lymphocytic leukaemia: the spectrum of mature T-cell disorders. Nouv Rev Fr Hematol. 1988;30(5-6):347-51.
• Catovsky D, Fooks J, Richards S. The UK Medical Research Council CLL trials 1 and 2. Nouv Rev Fr Hematol. 1988;30(5-6):423-7.
• Brito-Babapulle V, Daly P, Catovsky D. Possible association of disseminated intravascular coagulation (DIC) with the chromosomal region 17q12-21 and the gene for glycoprotein IIb-IIIa complex. Br J Haematol. 1988 Jan;68(1):142. 
• Yamaguchi K, Matutes E, Kiyokawa T, Nishimura Y, Ishii T, Takatsuki K, Catovsky D. Comparison of immunoperoxidase staining with indirect immunofluorescence, ELISA, and Western blotting assays for detecting anti-HTLV-I antibodies in systemic lupus erythematosus. J Clin Pathol. 1988 Jan;41(1):57-61. 
• Zola H, Furness V, Nikoloutsopoulos A, Bradley J, Melo JV, Catovsky D. B prolymphocytic leukemia cell lines: phenotype and response to B cell differentiation factor. Pathology. 1988 Jan;20(1):10-4. 
• Catovsky D, Dearden C. Response to deoxycoformycin in T cell leukaemias. Br Med J (Clin Res Ed). 1988 Jan 30;296(6618):356. 
• Brito-Babapulle F, Huang D, Lavender P, Galton D, Catovsky D. Regression of intracerebral lesions in T prolymphocytic leukaemia treated with intravenous deoxycoformycin. Eur J Haematol. 1988 Feb;40(2):185-7. 
• Foroni L, Matutes E, Foldi J, Morilla R, Rabbitts T, Luzzatto L, Catovsky D. T-cell leukemias with rearrangement of the gamma but not beta T-cell receptor genes. Blood. 1988 Feb;71(2):356-62. 
• Yamaguchi K, Kiyokawa T, Nakada K, Yul LS, Asou N, Ishii T, Sanada I, Seiki M, Yoshida M, Matutes E, Catovsky D, Takatsuki K. Polyclonal integration of HTLV-I proviral DNA in lymphocytes from HTLV-I seropositive individuals: an intermediate state between the healthy carrier state and smouldering ATL. Br J Haematol. 1988 Feb;68(2):169-74. 
• Brito-Babapulle F, Catovsky D, Galton DA. Myelodysplastic relapse of de novo acute myeloid leukaemia with trilineage myelodysplasia: a previously unrecognized correlation. Br J Haematol. 1988 Apr;68(4):411-5. 
• Jones MP, Gunapala DE, Matutes E, Catovsky D, Coates AR. A novel human macrophage-activating factor: distinction from interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GMCSF). Cell Immunol. 1988 May;113(2):361-75. 
• Matutes E, Pombo de Oliveira M, Foroni L, Morilla R, Catovsky D. The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukaemia. Br J Haematol. 1988 Jun;69(2):205-11. 
• Parreira A, Pombo de Oliveira MS, Matutes E, Foroni L, Morilla R, Catovsky D. Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia. Br J Haematol. 1988 Jun;69(2):219-24. 
• Rassool F, Foroni L, Rahemtulla A, Dreazen O, Wiedemann L, Guo AP, Legon S, Catovsky D, Luzzatto L, Goldman J. The genomic breakpoint in a patient with Philadelphia-positive acute leukemia is 5′ of the breakpoint cluster region. Cancer Genet Cytogenet. 1988 Jun;32(2):217-27. 
• Melo JV, Foroni L, Brito-Babapulle V, Luzzatto L, Catovsky D. The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement. Clin Exp Immunol. 1988 Jul;73(1):23-8. 
• Dearden C, Catovsky D. Current treatment of hairy cell leukaemia. Eur J Haematol. 1988 Sep;41(3):193-6. 
• Melo JV, Robinson DS, De Oliveira MP, Thompson IW, Lampert IA, Ng JP, Galton DA, Catovsky D. Morphology and immunology of circulating cells in leukaemic phase of follicular lymphoma. J Clin Pathol. 1988 Sep;41(9):951-9. 
• Dalgleish A, Richardson J, Matutes E, Cruickshank K, Newell A, Sinclair A, Thorpe R, Brasher M, Weber J, Catovsky D, Rudge P. HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response. AIDS Res Hum Retroviruses. 1988 Dec;4(6):475-85. 

1989

• Catovsky D, Hoffbrand AV. Acute leukaemia, In Hoffbrand AV, Lewis SM, Eds. Postgraduate Haematology. 3rd edition. Oxford, UK: Heinemann; 1989:379‑417.
• Catovsky D. Chronic lymphoid leukaemias. In Hoffbrand AV, Lewis SM, Eds. Postgraduate Haematology. 3rd edition. Oxford, UK: Heinemann; 1989:418‑462.
• De Oliveira MSP, Matutes E, Catovsky D. The cytochemistry, membrane markers and ultrastructure of megakaryoblastic (M7) and erythro (M6) leukaemias. In Scott CS, Ed. Leukaemia Cytochemistry and Diagnosis: Principles and Practice. Chichester, UK: Ellis Horwood; 1989:137‑154.
• Gogoi PK, Stewart ID, Keane PF, Scott R, Dunn GD, Catovsky D. Chronic lymphocytic leukaemia presenting with bilateral breast involvement. Clin Lab Haematol. 1989;11(1):57-60. 
• Matutes E, Worner I, Sainati L, de Oliveira MP, Catovsky D. Advances in the lymphoproliferative disorders. Review of our experience in the study of over 1000 cases. Biología & clínica hematológica. 1989;11:53‑62.
• Nieto LH, Lampert IA, Catovsky D. Bone marrow histological patterns in B-cell and T-cell prolymphocytic leukemia. Hematol Pathol. 1989;3(2):79-84.
• Robinson D, Lackie P, Aber V, Catovsky D. Morphometric analysis of chronic B-cell leukemias–an aid to the classification of lymphoid cell types. Leuk Res. 1989;13(5):357-65. 
• Scott CS, Vulliamy T, Catovsky D, Matutes E, Norfolk DR. DNA genotypic conservation during phenotypic switch from T-cell acute lymphoblastic leukaemia to acute myeloblastic leukaemia. Leuk Lymphoma. 1989;1(1):21-8. 
• Foroni L, Laffan M, Boehm T, Rabbitts TH, Catovsky D, Luzzatto L. Rearrangement of the T-cell receptor delta genes in human T-cell leukemias. Blood. 1989 Feb;73(2):559-65. 
• Binet JL, Catovsky D, Dighiero G, Gale RP, Montserrat E, Rai KR, Rozman C, Sawitsky A. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. Ann Intern Med. 1989 Feb 1;110(3):236-238. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol. 1989 Jun;42(6):567-84. 
• Catovsky D, Fooks J, Richards S. Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults. Br J Haematol. 1989 Jun;72(2):141-9. 
• Pierre RV, Catovsky D, Mufti GJ, Swansbury GJ, Mecucci C, Dewald GW, Ruutu T, Van Den Berghe H, Rowley JD, Mitelman F, Reeves BR, Alimena G, Garson OM, Lawler SD, de la Chapelle A. Clinical-cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genet Cytogenet. 1989 Jul 15;40(2):149-61. 
• Brito-Babapulle F, Bowcock SJ, Marcus RE, Apperley J, Th’ng KH, Dowding C, Rassool F, Guo AP, Catovsky D, Galton DA, McCarthy D, Goldman JM. Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis. Br J Haematol. 1989 Sep;73(1):76-81. 
• De Oliveira MS, Jaffe ES, Catovsky D. Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases. J Clin Pathol. 1989 Sep;42(9):962-72. 
• Walls EV, Doyle MG, Patel KK, Allday MJ, Catovsky D, Crawford DH. Activation and immortalization of leukaemic B cells by Epstein-Barr virus. Int J Cancer. 1989 Nov 15;44(5):846-53. 

1990

• Catovsky D, Foa R. The Lymphoid Leukaemias. London, UK: Butterworths, London; 1990.
• Catovsky D. Prolymphocytic and hairy cell leukemias. In Henderson ES, Lister TA, Eds. Leukemia. 5th Edition. Philadelphia, PA: Saunders; 1990:639‑660.
• Matutes E, Brito Babapulle V, Foroni L, Yamaguchi K, Dearden C, Gates A, Catovsky D. The classification of T cell leukemias. In Hanaoka M, Mikata A, Kadin ME, Watanabe S, Eds. Lymphoid Malignancy: Immunocytochemistry and Cytogenetics. New York, NY: Field & Wood Medical Publishers; 1990: 97-108.
• Bain B, Morilla R, Monard S, Kokai Y, Catovsky D. Spectrum of reactivity with three monoclonal antibodies-MHM6(CD23), L30(CD24) and UCHB1-in B-cell leukaemias. Leuk Lymphoma. 1990;3(2):97-102. https://doi.org/10.3109/10428199009050982
• Dearden C, Catovsky D. Treatment of hairy cell leukaemia with 2′-deoxycoformycin. Leuk Lymphoma. 1990;1(3-4):179-85. https://doi.org/10.3109/10428199009042478
• Melo N, Hobday C, Dowsett M, Catovsky D, Matutes E, Morilla R, Polliack A. Oestrogen receptor (ER) analysis in B-cell chronic lymphocytic leukemia: correlation of biochemical and immunocytochemical methods. Leuk Res. 1990;14(11-12):949-52. 
• Mertens F, Johansson B, Heim S, Kristoffersson U, Mandahl N, Turesson I, Malm C, Othzén A, Bartram CR, Catovsky D, Mitelman F. Trisomy 14 in atypical chronic myeloid leukemia. Leukemia. 1990 Feb;4(2):117-20.
• Matutes E, Keeling DM, Newland AC, Scott CS, Mitchell D, Traub N, Wardle DG, Catovsky D. Sezary cell-like leukemia: a distinct type of mature T cell malignancy. Leukemia. 1990 Apr;4(4):262-6.
• Worner I, Matutes E, Beverley PC, Catovsky D. The distribution of CD45R, CD29 and CD45RO (UCHL1) antigens in mature CD4 positive T-cell leukaemias. Br J Haematol. 1990 Apr;74(4):439-44. 
• Mackinnon S, Hows JM, Goldman JM, Arthur CK, Hughes T, Apperley JF, Jones L, Batchelor JR, Brookes P, Catovsky D, et al. Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors. Exp Hematol. 1990 Jun;18(5):421-5.
• Dearden C, Catovsky D. Deoxycoformycin in the treatment of mature B-cell malignancies. Br J Cancer. 1990 Jul;62(1):4-5. 
• Sainati L, Matutes E, Mulligan S, de Oliveira MP, Rani S, Lampert IA, Catovsky D. A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients. Blood. 1990 Jul 1;76(1):157-62. 
• Mulligan SP, Travade P, Matutes E, Dearden C, Visser L, Poppema S, Catovsky D. B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. Blood. 1990 Sep 1;76(5):959-64. 
• de Oliveira MS, Matutes E, Famadas LC, Schulz TF, Calabro ML, Nucci M, Andrada-Serpa MJ, Tedder RS, Weiss RA, Catovsky D. Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. Lancet. 1990 Oct 20;336(8721):987-90.
• Bain B, Catovsky D. Current concerns in haematology. 2: Classification of acute leukaemia. J Clin Pathol. 1990 Nov;43(11):882-7. 

1991

• Catovsky D. Overview. In Catovsky D, Ed. The Leukemic Cell. Edinburgh, UK: Churchill Livingstone; 1991:1‑22.
• Catovsky D. Leucocyte cytochemical and immunological techniques. In Dacie JV, Lewis SM, Eds. Practical Haematology. 7th Edition. Edinburgh, UK: Churchill Livingstone; 1991:125‑155.
• Ganeshaguru K, de Mel WC, Sissolak G, Catovsky D, Dearden CE, Mehta AB, Hoffbrand AV. Increase in 2′,5′-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia. Adv Exp Med Biol. 1991;309A:65-8. 
• Hernandez Ramirez P, Rivero Jimenez R, Ballester Santovenia M, Navea Leyva L, Matutes E, Catovsky D, Yamaguchi K, Fukuyoshi Y, Nishimura Y, Kiyokawa T, Takatsuki K. Very low seroprevalence of HTLV-I/II in Cuba: antibodies in blood donors and in hematological and nonhematological patients. Vox Sang. 1991;61(4):277-8. 
• Matutes E, Catovsky D. Mature T-cell leukemias and leukemia/lymphoma syndromes: review of our experience in 175 cases. Leuk Lymphoma. 1991;4(2):81-91. 
• Matutes E, Bain B, Catovsky D. Teaching cases from the Royal Marsden Hospital case 1: a young man with petechiae and splenomegaly. Leuk Lymphoma. 1991;4(5-6):429-30. 
• Bain B, Matutes E, Catovsky D. Teaching cases from the Royal Marsden Hospital case 2: a young man with bruising. Leuk Lymphoma. 1991;5(1):75-6. 
• Juliusson G, Oscier D, Juliusson G, Gahrton G, Oscier D, Fitchett M, Ross F, Brito-Babapulle V, Catovsky D, Knuutila S, Elonen E, Lechleitner M, Tanzer J, Schoenwald M, Castoldi GL, Cuneo A, Nowell P, Peterson L, Kay N. Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of data on 662 patients. Leuk Lymphoma. 1991;5(Suppl 1):21-5. 
• Catovsky D, Richards S, Fooks J, Hamblin TJ. CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3. Leuk Lymphoma. 1991;5(Suppl 1):105-11. 
• Catovsky D. The treatment of CLL: summing up. Leuk Lymphoma. 1991;5(Suppl 1):149-50. https://doi.org/10.3109/10428199109103397
• Matutes E, Catovsky D. The classification of lymphoid leukaemias. Leuk Lymphoma. 1991;5(Suppl 1):153-5. https://doi.org/10.3109/10428199109103398
• Brito-Babapulle V, Crawford A, Khokhar T, Laffan M, Matutes E, Fairhead S, Catovsky D. Translocations t(14;18) and t(8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3). Leukemia. 1991 Jan;5(1):83-7.
• Catovsky D, Matutes E, Buccheri V, Shetty V, Hanslip J, Yoshida N, Morilla R. A classification of acute leukaemia for the 1990s. Ann Hematol. 1991 Feb;62(1):16-21. 
• Bain B, Matutes E, Robinson D, Lampert IA, Brito-Babapulle V, Morilla R, Catovsky D. Leukaemia as a manifestation of large cell lymphoma. Br J Haematol. 1991 Mar;77(3):301-10. 
• Mulligan SP, Matutes E, Dearden C, Catovsky D. Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. Br J Haematol. 1991 Jun;78(2):206-9. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol. 1991 Jul;78(3):325-9. 
• Whelan JS, Davis CL, Rule S, Ranson M, Smith OP, Mehta AB, Catovsky D, Rohatiner AZ, Lister TA. Fludarabine phosphate for the treatment of low grade lymphoid malignancy. Br J Cancer. 1991 Jul;64(1):120-3. 
• Brito-Babapulle V, Catovsky D. Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. Cancer Genet Cytogenet. 1991 Aug;55(1):1-9. 
• Schulz TF, Calabrò ML, Hoad JG, Carrington CV, Matutes E, Catovsky D, Weiss RA. HTLV-1 envelope sequences from Brazil, the Caribbean, and Romania: clustering of sequences according to geographic origin and variability in an antibody epitope. Virology. 1991 Oct;184(2):483-91. 
• Dearden C, Matutes E, Catovsky D. Deoxycoformycin in the treatment of mature T-cell leukaemias. Br J Cancer. 1991 Nov;64(5):903-6. 
• Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, Sempere A, Catovsky D. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood. 1991 Dec 15;78(12):3269-74. 

1992

• Catovsky D. Diagnosis and treatment of CLL Variants. In Cheson B, Ed. Chronic Lymphocytic Leukemia: Scientific Advances and Clinical Developments. New York, NY: Marcel Dekker; 1992:369‑397.
• Catovsky D, Matutes E. Leukemias of mature T cells. In Knowles DM, Ed. Neoplastic Hematopathology. Baltimore, MD: Williams & Wilkins; 1992:1267‑1279.
• Matutes E, Catovsky D. Adult T cell leukaemia lymphoma. In Whittaker JA, Ed. Leukaemia. Second Edition. Oxford, UK: Blackwell Scientific Publications; 1992:416‑433.
• Catovsky D, Matutes E. The classification of acute leukaemia. Leukemia. 1992;6(Suppl 2):1-6.
• Mulligan SP, Catovsky D. Splenic lymphoma with villous lymphocytes. Leuk Lymphoma. 1992;6(2):97‑105. 
• Matutes E, Bain B, MacLennan K, Roques T, Catovsky D. Teaching cases from the Royal Marsden Hospital case 3: a lymphoproliferative disorder of 17 years duration. Leuk Lymphoma. 1992;6(4-5):441‑442. 
• Hanslip JI, Swansbury GJ, Pinkerton R, Catovsky D. The translocation t(8;16)(p11;p13) defines an AML subtype with distinct cytology and clinical features. Leuk Lymphoma. 1992;6(6):479‑486.
• Bain B, Matutes E, MacLennan K, Catovsky D. Teaching cases from the Royal Marsden Hospital case 4: fever, hepatic dysfunction and cytopenia. Leuk Lymphoma. 1992;6(6):527‑528. 
• Luckit J, Ogilvie D, Treleaven J, Catovsky D. Teaching cases from the Royal Marsden Hospital case 5: a child with fever, hepatosplenomegaly and cytopenia. Leuk Lymphoma. 1992 Jun;7(3):257-8. 
• Buccheri V, Shetty V, Yoshida N, Morilla R, Matutes E, Catovsky D. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry. Br J Haematol. 1992 Jan;80(1):62-8. 
• Secker-Walker LM, Morgan GJ, Min T, Swansbury GJ, Craig J, Yamada T, Desalvo L, Medina JW, Chowdhury V, Donahue RP, Polliack A, Catovsky D. Inversion of chromosome 16 with the Philadelphia chromosome in acute myelomonocytic leukemia with eosinophilia. Report of two cases. Cancer Genet Cytogenet. 1992 Jan;58(1):29-34. 
• Ganeshaguru K, de Mel WC, Sissolak G, Catovsky D, Dearden CE, Mehta AB, Hoffbrand AV. Increase in 2′,5′-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia. Br J Haematol. 1992 Feb;80(2):194-8. 
• Cordone I, Matutes E, Catovsky D. Characterisation of normal peripheral blood cells in cycle identified by monoclonal antibody Ki-67. J Clin Pathol. 1992 Mar;45(3):201-5. 
• Urbano-Ispizua A, Gill R, Matutes E, Levi S, Wiedemann LM, Catovsky D, Marshall CJ. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case. Leukemia. 1992 Apr;6(4):342-6.
• Montserrat E, Binet JL, Catovsky D, Dighiero G, Gale RP, Rai KR, Rozman C. 5th International Workshop on Chronic Lymphocytic Leukemia. Leuk Res. 1992 Jun-Jul;16(6-7):717-20. 
• de Melo N, Matutes E, Cordone I, Morilla R, Catovsky D. Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders. J Clin Pathol. 1992 Aug;45(8):660-3. 
• Brito-Babapulle V, Ellis J, Matutes E, Oscier D, Khokhar T, MacLennan K, Catovsky D. Translocation t(11;14)(q13;q32) in chronic lymphoid disorders. Genes Chromosomes Cancer. 1992 Sep;5(2):158-65. 
• Catovsky D. The classification of leukaemias and leukaemia/lymphoma syndromes. Br J Haematol. 1992 Sep;82(1):226‑29. 
• Cordone I, Matutes E, Catovsky D. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity. Leukemia. 1992 Sep;6(9):902-6.
• Matutes E, Bain B, Maclennan K, Swirsky D, Catovsky D. Teaching cases from the Royal Marsden Hospital. Case 6: a man with a large cervical mass. Leuk Lymphoma. 1992 Sep;8(1-2):157-9. 
• Mercieca J, Matutes E, Moskovic E, MacLennan K, Matthey F, Costello C, Behrens J, Basu S, Roath S, Fairhead S, Flandrin G, Brizard A, Catovsky D. Massive abdominal lymphadenopathy in hairy cell leukaemia: a report of 12 cases. Br J Haematol. 1992 Nov;82(3):547-54. 

1993

• Catovsky D. Diagnosis and treatment of CLL variants. In Cheson B, Ed. Chronic Lymphocytic Leukemia: Scientific Advances and Clinical Developments. New York, NY: Marcel Dekker; 1993:369-397.
• Catovsky D. The significance of lymphadenopathy in leukemia. In Pangalis GA, Polliack A, Eds. Benign and Malignant Lymphadenopathies: Clinical and Laboratory Diagnosis. Chur, Switzerland: Harwood Academic Publishers; 1993:83‑92.
• Dyer MJS, Catovsky D. Themes and variations among the mature lymphoid leukemias. In Kirsch IR, Ed. The Causes and Consequences of Chromosomal Aberrations. Boca Raton, FL: CRC Press; 1993:351‑357.
• Matutes E, Buccheri V, Morilla R, Shetty V, Dyer M, Catovsky D. Immunological, ultrastructural and molecular features of unclassifiable acute leukaemia. Recent Results Cancer Res. 1993;131:41-52. 
• Mulligan SP, Catovsky D. The chronic B-cell leukaemias. Aust N Z J Med. 1993 Feb;23(1):42-50. 
• Bain B, Matutes E, Catovsky D. Teaching cases from the Royal Marsden Hospital. Case 7: an east African with fever. Leuk Lymphoma. 1993 Apr;9(6):517-8. 
• Matutes E, Catovsky D. [The clinical and laboratory characteristics of mature (postthymic) T-cell malignant neoplasms]. [Article in Russian.] Gematol Transfuziol. 1993 May;38(5):3-6.
• Matutes E, Catovsky D. CLL should be used only for the disease with B-cell phenotype. Leukemia. 1993 Jun;7(6):917-8.
• Buccheri V, Matutes E, Dyer MJ, Catovsky D. Lineage commitment in biphenotypic acute leukemia. Leukemia. 1993 Jun;7(6):919-27.
• Coad JE, Matutes E, Catovsky D. Splenectomy in lymphoproliferative disorders: a report on 70 cases and review of the literature. Leuk Lymphoma. 1993 Jul;10(4-5):245-64. 
• Que TH, Marco JG, Ellis J, Matutes E, Babapulle VB, Boyle S, Catovsky D. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. Blood. 1993 Jul 15;82(2):571-5. 
• Buccheri V, Mihaljević B, Matutes E, Dyer MJ, Mason DY, Catovsky D. mb-1: a new marker for B-lineage lymphoblastic leukemia. Blood. 1993 Aug 1;82(3):853-7. 
• Dyer MJ, Heward JM, Zani VJ, Buccheri V, Catovsky D. Unusual deletions within the immunoglobulin heavy-chain locus in acute leukemias. Blood. 1993 Aug 1;82(3):865-71. 
• Crawford DH, Catovsky D. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40. Immunology. 1993 Sep;80(1):40-4. 
• Hickish T, Roldan A, Cunningham D, Mansi J, Ashley S, Nicolson V, Gore ME, Catovsky D, Smith IE. EPIC: an effective low toxicity regimen for relapsing lymphoma. Br J Cancer. 1993 Sep;68(3):599-604. 
• Mitchell P, Powles R, Rege K, Treleaven J, Catovsky D, Mehta J, Jameson B. Phenoxyethanol is effective topical therapy of gram-negative cellulitis in neutropenic patients. J Hosp Infect. 1993 Sep;25(1):53-6. 
• Shetty V, Chitale A, Matutes E, Buccheri V, Morilla R, Catovsky D. Immunological and ultrastructural studies in acute biphenotypic leukaemia. J Clin Pathol. 1993 Oct;46(10):903-7. 
• Bain B, Matutes E, Catovsky D. Teaching cases from the Royal Marsden Hospital. Case 8: a Japanese patient with leukaemia and headache. Leuk Lymphoma. 1993 Nov;11(5-6):477-9. 
• Doyle MG, Catovsky D, Crawford DH. Infection of leukaemic B lymphocytes by Epstein Barr virus. Leukemia. 1993 Nov;7(11):1858-64.
• Oscier DG, Matutes E, Gardiner A, Glide S, Mould S, Brito-Babapulle V, Ellis J, Catovsky D. Cytogenetic studies in splenic lymphoma with villous lymphocytes. Br J Haematol. 1993 Nov;85(3):487-91. 
• Tiley C, Powles R, Treleaven J, Catovsky D, Milan S, Teo CP, Catalano J, Mehta J, Shields M, Gupta P, Richards S, Millar J, Gorman C. Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia. Bone Marrow Transplant. 1993 Nov;12(5):449-55.
• Bain BJ, Catovsky D, Ewan PW. Acquired angioedema as the presenting feature of lymphoproliferative disorders of mature B-lymphocytes. Cancer. 1993 Dec 1;72(11):3318-22. 

1994

• Matutes E, Catovsky D. ATL of Caribbean origin. In Takatsuki K, Ed. Adult T‑Cell Leukaemia. Oxford, UK: Oxford University Press; 1994:113‑138.
• Matutes E, Catovsky D. The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B-cell disorders. Leuk Lymphoma. 1994;13(Suppl 1):11-4. https://doi.org/10.3109/10428199409052666
• Kayano H, Dyer MJ, Zani VJ, Laffan MA, Matutes E, Asou N, Katayama I, Catovsky D. Aberrant rearrangements within the immunoglobulin heavy chain locus in hairy cell leukemia. Leuk Lymphoma. 1994;14(Suppl 1):41-7.
• Matutes E, Morilla R, Owusu‑Ankomah K, Houliham A, Meeus P, Catovsky D. The immunophenotype of Hairy Cell Leukemia (HCL). Proposal for a scoring system to distinguish HCL from B‑cell disorders with hairy or villous lymphocytes. Leuk Lymphoma. 1994;14(Suppl 1):57‑61.
• Mercieca J, Puga M, Matutes E, Moskovic E, Salim S, Catovsky D. Incidence and significance of abdominal lymphadenopathy in hairy cell leukaemia. Leuk Lymphoma. 1994;14(Suppl 1):79-83.
• Catovsky D, Matutes E, Talavera JG, O’Connor NT, Johnson SA, Emmett E, Corbett L, Swansbury J. Long term results with 2’deoxycoformycin in hairy cell leukemia. Leuk Lymphoma. 1994;14(Suppl 1):109-13.
• O’Brien ME, Matutes E, Cunningham D, Hill M, Emmett E, Ellis PA, Milan S, Hickish T, Mercieca J, Catovsky D. Fludarabine in lymphoproliferative disorders: the Royal Marsden Hospital experience. Leuk Lymphoma. 1994;14(Suppl 2):17-23. 
• Matutes E, Morilla R, Owusu-Ankomah K, Houlihan A, Catovsky D. The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood. 1994 Mar 15;83(6):1558-62. 
• McArthur JR, Miwa S, Catovsky D. Morphology in hematology. Rev Invest Clin. 1994 Apr;Suppl:115-7, 81-2.
• Garcìa-Marco J, Matutes E, Morilla R, Ellis J, Oscier D, Fantes J, Catovsky D, Price CM. Trisomy 12 in B-cell chronic lymphocytic leukaemia: assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization. Br J Haematol. 1994 May;87(1):44-50. 
• Hiorns LR, Min T, Swansbury GJ, Zelent A, Dyer MJ, Catovsky D. Interstitial insertion of retinoic acid receptor-alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. Blood. 1994 May 15;83(10):2946-51. 
• Jadayel D, Matutes E, Dyer MJ, Brito-Babapulle V, Khohkar MT, Oscier D, Catovsky D. Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene. Blood. 1994 Jun 15;83(12):3664-71. 
• Brito-Babapulle V, Matutes E, Oscier D, Mould S, Catovsky D. Chromosome abnormalities in hairy cell leukaemia variant. Genes Chromosomes Cancer. 1994 Jul;10(3):197-202. 
• Matamoros N, Matutes E, Hernandez M, Galmes A, Perez-Payarols J, Buccheri V, Morilla R, Catovsky D, Healy LE, Ridge SA, Greaves MF. Neonatal mixed lineage acute leukaemia. Leukemia. 1994 Jul;8(7):1236-42.
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick H, Sultan C, Cox C. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol. 1994 Aug;87(4):746-54. 
• Kamihira S, Matutes E, Marco J, Hoda S, Morilla R, Owusuankomah K, Crowford A, Ellis J, Catovsky D. Flow-cytometry detection of minimal DNA aneuploidy in mature lymphoid leukemias – comparison with metaphase and interphase cytogenetics. Int J Oncol. 1994 Aug;5(2):211-4. 
• Farahat N, van der Plas D, Praxedes M, Morilla R, Matutes E, Catovsky D. Demonstration of cytoplasmic and nuclear antigens in acute leukaemia using flow cytometry. J Clin Pathol. 1994 Sep;47(9):843-9. 
• Mehta J, Powles R, Horton C, Milan S, Treleaven J, Tait D, Catovsky D. Bone marrow transplantation for primary refractory acute leukaemia. Bone Marrow Transplant. 1994 Sep;14(3):415-8.
• Agrawal S, Matutes E, Voke J, Dyer MJ, Khokhar T, Catovsky D. Persistent polyclonal B-cell lymphocytosis. Leuk Res. 1994 Oct;18(10):791-5. 
• Height SE, Dainton MG, Kearney L, Swansbury GJ, Matutes E, Dyer MJ, Treleaven JG, Powles RL, Catovsky D. Acute myelomonocytic leukemia with t(10;11)(p13;q23): heterogeneity of breakpoints at 11q23 and association with recombinase activation. Genes Chromosomes Cancer. 1994 Oct;11(2):136-9. 
• Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994 Oct;8(10):1640-5.
• Cabrera ME, Labra S, Catovsky D, Ford AM, Colman SM, Greaves MF, Matutes E. HTLV-I positive adult T-cell leukaemia/lymphoma (ATLL) in Chile. Leukemia. 1994 Oct;8(10):1763-7.
• Agrawal S, Abboudi Z, Matutes E, Catovsky D. First report of fludarabine in gamma-heavy chain disease. Br J Haematol. 1994 Nov;88(3):653-5. 
• Zomas A, Mehta J, Powles R, Treleaven J, Iveson T, Singhal S, Jameson B, Paul B, Brincat S, Catovsky D. Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant. 1994 Nov;14(5):799-803.
• Levine PH, Cleghorn F, Manns A, Jaffe ES, Navarro-Roman L, Blattner WA, Hanchard B, De Oliveira MS, Matutes E, Catovsky D, Shimoyama M, Tajima K, Sonoda S, Yamaguchi K, Takatsuki K. Adult T-cell leukemia/lymphoma: a working point-score classification for epidemiological studies. Int J Cancer. 1994 Nov 15;59(4):491-3. 
• Kamihira S, Matutes E, Sohda H, Atogami S, Tomonaga M, Catovsky D. Morphological and immunophenotypical characterization of Japanese B-cell lymphocytic leukemia. Leuk Lymphoma. 1994 Dec;16(1-2):113-9.
• Lens D, Matutes E, Farahat N, Morilla R, Catovsky D. Differential expression of c-myc protein in B and T lymphocytes. Leukemia. 1994 Dec;8(12):2102-10.
• Mercieca J, Matutes E, Dearden C, MacLennan K, Catovsky D. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol. 1994 Dec;12(12):2588-93. 
• Isaacson PG, Matutes E, Burke M, Catovsky D. The histopathology of splenic lymphoma with villous lymphocytes. Blood. 1994 Dec 1;84(11):3828-34. 

1995

• Catovsky D. Leucocyte cytochemical and immunological techniques. In Dacie JV, Lewis SM, Eds. Practical Haematology. 8th Edition. Edinburgh, UK: Churchill Livingstone; 1995:143‑174.
• Bosanquet AG, McCann SR, Crotty GM, Mills MJ, Catovsky D. Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay. Acta Haematol. 1995;93(2-4):73-9. 
• Catovsky D. Chronic lymphoproliferative disorders. Curr Opin Oncol. 1995 Jan;7(1):3-11. 
• Hill M, Milan S, Cunningham D, Mansi J, Smith I, Catovsky D, Gore M, Zulian G, Selby P, Horwich A, O’Brien M, Nicolson M, Hickish T. Evaluation of the efficacy of the VEEP regimen in adult Hodgkin’s disease with assessment of gonadal and cardiac toxicity. J Clin Oncol. 1995 Feb;13(2):387-95. 
• Mallett RB, Matutes E, Catovsky D, Maclennan K, Mortimer PS, Holden CA. Cutaneous infiltration in T-cell prolymphocytic leukaemia. Br J Dermatol. 1995 Feb;132(2):263-6. 
• Stranks G, Height SE, Mitchell P, Jadayel D, Yuille MA, De Lord C, Clutterbuck RD, Treleaven JG, Powles RL, Nacheva E, Oscier DG, Karpas A, Lenoir GM, Smith SD, Millar JL, Catovsky D, Dyer MJS. Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood. 1995 Feb 15;85(4):893-901. 
• Bain BJ, Catovsky D. The leukaemic phase of non-Hodgkin’s lymphoma. J Clin Pathol. 1995 Mar;48(3):189-93. 
• Matutes E, Spittle MF, Smith NP, Eady RA, Catovsky D. The first report of familial adult T-cell leukaemia lymphoma in the United Kingdom. Br J Haematol. 1995 Mar;89(3):615-9. 
• Pombo de Oliveira MS, Matutes E, Schulz T, Carvalho SM, Noronha H, Reaves JD, Loureiro P, Machado C, Catovsky D. T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases. Int J Cancer. 1995 Mar 16;60(6):823-7. 
• Farahat N, Lens D, Morilla R, Matutes E, Catovsky D. Differential TdT expression in acute leukemia by flow cytometry: a quantitative study. Leukemia. 1995 Apr;9(4):583-7.
• Crawford DH, Thomas JA, Gregory CD, Catovsky D, Chaggar K. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40. Leukemia. 1995 May;9(5):747-53.
• Kamihira S, Atogami S, Sohda H, Tsuruta K, Tomonaga M, Matutes E, Morilla R, Marco JG, Catovsky D. [Phenotypical diagnosis of Japanese chronic lymphocytic leukemia–an international cooperative study based on the French-American-British classification of mature B-cell leukemias]. [Article in Japanese.] Rinsho Byori. 1995 May;43(5):501-7.
• Jadayel D, Calabrese G, Min T, van Rhee F, Swansbury GJ, Dyer MJ, Maitland J, Palka G, Catovsky D. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation. Leukemia. 1995 Jun;9(6):981-7.
• Newman A, Clutterbuck RD, DeLord C, Powles RL, Catovsky D, Millar JL. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation. J Investig Med. 1995 Jun;43(3):269-74.
• Shipley J, Williams S, O’Byrne A, Kearney L, Jones T, Young B, Dyer M, Catovsky D, Sheer D, Gusterson B. Characterization of a t(10;11)(p13-14;q14-21) in the monoblastic cell line U937. Genes Chromosomes Cancer. 1995 Jun;13(2):138-42.
• Allan NC, Richards SM, Shepherd PCA, Burnett AK, Al-Ismail S, Barkhan P, Barrett A, Beard MEJ, Bellingham AJ, Black AJ, Bridges JM, Bunch C, Carey P, Catovsky D, Cawley JC, Child JA, Clark R, Cuthbert M, Cuzick JM, Dastgir M, Delamore IW, Dodd NH, Durie B, Durrant J, Franklin IM, Galton DAG, Gates A, Goldman JM, Goldstone AH, Gray R, Hamblin TJ, Hamilton P, Hobbs J, Hoffbrand AV, Hutchinson RM, Jones FGC, Linch D, Littlewood TJ, MacLennan ICM, McCann SR, McDonald GA, McElwain T, Maton-Howarth W, Milligan DW, Mufti GJ, Murphy B, Newland AC, Peto R, Powles R, Prentice AG, Prentice HG, Rajman A, Rees JKH, Roath OS, Roberts BE, Schey SA, Smith A, Stableforth PJ, Tansey PJ, Temperley I, Varcoe R, Wheatley K, Whittaker JA, Wilson E, Winfield DA, Liu Yin JA. UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council’s Working Parties for Therapeutic Trials in Adult Leukaemia. Lancet. 1995 Jun 3;345(8962):1392-7. 
• Khokhar MT, Brito-Babapulle V, Matutes E, Catovsky D. Cytogenetic abnormalities in the leukemic phase of non-Hodgkin lymphoma. Cancer Genet Cytogenet. 1995 Aug;83(1):18-24.
• Matutes E, Schulz T, Dyer M, Ellis J, Hedges M, Catovsky D. Immunoblastic transformation of a Sezary syndrome in a black Caribbean patient without evidence of HTLV-I. Leuk Lymphoma. 1995 Aug;18(5-6):521-7. 
• Brace W, Bain B, Walker M, Catovsky D. Teaching cases from the Royal Marsden Hospital. Case 9: an elderly patient with unusual circulating cells. Leuk Lymphoma. 1995 Aug;18(5-6):529-30. 
• Hiorns LR, Swansbury GJ, Catovsky D. An eight-way variant t(15;17) in acute promyelocytic leukemia elucidated using fluorescence in situ hybridization. Cancer Genet Cytogenet. 1995 Sep;83(2):136-9. 
• Miguel-Garcia A, Matutes E, Tarin F, Garcia-Talavera J, Miguel-Sosa A, Carbonell F, Catovsky D. Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy. J Clin Pathol. 1995 Sep;48(9):835-9. 
• Maljaie SH, Brito-Babapulle V, Matutes E, Hiorns LR, De Schouwer PJ, Catovsky D. Expression of c-myc oncoprotein in chronic T cell leukemias. Leukemia. 1995 Oct;9(10):1694-9.
• Farahat N, Lens D, Zomas A, Morilla R, Matutes E, Catovsky D. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors. Br J Haematol. 1995 Nov;91(3):640-6. 
• Catovsky D, Murphy RL. Key issues in the treatment of chronic lymphocytic leukaemia (CLL). Eur J Cancer. 1995 Dec;31A(13-14):2146-54. 

1996

• Catovsky D. The classification of leukaemia. In Weatherall D, Ledingham JGG, Warrell DA, Eds. Oxford textbook of Medicine. Third Edition. Oxford, UK: Oxford University Press; 1996:3399-3404.
• Catovsky D. Chronic lymphocytic leukaemia and other leukaemias of mature B and T cells. In Weatherall D, Ledingham JGG, Warrell DA, Eds. Oxford textbook of Medicine. Third Edition. Oxford, UK: Oxford University Press; 1996:3419-3425.
• Catovsky D. Myelodysplastic syndrome. In Weatherall D, Ledingham JGG, Warrell DA, Eds. Oxford textbook of Medicine. Third Edition. Oxford, UK: Oxford University Press; 1996:3425-3432.
• Hiorns LR, Swansbury GJ, Zomas A, Catovsky D. Partial trisomy of chromosome 4 resulting from a novel t[4;7) translocation in a case of AML M2 with eosinophilia. Cancer Genet Cytogenet. 1996 Jan;86(1):89-91. 
• Valverde LR, Matutes E, Farahat N, Heffernan A, Owusu-Ankomah K, Morilla R, Catovsky D. C-kit receptor (CD117) expression in acute leukemia. Ann Hematol. 1996 Jan;72(1):11-5. 
• Matutes E, Coelho E, Aguado MJ, Morilla R, Crawford A, Owusu-Ankomah K, Catovsky D. Expression of TIA-1 and TIA-2 in T cell malignancies and T cell lymphocytosis. J Clin Pathol. 1996 Feb;49(2):154-8. 
• Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R, Hamblin T, Lens D, Swansbury GJ, Catovsky D. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol. 1996 Feb;92(2):382-8. 
• Karakantza M, Matutes E, MacLennan K, O’Connor NT, Srivastava PC, Catovsky D. Association between sarcoidosis and lymphoma revisited. J Clin Pathol. 1996 Mar;49(3):208-12. 
• Mehta J, Powles R, Singhal S, Iveson T, Treleaven J, Catovsky D. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia. Bone Marrow Transplant. 1996 Mar;17(3):371-5.
• Mercieca J, Bain B, Barbour G, Catovsky D. Teaching cases from the Royal Marsden and St. Mary’s Hospitals case 10 microcytic anaemia and thrombocytosis. Leuk Lymphoma. 1996 Mar;21(1-2):185-6. 
• Rossi E, Matutes E, Morilla R, Owusu-Ankomah K, Heffernan AM, Catovsky D. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. Leukemia. 1996 Mar;10(3):494-7.
• Osterborg A, Fassas AS, Anagnostopoulos A, Dyer MJ, Catovsky D, Mellstedt H. Humanized CD52 monoclonal antibody Campath-1H as first-line treatment in chronic lymphocytic leukaemia. Br J Haematol. 1996 Apr;93(1):151-3. 
• Ozanne C, Bain B, Catovsky D. Teaching cases from the Royal Marsden and St Mary’s Hospital case 11 dysplastic neutrophils in an African women. Leuk Lymphoma. 1996 Apr;21(3-4):351-2. 
• Zani VJ, Asou N, Jadayel D, Heward JM, Shipley J, Nacheva E, Takasuki K, Catovsky D, Dyer MJ. Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. Blood. 1996 Apr 15;87(8):3124-34. 
• Matutes E, Catovsky D. Similarities between T-cell chronic lymphocytic leukemia and the small-cell variant of T-prolymphocytic leukemia. Blood. 1996 Apr 15;87(8):3520-1. 
• Astsaturov IA, Matutes E, Morilla R, Seon BK, Mason DY, Farahat N, Catovsky D. Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia. Leukemia. 1996 May;10(5):769-73.
• Mehta J, Powles R, Singhal S, Matthey F, Hamblin M, Middleton G, Prendiville J, Glynne P, Zomas A, Treleaven J, Catovsky D. T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure. Bone Marrow Transplant. 1996 May;17(5):881-3.
• Mercieca J, Matutes E, Emmett E, Coles H, Catovsky D. 2-Chlorodeoxyadenosine in the treatment of hairy cell leukaemia: differences in response in patients with and without abdominal lymphadenopathy. Br J Haematol. 1996 May;93(2):409-11. 
• Rochant H, Castaigne S, Catovsky D, Delannoy A, Michaux JL, Troussard X. Leucémie à tricholeucocytes : nouveaux choix thérapeutiques? Hématologie. 1996 May-Jun;2(3):251-61. 
• Pawson R, A’Hern R, Catovsky D. Second malignancy in hairy cell leukaemia: no evidence of increased incidence after treatment with interferon alpha. Leuk Lymphoma. 1996 Jun;22(1-2):103-6. 
• Philpott NJ, Elebute MO, Powles R, Treleaven JG, Gore M, Dainton MG, Min T, Swansbury GJ, Catovsky D. Platinum agents and secondary myeloid leukaemia: two cases treated only with platinum-based drugs. Br J Haematol. 1996 Jun;93(4):884-7. 
• Ginaldi L, Matutes E, Farahat N, De Martinis M, Morilla R, Catovsky D. Differential expression of CD3 and CD7 in T-cell malignancies: a quantitative study by flow cytometry. Br J Haematol. 1996 Jun;93(4):921-7. 
• Mitchell PL, Clutterbuck RD, Powles RL, De Lord C, Morilla R, Hiorns LR, Titley J, Catovsky D, Millar JL. Interleukin-4 enhances the survival of severe combined immunodeficient mice engrafted with human B-cell precursor leukemia. Blood. 1996 Jun 1;87(11):4797-803. 
• Height SE, Swansbury GJ, Matutes E, Treleaven JG, Catovsky D, Dyer MJ. Analysis of clonal rearrangements of the Ig heavy chain locus in acute leukemia. Blood. 1996 Jun 15;87(12):5242-50. 
• Dyer MJ, Lillington DM, Bastard C, Tilly H, Lens D, Heward JM, Stranks G, Morilla R, Monrad S, Guglielmi P, Kluin-Nelemans JC, Hagemeijer A, Young BD, Catovsky D. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus. Leukemia. 1996 Jul;10(7):1198-208.
• Ginaldi L, Farahat N, Matutes E, De Martinis M, Morilla R, Catovsky D. Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry. J Clin Pathol. 1996 Jul;49(7):539-44. 
• Carbonell F, Swansbury J, Min T, Matutes E, Farahat N, Buccheri V, Morilla R, Secker-Walker L, Catovsky D. Cytogenetic findings in acute biphenotypic leukaemia. Leukemia. 1996 Aug;10(8):1283-7.
• Resnitzky P, Matutes E, Hedges M, Morilla R, Brito-Babapulle V, Khokhar T, Catovsky D. The ultrastructure of mantle cell lymphoma and other B-cell disorders with translocation t(11;14)(q13;q32). Br J Haematol. 1996 Aug;94(2):352-61. 
• Catovsky D, Matutes E, Brito-Babapulle V. Is T-cell CLL a disease entity? Br J Haematol. 1996 Sep;94(3):580.
• Durosinmi MA, Matutes E, Ryan K, Nathwani A, Hedges M, Catovsky D. Royal Marsden teaching cases. An elderly man with weight loss and anaemia. Leuk Lymphoma. 1996 Sep;23(1-2):181-3. 
• Yuille MA, Galiegue-Zouitina S, Hiorns LR, Jadayel D, De Schouwer PJ, Catovsky D, Dyer MJ, Kerckaert JP. Heterogeneity of breakpoints at the transcriptional co-activator gene, BOB-1, in lymphoproliferative disease. Leukemia. 1996 Sep;10(9):1492-6.
• Garcia-Marco JA, Caldas C, Price CM, Wiedemann LM, Ashworth A, Catovsky D. Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia. Blood. 1996 Sep 1;88(5):1568-75. 
• Catovsky D, Oscier DG, Einhorn S, Garcia-Marco JA. Cellular/cytogenetic events in CLL. Leuk Lymphoma. 1996 Oct;22(Suppl 2):41-5. 
• Deardren C, Corbin D, Prussia P, Williams E, Hanshard B, Matutes E, Catovsky D. Clinical and laboratory features of adult T-cell leukaemia lymphoma in Barbados. Leuk Lymphoma. 1996 Nov;23(5-6):561-5. 
• Garcìa-Marco JA, Price CM, Ellis J, Morey M, Matutes E, Lens D, Colman S, Catovsky D. Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia. Leukemia. 1996 Nov;10(11):1705-11.
• Millar BC, Millar JL, Bell JB, Raje N, Milan S, Mehta J, Singhal S, Middleton GW, Sheperd V, Catovsky D, Powles RL. Role of CD34+ cells in engraftment after high-dose melphalan in multiple myeloma patients given peripheral blood stem cell rescue. Bone Marrow Transplant. 1996 Nov;18(5):871-8.
• Pawson R, Catovsky D, Schulz TF. Lack of evidence of HHV-8 in mature T-cell lymphoproliferative disorders. Lancet. 1996 Nov 23;348(9039):1450-1. 
• Catovsky D. Current approach to the biology and treatment of chronic lymphoid malignancies other than CLL. Hematol Cell Ther. 1996 Dec;38(Suppl 2):S63-6.
• Catovsky D. Clinical experience with 2′-deoxycoformycin. Hematol Cell Ther. 1996 Dec;38(Suppl 2):S103-7.
• Zomas AP, Matutes E, Morilla R, Owusu-Ankomah K, Seon BK, Catovsky D. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia. 1996 Dec;10(12):1966-70.

1997

• Brito-Babapulle V, Garcia-Marco J, Maljaie SH, Hiorns L, Coignet L, Conchon M, Catovsky D. The impact of molecular cytogenetics on chronic lymphoid leukaemia. Acta Haematol. 1997;98(4):175-86. 
• Catovsky D. Immunophenotypic analysis of chronic lymphoid leukemias. Rev Clin Exp Hematol. 1997;1:3‑14.
• Jadayel DM, Lukas J, Nacheva E, Bartkova J, Stranks G, De Schouwer PJ, Lens D, Bartek J, Dyer MJ, Kruger AR, Catovsky D. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin’s lymphomas. Functional studies in a cell line (Granta 519). Leukemia. 1997 Jan;11(1):64-72. 
• Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M, Catovsky D. Definition of acute biphenotypic leukemia. Haematologica. 1997 Jan-Feb;82(1):64-6. 
• Hiorns LR, Swansbury GJ, Mehta J, Min T, Dainton MG, Treleaven J, Powles RL, Catovsky D. Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia. Br J Haematol. 1997 Feb;96(2):314-21. 
• Newman A, Clutterbuck RD, Powles RL, Catovsky D, Millar JL. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors. Leuk Lymphoma. 1997 Feb;24(5-6):533-7. 
• Bowen AL, Zomas A, Emmett E, Matutes E, Dyer MJ, Catovsky D. Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia. Br J Haematol. 1997 Mar;96(3):617-9. 
• Brito-Babapulle V, Maljaie SH, Matutes E, Hedges M, Yuille M, Catovsky D. Relationship of T leukaemias with cerebriform nuclei to T-prolymphocytic leukaemia: a cytogenetic analysis with in situ hybridization. Br J Haematol. 1997 Mar;96(4):724-32. 
• Csanaky G, Matutes E, Vass JA, Morilla R, Catovsky D. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias. Leukemia. 1997 Mar;11(3):408-15. 
• Garcia-Marco JA, Price CM, Catovsky D. Interphase cytogenetics in chronic lymphocytic leukemia. Cancer Genet Cytogenet. 1997 Mar;94(1):52-8. 
• Zomas AP, Swansbury GJ, Matutes E, Pinkerton R, Hiorns LR, Min T, Farahat N, Catovsky D. Bilineal acute leukemia of B and T lineage with a novel translocation t(9;17)(p11;q11). Leuk Lymphoma. 1997 Mar;25(1-2):179-85. 
• Lens D, De Schouwer PJ, Hamoudi RA, Abdul-Rauf M, Farahat N, Matutes E, Crook T, Dyer MJ, Catovsky D. p53 abnormalities in B-cell prolymphocytic leukemia. Blood. 1997 Mar 15;89(6):2015-23. 
• Osterborg A, Dyer MJ, Bunjes D, Pangalis GA, Bastion Y, Catovsky D, Mellstedt H. Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia. J Clin Oncol. 1997 Apr;15(4):1567-74. 
• Conchon M, McManus AP, Min T, Maljaie SH, Crawford A, Brito-Babapulle V, Matutes E, Catovsky D. Two unbalanced translocations, t(12;22)(p13;q11) and t(12;?)(p13;?), in an aggressive chronic B-cell leukemia: TEL gene analysis using FISH. Cancer Genet Cytogenet. 1997 Jun;95(2):137-40. 
• Dyer MJ, Kelsey SM, Mackay HJ, Emmett E, Thornton P, Hale G, Waldmann H, Newland AC, Catovsky D. In vivo ‘purging’ of residual disease in CLL with Campath-1H. Br J Haematol. 1997 Jun;97(3):669-72. 
• Mehta J, Powles R, Singhal S, Riley U, Treleaven J, Catovsky D. Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation. Leuk Lymphoma. 1997 Jun;26(1-2):83-8. 
• Millar BC, Millar JL, Powles RL, Catovsky D. Interferon-gamma+ and interleukin-2+ T cells in peripheral blood from multiple myeloma patients in relation to disease status and maintenance therapy with interferon-alpha2b (intron A). Br J Haematol. 1997 Jul;98(1):119-25. 
• Pawson R, Dyer MJ, Barge R, Matutes E, Thornton PD, Emmett E, Kluin-Nelemans JC, Fibbe WE, Willemze R, Catovsky D. Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. J Clin Oncol. 1997 Jul;15(7):2667-72. 
• Pawson R, Matutes E, Brito-Babapulle V, Maljaie H, Hedges M, Mercieca J, Dyer M, Catovsky D. Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia? Leukemia. 1997 Jul;11(7):1009-13. 
• Farias de Carvalho SM, Pombo de Oliveira MS, Thuler LC, Rios M, Coelho RC, Rubim LC, Silva EM, Reis AM, Catovsky D. HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jul 1;15(3):238-42. 
• Clutterbuck RD, Newman A, Powles R, Catovsky D, Millar JL. G-CSF mobilization of haemopoietic cell populations in SCID mice engrafted with human leukaemia. Bone Marrow Transplant. 1997 Aug;20(4):325-32. 
• Matutes E, Meeus P, McLennan K, Catovsky D. The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long-term follow-up study. Br J Haematol. 1997 Aug;98(2):375-83. Pawson R, Schulz TF, Matutes E, Catovsky D. The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia. Leukemia. 1997 Aug;11(8):1305-11. 
• Atra A, Abboudi Z, Farahat N, Catovsky D. Quantitative flow cytometry can predict childhood acute lymphoblastic leukaemia presenting with aplasia. Leuk Lymphoma. 1997 Sep;27(1-2):173-7. 
• Maynadié M, Matutes E, Catovsky D. Quantification of P-glycoprotein in chronic lymphocytic leukemia by flow cytometry. Leuk Res. 1997 Sep;21(9):825-31. 
• Prentice HG, Hann IM, Herbrecht R, Aoun M, Kvaloy S, Catovsky D, Pinkerton CR, Schey SA, Jacobs F, Oakhill A, Stevens RF, Darbyshire PJ, Gibson BE. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol. 1997 Sep;98(3):711-8. 
• Bazarbachi A, Soriano V, Pawson R, Vallejo A, Moudgil T, Matutes E, Peries J, Molina A, de The H, Schulz TF, Catovsky D, Gill PS. Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol. 1997 Sep;98(4):927-33. 
• Oscier DG, Matutes E, Copplestone A, Pickering RM, Chapman R, Gillingham R, Catovsky D, Hamblin TJ. Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. Br J Haematol. 1997 Sep;98(4):934-9. 
• Vorechovský I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarström L, Webster AD, Yuille MA. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet. 1997 Sep;17(1):96-9. 
• Steele JP, Clutterbuck RD, Powles RL, Mitchell PL, Horton C, Morilla R, Catovsky D, Millar JL. Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice. Blood. 1997 Sep 1;90(5):2015-9. 
• Willis TG, Jadayel DM, Coignet LJ, Abdul-Rauf M, Treleaven JG, Catovsky D, Dyer MJ. Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood. 1997 Sep 15;90(6):2456-64. 
• Moreau EJ, Matutes E, A’Hern RP, Morilla AM, Morilla RM, Owusu-Ankomah KA, Seon BK, Catovsky D. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol. 1997 Oct;108(4):378-82. 
• Cabezudo E, Matutes E, Ramrattan M, Morilla R, Catovsky D. Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry. Leukemia. 1997 Nov;11(11):1909-14. 
• Catovsky D. The search for genetic clues in chronic lymphocytic leukemia. Hematol Cell Ther. 1997 Nov;39(Suppl 1):S5-11. 
• Lens D, Dyer MJ, Garcia-Marco JM, De Schouwer PJ, Hamoudi RA, Jones D, Farahat N, Matutes E, Catovsky D. p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. Br J Haematol. 1997 Dec;99(4):848-57. 

1998

• Johnson SA, Catovsky D, Child JA, Newland AC, Milligan DW, Janmohamed R. Phase I/II evaluation of pentostatin (2′-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia. Invest New Drugs. 1998;16(2):155-60. 
• Luo L, Lu F-M, Dyer MJS, Catovsky D, Yuille MAR, Vorechovský I. ATM as a tumour suppressor in T-cell prolymphocytic leukaemia: is there an epigenetic inactivation? Dis Markers. 1998;14:52-54.
• Ginaldi L, De Martinis M, Matutes E, Farahat N, Morilla R, Dyer MJ, Catovsky D. Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H. Leuk Res. 1998 Feb;22(2):185-91. 
• Luckit J, Bain B, Matutes E, Min T, Pinkerton R, Catovsky D. Teaching cases from the Royal Marsden and St Mary’s Hospitals. Case 13: an orbital mass in a young girl. Leuk Lymphoma. 1998 Feb;28(5-6):621-2. 
• Bain B, Matutes E, Catovsky D. Teaching cases from the Royal Marsden and St Mary’s Hospitals. Case 14: persistent lymphocytosis in a middle aged smoker. Leuk Lymphoma. 1998 Feb;28(5-6):623-5. 
• Matutes E, Barton DP, McCarthy K, Moskovic E, Catovsky D. Teaching cases from the Royal Marsden and St Mary’s Hospitals. Case 15: uterine mass in an asymptomatic female. Leuk Lymphoma. 1998 Feb;28(5-6):627-30. 
• Yuille MA, Coignet LJ, Abraham SM, Yaqub F, Luo L, Matutes E, Brito-Babapulle V, Vorechovský I, Dyer MJ, Catovsky D. ATM is usually rearranged in T-cell prolymphocytic leukaemia. Oncogene. 1998 Feb 12;16(6):789-96. 
• De Lord C, Powles R, Mehta J, Wilson K, Treleaven J, Meller S, Catovsky D. Familial acute myeloid leukaemia: four male members of a single family over three consecutive generations exhibiting anticipation. Br J Haematol. 1998 Mar;100(3):557-60. 
• Killick S, Matutes E, Lo S, Taylor G, Wotherspoon A, Catovsky D. Teaching cases from the Royal Marsden Hospital. Case 16: T-cell non Hodgkin’s lymphoma associated with hypercalcaemia in a black Caribbean. Leuk Lymphoma. 1998 Mar;29(1-2):211-5. 
• Willis TG, Zalcberg IR, Coignet LJ, Wlodarska I, Stul M, Jadayel DM, Bastard C, Treleaven JG, Catovsky D, Silva ML, Dyer MJ. Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood. 1998 Mar 15;91(6):1873-81. 
• Farahat N, Morilla A, Owusu-Ankomah K, Morilla R, Pinkerton CR, Treleaven JG, Matutes E, Powles RL, Catovsky D. Detection of minimal residual disease in B-lineage acute lymphoblastic leukaemia by quantitative flow cytometry. Br J Haematol. 1998 Apr;101(1):158-64.
• García-Marco JA, Nouel A, Navarro B, Matutes E, Oscier D, Price CM, Catovsky D. Molecular cytogenetic analysis in splenic lymphoma with villous lymphocytes: frequent allelic imbalance of the RB1 gene but not the D13S25 locus on chromosome 13q14. Cancer Res. 1998 Apr 15;58(8):1736-40. 
• Catovsky D, Farahat N, Matutes E, Powles RL, Pinkerton CR. Minimal residual disease in children with acute lymphoblastic leukaemia. Lancet. 1998 Apr 25;351(9111):1287. 
• Ginaldi L, De Martinis M, Matutes E, Farahat N, Morilla R, Catovsky D. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol. 1998 May;51(5):364-9. 
• Maljaei SH, Brito-Babapulle V, Hiorns LR, Catovsky D. Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization. Cancer Genet Cytogenet. 1998 Jun;103(2):110-6. 
• Luo L, Lu FM, Hart S, Foroni L, Rabbani H, Hammarström L, Yuille MR, Catovsky D, Webster AD, Vorechovský I. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL. Cancer Res. 1998 Jun 1;58(11):2293-7. 
• Clutterbuck RD, Millar BC, Powles RL, Newman A, Catovsky D, Jarman M, Millar JL. Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice. Br J Haematol. 1998 Jul;102(2):522-7. 
• Sternberg AJ, Matutes E, Killick S, Wotherspoon AC, Catovsky D. Prolonged disease-free survival in relapsed/refractory low-grade lymphoma treated with fludarabine: a report of four cases. Br J Haematol. 1998 Jul;102(2):532-4. 
• Killick S, Matutes E, Swansbury J, Catovsky D. Teaching Cases from the Royal Marsden Hospital. Case 17: Essential thrombocythaemia with inversion 3 terminating in acute leukaemia. Leuk Lymphoma. 1998 Aug;30(5-6):661-4. 
• Millar JL, Millar BC, Powles RL, Steele JP, Clutterbuck RD, Mitchell PL, Cox G, Forssen E, Catovsky D. Liposomal vincristine for the treatment of human acute lymphoblastic leukaemia in severe combined immunodeficient (SCID) mice. Br J Haematol. 1998 Aug;102(3):718-21. 
• Pawson R, Schulz T, Matutes E, Catovsky D. Absence of HTLV-I/II in T-prolymphocytic leukaemia. Br J Haematol. 1998 Aug;102(3):872-3. 
• Millar BC, Millar JL, Shepherd V, Blackwell P, Porter H, Cunningham D, Judson I, Treleaven J, Powles RL, Catovsky D. The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue. Bone Marrow Transplant. 1998 Sep;22(5):469-75. 
• Navarro B, García-Marco JA, Jones D, Price CM, Catovsky D. Association and clonal distribution of trisomy 12 and 13q14 deletions in chronic lymphocytic leukaemia. Br J Haematol. 1998 Sep;102(5):1330-4. 
• De Lord C, Mercieca J, Ashton-Key M, Singh L, Ryley S, Isaacson P, Catovsky D. Aggressive NK cell lymphoma preceded by a ten year history of neutropenia associated with large granular lymphocyte lymphocytosis. Leuk Lymphoma. 1998 Oct;31(3-4):417-21. 
• Yuille MR, Houlston RS, Catovsky D. Anticipation in familial chronic lymphocytic leukaemia. Leukemia. 1998 Nov;12(11):1696-8. 
• Shaft D, Shtalrid M, Berebi A, Catovsky D, Resnitzky P. Ultrastructural characteristics and lysozyme content in hypergranular and variant type of acute promyelocytic leukaemia. Br J Haematol. 1998 Dec;103(3):729-39. 

1999

• Catovsky D, Hoffbrand AV. Acute leukaemia. In Hoffbrand AV, Lewis SM, Tuddenham EGD, Eds. Postgraduate Haematology. Fourth Edition. Oxford, UK: Butterworth Heinemann; 1999:373-404.
• Catovsky D. Chronic lymphoid leukaemias. In Hoffbrand AV, Lewis SM, Tuddenham EGD, Eds. Postgraduate Haematology. Fourth Edition. Oxford, UK: Butterworth Heinemann; 1999:405-433.
• Matutes E, Dearden C, Catovsky D. CAMPATH 1H (CD52) antibody therapy in lymphoid disorders. Haematologica. 1999;84(Suppl 1):187-192.
• Bevan S, Yuille MR, Marossy A, Catovsky D, Houlston RS. Ataxia telangiectasia gene mutations and chronic lymphocytic leukaemia. Lancet. 1999 Feb 27;353(9154):753. 
• Gruszka-Westwood AM, Matutes E, Coignet LJ, Wotherspoon A, Catovsky D. The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH. Br J Haematol. 1999 Mar;104(3):600-4. 
• Catovsky D, Matutes E. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Semin Hematol. 1999 Apr;36(2):148-54.
• CLL Trialists’ Collaborative Group. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists’ Collaborative Group. J Natl Cancer Inst. 1999 May 19;91(10):861-8. 
• Catovsky D. Morphology, atypical chronic lymphocytic leukaemia and prognostic features affecting choice of therapy. Haematologica. 1999 Jun;84 Suppl EHA-4:92-3.
• Lens D, Coignet LJ, Brito-Babapulle V, Lima CS, Matutes E, Dyer MJ, Catovsky D. B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene. Leukemia. 1999 Jun;13(6):873-6. 
• Thornton PD, Hamblin M, Treleaven JG, Matutes E, Lakhani AK, Catovsky D. High dose methyl prednisolone in refractory chronic lymphocytic leukaemia. Leuk Lymphoma. 1999 Jun;34(1-2):167-70. 
• Coignet LJ, Lima CS, Min T, Streubel B, Swansbury J, Telford N, Swanton S, Bowen A, Nagai M, Catovsky D, Fonatsch C, Dyer MJ. Myeloid- and lymphoid-specific breakpoint cluster regions in chromosome band 13q14 in acute leukemia. Genes Chromosomes Cancer. 1999 Jul;25(3):222-9. 
• Dearden CE, Matutes E, Hilditch BL, Swansbury GJ, Catovsky D. Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine. Br J Haematol. 1999 Aug;106(2):515-9. 
• Killick S, Matutes E, Powles RL, Hamblin M, Swansbury J, Treleaven JG, Zomas A, Atra A, Catovsky D. Outcome of biphenotypic acute leukemia. Haematologica. 1999 Aug;84(8):699-706. 
• Killick S, Matutes E, Powles RL, Min T, Treleaven JG, Rege KP, Atra A, Catovsky D. Acute erythroid leukemia (M6): outcome of bone marrow transplantation. Leuk Lymphoma. 1999 Sep;35(1-2):99-107. 
• Bevan S, Catovsky D, Marossy A, Matutes E, Popat S, Antonovic P, Bell A, Berrebi A, Gaminara E, Quabeck K, Ribeiro I, Mauro FR, Stark P, Sykes H, van Dongen J, Wimperis J, Wright S, Yuille MR, Houlston RS. Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia. Leukemia. 1999 Oct;13(10):1497-500. 
• Frydecka I, Kaczmarek P, Boćko D, Kosmaczewska A, Morilla R, Catovsky D. Expression of signal-transducing zeta chain in peripheral blood T cells and natural killer cells in patients with Hodgkin’s disease in different phases of the disease. Leuk Lymphoma. 1999 Nov;35(5-6):545-54.
• Matutes E, Carrara P, Coignet L, Brito-Babapulle V, Villamor N, Wotherspoon A, Catovsky D. FISH analysis for BCL-1 rearrangements and trisomy 12 helps the diagnosis of atypical B cell leukaemias. Leukemia. 1999 Nov;13(11):1721-6. 
• Ribeiro I, Tsatalas C, Catovsky D. Treatment of red cell aplasia in CLL with fludarabine. Leukemia. 1999 Nov;13(11):1897. 
• Vallianatou K, Brito-Babapulle V, Matutes E, Atkinson S, Catovsky D. p53 gene deletion and trisomy 12 in hairy cell leukemia and its variant. Leuk Res. 1999 Nov;23(11):1041-5. 
• Bradshaw PS, Hamoudi R, Min T, Catovsky D, Houlston RS, Yuille MR. Fluorescent BAT-25 and BAT-26 analysis of T cell prolymphocytic leukaemia. Leukemia. 1999 Dec;13(12):2104-6. 

2000

• Brito-Babapulle V, Matutes E, Catovsky D. Cytogenetics, molecular genetics and immunophenotyping in hairy cell leukemia. In Tallman M, Polliack A, Eds. Hairy Cell Leukemia. Amsterdam, Netherlands: Harwood Academic; 2000:49-63.
• Matutes E, Catovsky D. (2000) The role of splenectomy in hairy cell leukemia. In Tallman M, Polliack A, Eds. Hairy Cell Leukemia. Amsterdam, Netherlands: Harwood Academic; 2000:127-139.
• Lens D, Matutes E, Catovsky D, Coignet LJ. Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL). Leukemia. 2000 Mar;14(3):427-30. https://doi.org/10.1038/sj.leu.2401644
• Sapunar F, Catovsky D, Wotherspoon A, Matutes E. Follicular lymphoma. A series of 11 patients with minimal or no treatment and long survival. Leuk Lymphoma. 2000 Mar;37(1-2):163-7. 
• Dearden CE, Matutes E, Catovsky D. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies. Semin Oncol. 2000 Apr;27(2 Suppl 5):22-6.
• Catovsky D. CLL variants and T-cell-related issues. Hematol Cell Ther. 2000 Jun;42(1):15-9. 
• Dearden C, Matutes E, Catovsky D. Pentostatin treatment of cutaneous T-cell lymphoma. Oncology (Williston Park). 2000 Jun;14(6 Suppl 2):37-40. 
• Yuille MR, Matutes E, Marossy A, Hilditch B, Catovsky D, Houlston RS. Familial chronic lymphocytic leukaemia: a survey and review of published studies. Br J Haematol. 2000 Jun;109(4):794-9. 
• Houlston RS, Catovsky D, Yuille MR. Pseudoautosomal linkage in chronic lymphocytic leukaemia. Br J Haematol. 2000 Jun;109(4):899-900. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Willman CL. Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17). Leukemia. 2000 Jul;14(7):1197-200. 
• Brito-Babapulle V, Hamoudi R, Matutes E, Watson S, Kaczmarek P, Maljaie H, Catovsky D. p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sezary syndrome. Br J Haematol. 2000 Jul;110(1):180-7. 
• De Schouwer PJ, Dyer MJ, Brito-Babapulle VB, Matutes E, Catovsky D, Yuille MR. T-cell prolymphocytic leukaemia: antigen receptor gene rearrangement and a novel mode of MTCP1 B1 activation. Br J Haematol. 2000 Sep;110(4):831-8.
• Sorour A, Brito-Babapulle V, Smedley D, Yuille M, Catovsky D. Unusual breakpoint distribution of 8p abnormalities in T-prolymphocytic leukemia: a study with YACS mapping to 8p11-p12. Cancer Genet Cytogenet. 2000 Sep;121(2):128-32. 
• Clutterbuck R, Powles R, Millar J, Catovsky D. Interleukin-6 and other gp130-dependent cytokines selectively inhibit proliferation of macrophage-lineage hemopoietic progenitor cells. Exp Hematol. 2000 Oct;28(10):1120-8. 
• Lopez-Matas M, Rodriguez-Justo M, Morilla R, Catovsky D, Matutes E. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia. Haematologica. 2000 Nov;85(11):1140-5. 
• Rege K, Swansbury GJ, Atra AA, Horton C, Min T, Dainton MG, Matutes E, Durosinmi M, Treleaven JG, Powles RL, Catovsky D. Disease features in acute myeloid leukemia with t(8;21)(q22;q22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival. Leuk Lymphoma. 2000 Dec;40(1-2):67-77. 
• Bevan S, Catovsky D, Matutes E, Antunovic P, Auger MJ, Ben-Bassat I, Bell A, Berrebi A, Gaminara EJ, Júnior ME, Mauro FR, Quabeck K, Rassam SM, Reid C, Ribeiro I, Stark P, van Dongen JJ, Wimperis J, Wright S, Marossy A, Yuille MR, Houlston RS. Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia. Blood. 2000 Dec 1;96(12):3982-4. 

2001

• Catovsky D. B-prolymphocytic leukemia (B-PLL). In Brenner S, Miller JH, Eds. The Encyclopedia of Genetics. London, UK: Academic Press; 2001:236.
• Catovsky D. Hairy cell leukemia (HCL). In Brenner S, Miller JH, Eds. The Encyclopedia of Genetics. London, UK: Academic Press; 2001:903.
• Catovsky D, Matutes E. Leukemias of mature T-cells. In Knowles DM, Ed. Neoplastic Hematopathology. Second edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2001: 1589-1602.
• Matutes E, Morilla R, Catovsky D. Immunophenotyping. In Lewis SM, Bain B, Bates I, Eds. Practical Haematology. Ninth edition. London, UK: Churchill Livingstone; 2001: 297-314.
• Matutes E, Brito-Babapulle V, Yuillie MR, Catovsky D, Dearden C. Prolymphocytic leukemia of B- and T-cell types: biology and therapy. In Cheson B, Ed. Chronic Lymphocytic Leukemia. Second edition. Marcel Dekker, Inc. 2001; 525-541.
• Müller-Hermelink HK, Catovsky D, Montserrat E, Harris NL. Chronic lymphocytic leukaemia/small lymphocytic leukaemia. In Jaffe E, Harris NL, Stein H, Vardiman JW, Eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:127-130.
• Catovsky D, Montserrat E, Müller-Hermelink HK, Harris NL. B-cell prolymphocytic leukaemia. In Jaffe E, Harris NL, Stein H, Vardiman JW, Eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:131-134.
• Isaacson PG, Piris MA, Catovsky D, Swerdlow S, Montserrat E, Berger F, Müller-Hermelink HK, Nathwani B, Harris NL. Splenic marginal zone lymphoma. In Jaffe E, Harris NL, Stein H, Vardiman JW, Eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:135-136.
• Foucar K, Catovsky D. Hairy cell leukaemia. In Jaffe E, Harris NL, Stein H, Vardiman JW, Eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:138-141.
• Catovsky D, Ralfkiaer E, Müller-Hermelink HK. T-cell prolymphocytic leukaemia. In Jaffe E, Harris NL, Stein H, Vardiman JW, Eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:195-196.
• Chan WC, Catovsky D, Foucar K, Montserrat E. T-cell large granular lymphocyte leukaemia. In Jaffe E, Harris NL, Stein H, Vardiman JW, Eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:197-198.
• Matutes E, Wotherspoon A, Brito-Babapulle V, Catovsky D. The natural history and clinico-pathological features of the variant form of hairy cell leukemia. Leukemia. 2001 Jan;15(1):184-6. 
• Elnenaei MO, Jadayel DM, Matutes E, Morilla R, Owusu-Ankomah K, Atkinson S, Titley I, Mandala EM, Catovsky D. Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies. Leuk Res. 2001 Feb;25(2):115-23. 
• Yuille MR, Condie A, Stone EM, Wilsher J, Bradshaw PS, Brooks L, Catovsky D. TCL1 is activated by chromosomal rearrangement or by hypomethylation. Genes Chromosomes Cancer. 2001 Apr;30(4):336-41. 
• Porter WM, Sidwell RU, Catovsky D, Bunker CB. Cutaneous presentation of chronic lymphatic leukaemia and response to ultraviolet B phototherapy. Br J Dermatol. 2001 May;144(5):1092-4. 
• Gruszka-Westwood AM, Hamoudi RA, Matutes E, Tuset E, Catovsky D. p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood. 2001 Jun 1;97(11):3552-8. 
• Brito-Babapulle V, Baou M, Matutes E, Morilla R, Atkinson S, Catovsky D. Deletions of D13S25, D13S319 and RB-1 mapping to 13q14.3 in T-cell prolymphocytic leukaemia. Br J Haematol. 2001 Aug;114(2):327-32. 
• Dearden CE, Matutes E, Cazin B, Tjønnfjord GE, Parreira A, Nomdedeu B, Leoni P, Clark FJ, Radia D, Rassam SM, Roques T, Ketterer N, Brito-Babapulle V, Dyer MJ, Catovsky D. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood. 2001 Sep 15;98(6):1721-6. 
• Boogaerts MA, Van Hoof A, Catovsky D, Kovacs M, Montillo M, Zinzani PL, Binet JL, Feremans W, Marcus R, Bosch F, Verhoef G, Klein M. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia. J Clin Oncol. 2001 Nov 15;19(22):4252-8. 
• Tuset E, Matutes E, Brito-Babapulle V, Morilla R, Catovsky D. Immunophenotype changes and loss of CD52 expression in two patients with relapsed T-cell prolymphocytic leukaemia. Leuk Lymphoma. 2001 Nov-Dec;42(6):1379-83. 
• Chau I, Webb A, Cunningham D, Hill M, Rao S, Ageli S, Norman A, Gill K, Howard A, Catovsky D. An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin’s lymphoma. Br J Haematol. 2001 Dec;115(4):786-92. 
• Matutes E, Wotherspoon AC, Parker NE, Osuji N, Isaacson PG, Catovsky D. Transformation of T-cell large granular lymphocyte leukaemia into a high-grade large T-cell lymphoma. Br J Haematol. 2001 Dec;115(4):801-6. 

2002

• Catovsky D. Familial chronic lymphocytic leukaemia. Haematologica. 2002;87(Suppl 2):3-4.
• Dearden CE, Matutes E, Catovsky D. Alemtuzumab in T-cell malignancies. Med Oncol. 2002;19 Suppl:S27-32. 
• Abdou SMH, Jadayel DM, Min T, Swansbury GJ, Dainton MG, Jafer O, Powles RL, Catovsky D. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia. Leuk Lymphoma. 2002 Jan;43(1):89-95. 
• Bradshaw PS, Condie A, Matutes E, Catovsky D, Yuille MR. Breakpoints in the ataxia telangiectasia gene arise at the RGYW somatic hypermutation motif. Oncogene. 2002 Jan 17;21(3):483-7. 
• Gruszka-Westwood AM, Atkinson S, Summersgill BM, Shipley J, Elnenaei MO, Jain P, Hamoudi RA, Kaeda JS, Wotherspoon AC, Matutes E, Catovsky D. Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene. Genes Chromosomes Cancer. 2002 Feb;33(2):206-12.
• Thomas R, Ribeiro I, Shepherd P, Johnson P, Cook M, Lakhani A, Kaczmarski R, Carrington P, Catovsky D. Spontaneous clinical regression in chronic lymphocytic leukaemia. Br J Haematol. 2002 Feb;116(2):341-5. 
• Brito-Babapulle V, Gruszka-Westwood AM, Platt G, Andersen CL, Elnenaei MO, Matutes E, Wotherspoon AC, Weston-Smith SG, Catovsky D. Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin’s lymphoma with leukemia. Haematologica. 2002 Apr;87(4):357-62. 
• Patel KC, Bain BJ, Matutes E, Catovsky D. Teaching cases from the royal marsden and St Mary’s Hospitals. Case 22: an unusual cause of lymphocytosis. Leuk Lymphoma. 2002 Apr;43(4):923-5. 
• Houlston RS, Catovsky D, Yuille MR. Genetic susceptibility to chronic lymphocytic leukemia. Leukemia. 2002 Jun;16(6):1008-14. 
• Yuille M, Condie A, Hudson C, Kote-Jarai Z, Stone E, Eeles R, Matutes E, Catovsky D, Houlston R. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood. 2002 Jun 1;99(11):4216-8. 
• Scolnik MP, Morilla R, de Bracco MM, Catovsky D, Matutes E. CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease. Leuk Res. 2002 Jul;26(7):615-9. 
• Summersgill B, Thornton P, Atkinson S, Matutes E, Shipley J, Catovsky D, Houlston RS, Yuille MR. Chromosomal imbalances in familial chronic lymphocytic leukaemia: a comparative genomic hybridisation analysis. Leukemia. 2002 Jul;16(7):1229-32. 
• Yuille MR, Condie A, Hudson CD, Bradshaw PS, Stone EM, Matutes E, Catovsky D, Houlston RS. ATM mutations are rare in familial chronic lymphocytic leukemia. Blood. 2002 Jul 15;100(2):603-9. 
• Ruchlemer R, Wotherspoon AC, Thompson JN, Swansbury JG, Matutes E, Catovsky D. Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemia. Br J Haematol. 2002 Sep;118(4):952-8. 
• Benzow KA, Koob MD, Condie A, Catovsky D, Matutes E, Yuille MR, Houlston RS. Instability of CAG-trinucleotide repeats in chronic lymphocytic leukemia. Leuk Lymphoma. 2002 Oct;43(10):1987-90. 
• Rawstron AC, Yuille MR, Fuller J, Cullen M, Kennedy B, Richards SJ, Jack AS, Matutes E, Catovsky D, Hillmen P, Houlston RS. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood. 2002 Oct 1;100(7):2289-90. 
• Solenthaler M, Matutes E, Brito-Babapulle V, Morilla R, Catovsky D. p53 and mdm2 in mantle cell lymphoma in leukemic phase. Haematologica. 2002 Nov;87(11):1141-50. 
• Jain P, Giustolisi GM, Atkinson S, Elnenaei MO, Morilla R, Owusu-Ankomah K, Rafiq-Mohammed F, Matutes E, Wotherspoon A, Catovsky D. Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry. J Clin Pathol. 2002 Dec;55(12):940-5. 

2003

• Catovsky D. The classification of leukaemia. In Warrell DA, Cox TM, Firth JD, Benz EJ, Eds. Oxford Textbook of Medicine. Fourth Edition. Oxford, UK: Oxford University Press;2003:525-529.
• Catovsky D. Chronic lymphocytic leukaemia and other leukaemias of mature B and T cells. In Warrell DA, Cox TM, Firth JD, Benz EJ, Eds. Oxford Textbook of Medicine. Fourth Edition. Oxford, UK: Oxford University Press;2003:539-546.
• Catovsky D. Causation of CLL — insights from family studies. Leuk Lymphoma. 2003;44:S37-S38.
• Gruszka-Westwood AM, Hamoudi R, Osborne L, Matutes E, Catovsky D. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes. Genes Chromosomes Cancer. 2003 Jan;36(1):57-69. 
• Elnenaei MO, Hamoudi RA, Swansbury J, Gruszka-Westwood AM, Brito-Babapulle V, Matutes E, Catovsky D. Delineation of the minimal region of loss at 13q14 in multiple myeloma. Genes Chromosomes Cancer. 2003 Jan;36(1):99-106. 
• Sah SP, Matutes E, Wotherspoon AC, Morilla R, Catovsky D. A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders. J Clin Pathol. 2003 Feb;56(2):129-32. 
• Tierens A, Delabie J, Malecka A, Wang J, Gruszka-Westwood A, Catovsky D, Matutes E. Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations. Am J Pathol. 2003 Feb;162(2):681-9. 
• Matutes E, Wotherspoon A, Catovsky D. The variant form of hairy-cell leukaemia. Best Pract Res Clin Haematol. 2003 Mar;16(1):41-56. 
• Parry-Jones N, Matutes E, Gruszka-Westwood AM, Swansbury GJ, Wotherspoon AC, Catovsky D. Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. Br J Haematol. 2003 Mar;120(5):759-64. 
• Chau I, Harries M, Cunningham D, Hill M, Ross PJ, Archer CD, Norman AR, Wotherspoon A, Koh DM, Gill K, Uzzell M, Prior Y, Catovsky D. Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin’s and non-Hodgkin’s lymphoma. Br J Haematol. 2003 Mar;120(6):970-7. 
• Elnenaei MO, Gruszka-Westwood AM, A’Hern R, Matutes E, Sirohi B, Powles R, Catovsky D. Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A. Haematologica. 2003 May;88(5):529-37. 
• Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E, Catovsky D, Thomas PW, Avet-Loiseau H, Oscier D. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood. 2003 Jun 15;101(12):4975-81. Epub 2003 Feb 27. 
• Chau I, Jones R, Cunningham D, Wotherspoon A, Maisey N, Norman AR, Jain P, Bishop L, Horwich A, Catovsky D. Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy? Br J Cancer. 2003 Jul 7;89(1):36-42. 
• Boyd RS, Adam PJ, Patel S, Loader JA, Berry J, Redpath NT, Poyser HR, Fletcher GC, Burgess NA, Stamps AC, Hudson L, Smith P, Griffiths M, Willis TG, Karran EL, Oscier DG, Catovsky D, Terrett JA, Dyer MJ. Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B. Leukemia. 2003 Aug;17(8):1605-12. 
• Matutes E, Catovsky D. Classification of mature T-cell leukemias. Leukemia. 2003 Aug;17(8):1682-3. 
• Houlston RS, Sellick G, Yuille M, Matutes E, Catovsky D. Causation of chronic lymphocytic leukemia–insights from familial disease. Leuk Res. 2003 Oct;27(10):871-6. 
• Osuji N, Fearfield L, Matutes E, Wotherspoon A, Bunker C, Catovsky D. Granulomatous slack skin disease–disease features and response to pentostatin. Br J Haematol. 2003 Oct;123(2):297-304. 
• Delgado J, Matutes E, Morilla AM, Morilla R, Owusu-Ankomah K, Rafiq-Mohammed F, del Giudice I, Catovsky D. Diagnostic significance of CD20 and FMC7 expression in B-cell disorders. Am J Clin Pathol. 2003 Nov;120(5):754-9. 
• Thornton PD, Matutes E, Bosanquet AG, Lakhani AK, Grech H, Ropner JE, Joshi R, Mackie PH, Douglas IDC, Bowcock SJ, Catovsky D. High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities. Ann Hematol. 2003 Dec;82(12):759-65. Epub 2003 Oct 10. 

2004

• Sellick G, Catovsky D, Houlston RS. Familial chronic lymphocytic leukaemia. In Hamblin T, Johnson S, Miles A, Eds. The Effective Management of Chronic Lymphocytic Leukaemia. London, UK: Aesculapius Medical Press; 2004: 3-15.
• Catovsky D. Clinical trials on chronic lymphocytic leukaemia in the United Kingdom. In Hamblin T, Johnson S, Miles A, Eds. The Effective Management of Chronic Lymphocytic Leukaemia. London, UK: Aesculapius Medical Press; 2004:179-190.
• Yuille MR, Catovsky D, Houlston RS. Inherited predisposition to chronic lymphocytic leukemia. In Faguet GB, ed. Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management. Totowa, NJ: Humana Press Inc. 2004; 389-400.
• Thornton PD, Gruzka-Westwood AM, Hamoudi RA, Atkinson S, Pawel K, Morilla RM, Hilditch BL, A’Hern R, Matutes E, Catovsky D. Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia. Hematol J. 2004;5(1):47-54. 
• Thornton PD, Fernandez C, Giustolisi G, Morilla R, Atkinson S, A’Hern R, Matutes E, Catovsky D. CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. Hematol J. 2004;5(2):145-51. 
• Del Giudice I, Matutes E, Morilla R, Morilla AM, Owusu-Ankomah K, Rafiq F, A Hern R, Delgado J, Bazerbashi A, Catovsky D. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica. 2004 Mar;89(3):303-8. 
• Alvares CL, Matutes E, Scully MA, Swansbury J, Min T, Gruszka-Westwood A, Atkinson S, Hilditch B, Morilla R, Wotherspoon AC, Catovsky D. Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findings. Leuk Lymphoma. 2004 Apr;45(4):769-75. 
• Hendry L, Bowen A, Matutes E, Swansbury J, Catovsky D. Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin’s lymphoma. Leuk Lymphoma. 2004 May;45(5):945-50. 
• Ruchlemer R, Parry-Jones N, Brito-Babapulle V, Attolico I, Wotherspoon AC, Matutes E, Catovsky D. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia. Br J Haematol. 2004 May;125(3):330-6. 
• Agnew KL, Ruchlemer R, Catovsky D, Matutes E, Bunker CB. Cutaneous findings in chronic lymphocytic leukaemia. Br J Dermatol. 2004 Jun;150(6):1129-35. 
• Sellick GS, Allinson R, Matutes E, Catovsky D, Houlston RS. Increased sex concordance of sibling pairs with chronic lymphocytic leukemia. Leukemia. 2004 Jun;18(6):1162-3. 
• Sellick GS, Rudd M, Eve P, Allinson R, Matutes E, Catovsky D, Houlston RS. The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):1065-7. 
• Catovsky D. Definition and diagnosis of sporadic and familial chronic lymphocytic leukemia. Hematol Oncol Clin North Am. 2004 Aug;18(4):783-94, vii. 
• Matutes E, Parry-Jones N, Brito-Babapulle V, Wotherspoon A, Morilla R, Atkinson S, Elnenaei MO, Jain P, Giustolisi GM, A’Hern RP, Catovsky D. The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients. Leuk Lymphoma. 2004 Oct;45(10):2007-15. 
• Maravelaki S, Burford A, Wotherspoon A, Joshi R, Matutes E, Catovsky D, Brito-Babapulle V. Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region. Cancer Genet Cytogenet. 2004 Oct 1;154(1):67-71. 
• Troen G, Nygaard V, Jenssen T, Ikonomou IM, Tierens A, Matutes E, Gruszka-Westwood A, Catovsky D, Myklebost O, Lauritzsen G, Hovig E, Delabie J. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. J Mol Diagn. 2004 Nov;6(4):297-307. 
• Catovsky D, Matutes E, Dearden C, Osuji N, Brito-Babapulle V, Herling M, Jones D. The WHO classification of mature T-cell leukemias. Blood. 2004 Nov 1;104(9):2989-90. 
• Rudd MF, Sellick GS, Allinson R, Matutes E, Catovsky D, Houlston RS. MTHFR polymorphisms and risk of chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2268-70. 

2005

• Catovsky D. Chronic lymphocytic leukaemia and other B-cell disorders. In Hoffbrand AV, Catovsky D, Tuddenhaun E, Eds. Postgraduate Haematology. Fifth Edition. Oxford, UK: Blackwell Publishing; 2005:619-643.
• Catovsky D. Familial multiple myeloma. Haematologica. 2005 Jan;90(1):3-4.
• Sellick GS, Coleman RJ, Talaban RV, Fleischmann C, Rudd MF, Allinson R, Catovsky D, Houlston RS. Germline mutations in Dok1 do not predispose to chronic lymphocytic leukemia. Leuk Res. 2005 Jan;29(1):59-61. 
• Milligan DW, Fernandes S, Dasgupta R, Davies FE, Matutes E, Fegan CD, McConkey C, Child JA, Cunningham D, Morgan GJ, Catovsky D. Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses. Blood. 2005 Jan 1;105(1):397-404. Epub 2004 Apr 29. 
• Andersen CL, Gruszka-Westwood A, Atkinson S, Matutes E, Catovsky D, Pedersen RK, Pedersen BB, Pulczynski S, Hokland P, Jacobsen E, Koch J. Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization. Cancer Genet Cytogenet. 2005 Jan 15;156(2):122-8. 
• Del Giudice I, Matutes E, Osuji N, Parry-Jones N, Swansbury J, Catovsky D. Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström’s macroglobulinemia. Haematologica. 2005 Feb;90(2):268-70. 
• Osuji N, Matutes E, Wotherspoon A, Catovsky D. Lessons from a case of T-cell large granular lymphocytic leukaemia suggesting that immunomodulatory therapy is more effective than intensive treatment. Leuk Res. 2005 Feb;29(2):225-8. 
• Osuji N, Matutes E, Dearden C, Catovsky D. Pregnancy improves neutropenia in T-cell large granular lymphocyte leukaemia. Br J Haematol. 2005 Mar;128(5):645-8. 
• Sellick GS, Pritchard-Jones K, Shepherd V, Swansbury J, Catovsky D, Houlston RS. Loci other than 21q22.12 (RUNX1) and 16q21-23.2 cause familial AML. Leukemia. 2005 Mar;19(3):465-6. 
• Thornton PD, Bellas C, Santon A, Shah G, Pocock C, Wotherspoon AC, Matutes E, Catovsky D. Richter’s transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. Leuk Res. 2005 Apr;29(4):389-95.
• Ng M, Waters J, Cunningham D, Chau I, Horwich A, Hill M, Norman AR, Wotherspoon A, Catovsky D. Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma. Br J Cancer. 2005 Apr 25;92(8):1352-7. 
• Osuji N, Del Giudice I, Matutes E, Morilla A, Owusu-Ankomah K, Morilla R, Dunlop A, Catovsky D. CD52 expression in T-cell large granular lymphocyte leukemia–implications for treatment with alemtuzumab. Leuk Lymphoma. 2005 May;46(5):723-7. 
• Osuji N, Matutes E, Morilla A, Del Giudice I, Wotherspoon A, Catovsky D. Prolonged treatment response in aggressive natural killer cell leukemia. Leuk Lymphoma. 2005 May;46(5):757-63. 
• Gotic M, Cemerikic V, Elezovic I, Boskovic D, Bila J, Magic Z, Jocic DJ, Pavlovic D, Grujicic D, Stosic T, Wotherspoon A, Catovsky D. Successful treatment of extranodal Hodgkin’s lymphoma in a patient with longstanding hairy cell leukemia. Leuk Lymphoma. 2005 May;46(5):765-9. 
• Jønsson V, Houlston RS, Catovsky D, Yuille MR, Hilden J, Olsen JH, Fajber M, Brandt B, Sellick G, Allinson R, Wiik A. CLL family ‘Pedigree 14’ revisited: 1947-2004. Leukemia. 2005 Jun;19(6):1025-8. 
• Song L, Zlobin A, Ghoshal P, Zhang Q, Houde C, Weijzen S, Jiang Q, Nacheva E, Yagan D, Davis E, Galiegue-Zouitina S, Catovsky D, Grogan T, Fisher RI, Miele L, Coignet LJ. Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas. Cancer Res. 2005 Jun 1;65(11):4554-61. 
• Osuji N, Matutes E, Catovsky D, Lampert I, Wotherspoon A. Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review. Am J Surg Pathol. 2005 Jul;29(7):935-41. 
• Sellick GS, Spendlove HE, Catovsky D, Pritchard-Jones K, Houlston RS. Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia. Leukemia. 2005 Jul;19(7):1276-8. 
• Sellick GS, Webb EL, Allinson R, Matutes E, Dyer MJ, Jonsson V, Langerak AW, Mauro FR, Fuller S, Wiley J, Lyttelton M, Callea V, Yuille M, Catovsky D, Houlston RS. A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci. Am J Hum Genet. 2005 Sep;77(3):420-9. Epub 2005 Aug 2. 
• Osuji NC, Del Giudice I, Matutes E, Wotherspoon AC, Dearden C, Catovsky D. The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53. Haematologica. 2005 Oct;90(10):1435-6. 
• Del Giudice I, Morilla A, Osuji N, Matutes E, Morilla R, Burford A, Maravelaki S, Owusu-Ankomah K, Swansbury J, A’hern R, Brito-Babapulle V, Catovsky D. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. Cancer. 2005 Nov 15;104(10):2124-32. 
• Else M, Ruchlemer R, Osuji N, Del Giudice I, Matutes E, Woodman A, Wotherspoon A, Swansbury J, Dearden C, Catovsky D. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years. Cancer. 2005 Dec 1;104(11):2442-8. 

2006

• Matutes M, Morilla R, Catovsky D. Immunophenotyping. In Lewis SM, Bain BJ, Bates I, Eds. Dacie and Lewis Practical Haematology. Tenth edition. Philadelphia, PA: Churchill‑Livingstone; 2006:335-355.
• Binet JL, Caligaris-Cappio F, Catovsky D, Cheson B, Davis T, Dighiero G, Dohner H, Hallek M, Hillmen P, Keating M, Montserrat E, Kipps TJ, Rai K. Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. Blood. 2006 Feb 1;107(3):859-61. Epub 2005 Oct 13. 
• Sellick GS, Catovsky D, Houlston RS. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med. 2006 Mar 16;354(11):1204-5.
• Milligan DW, Kochethu G, Dearden C, Matutes E, MacConkey C, Catovsky D; Haematological Studies Group, UK National Cancer Research Institute. High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemia. Br J Haematol. 2006 Apr;133(2):173-5. 
• Sellick GS, Catovsky D, Houlston RS. Familial chronic lymphocytic leukemia. Semin Oncol. 2006 Apr;33(2):195-201. 
• Tute R, Yuille M, Catovsky D, Houlston RS, Hillmen P, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults. Leukemia. 2006 Apr;20(4):728-9. 
• Carter A, Lin K, Sherrington PD, Atherton M, Peerson K, Douglas A, Burford A, Brito-Babapulle V, Matutes E, Catovsky D, Petitt AR. Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia. Leukemia. 2006 Apr;20(4):737-40. 
• Del Giudice I, Davis Z, Matutes E, Osuji N, Parry-Jones N, Morilla A, Brito-Babapulle V, Oscier D, Catovsky D. IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL). Leukemia. 2006 Jul;20(7):1231-7. Epub 2006 Apr 27. 
• Tsimberidou AM, Catovsky D, Schlette E, O’Brien S, Wierda WG, Kantarjian H, Garcia-Manero G, Wen S, Do KA, Lerner S, Keating MJ. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone. Cancer. 2006 Jul 1;107(1):125-35. 
• Rudd MF, Sellick GS, Webb EL, Catovsky D, Houlston RS. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood. 2006 Jul 15;108(2):638-44. Epub 2006 Mar 30. 
• Osuji N, Matutes E, Tjonnfjord G, Grech H, Del Giudice I, Wotherspoon A, Swansbury JG, Catovsky D. T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literature. Cancer. 2006 Aug 1;107(3):570-8. 
• Sellick GS, Catovsky D, Houlston RS. Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia. Leuk Res. 2006 Dec;30(12):1573-6. Epub 2006 Apr 3. 
• Sellick GS, Sullivan K, Catovsky D, Houlston RS. CHEK2*1100delC and risk of chronic lymphocytic leukemia. Leuk Lymphoma. 2006 Dec;47(12):2659-60. 

2007

• Huh YO, Abruzzo LV, Rassidakis GZ, Parry-Jones N, Schlette E, Brito-Bapabulle V, Matutes E, Wotherspoon A, Keating MJ, Medeiros LJ, Catovsky D.The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases. Br J Haematol. 2007 Jan;136(2):220-8. Epub 2006 Nov 27.
• Osuji N, Beiske K, Randen U, Matutes E, Tjonnfjord G, Catovsky D, Wotherspoon A.Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia. Histopathology. 2007 Apr;50(5):547-54.
• Parry-Jones N, Matutes E, Morilla R, Brito-Babapulle V, Wotherspoon A, Swansbury GJ, Catovsky D.Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISHBr J Haematol. 2007 Apr;137(2):117-24.
• Sellick GS, Qureshi M, Fielding S, Catovsky D, Houlston RS.Germline mutations in SPI1 and MADD do not contribute to familial chronic lymphocytic leukaemia. Leukemia. 2007 Jun;21(6):1315-8. Epub 2007 Apr 5.
• Sellick GS, Lubbe SJ, Matutes E, Catovsky D, Houlston RS.Microsatellite instability indicative of defects in the major mismatch repair genes is rare in patients with B-cell chronic lymphocytic leukemia: Evaluation with disease stage and family historyLeuk Lymphoma. 2007 Jul;48(7):1320-2.
• Catovsky D, Richards S, Matutes E, Oscier D, Dyer MJ, Bezares RF, Pettitt AR, Hamblin T, Milligan DW, Child JA, Hamilton MS, Dearden CE, Smith AG, Bosanquet AG, Davis Z, Brito-Babapulle V, Else M, Wade R, Hillmen P; UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group; NCRI Chronic Lymphocytic Leukaemia Working Group.Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trialLancet. 2007 Jul 21;370(9583):230-239.
• Matutes E, Wotherspoon A, Catovsky D. Differential diagnosis in chronic lymphocytic leukaemia. Best Pract Res Clin Haematol. 2007 Sep;20(3):367-84.
• Sellick GS, Goldin LR, Wild RW, Slager SL, Ressenti L, Strom SS, Dyer MJ, Mauro FR, Marti GE, Fuller S, Lyttelton M, Kipps TJ, Keating MJ, Call TG, Catovsky D, Caporaso N, Houlston RS.A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemiaBlood. 2007 Nov 1;110(9):3326-33. Epub 2007 Aug 8.
• Else M, Osuji N, Forconi F, Dearden C, Del Giudice I, Matutes E, Wotherspoon A, Lauria F, Catovsky D.The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemiaCancer. 2007 Nov 15;110(10):2240-7.
• Bain B, Catovsky D, Goldman J. Obituary. David Abraham Goitein Galton. Leuk Lymphoma. 2007 Dec;48(12):2277-8.
• Catovsky D. The changing face of chronic lymphocytic leukemia. Leuk Lymphoma. 2007 Dec;48(12):2283-4.
• Jønsson V, Tjønnfjord G, Samuelsen SO, Johannesen T, Olsen J, Sellick G, Houlston R, Yuille M, Catovsky D.Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative diseaseLeuk Lymphoma. 2007 Dec;48(12):2387-96.

2008

• Müller-Hermelink HK, Montserrat E, Catovsky D, Campo E, Harris NL, Stein H. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Eds. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2008: 216-220.
• Campo E, Catovsky D, Montserrat E, Müller-Hermelink HK, Harris NL, Stein H. B-cell prolymphocytic leukaemia. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Eds. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2008: 222-223.
• Foucar K, Falini B, Catovsky D, Stein H. Hairy Cell Leukaemia. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Eds. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2008: 226-229.
• Catovsky D, Müller-Hermelink HK, Ralfkiaer E. T-cell prolymphocytic leukaemia. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Eds. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2008: 346-348.
• Chan WC, Foucar KM, Morice WG, Catovsky D. T-cell large granular lymphocytic leukaemia. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Eds. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2008: 348-351.
• Catovsky D. Current issues on the management of CLL. Acta Haematol Pol. 2008;39:125-130.
• Sellick G, Fielding S, Qureshi M, Catovsky D, Consortium TI, Houlston R.Germline mutations in RAD51, RAD51AP1, RAD51B, RAD51C,RAD51D, RAD52 and RAD54L do not contribute to familial chronic lymphocytic leukemiaLeuk Lymphoma. 2008 Jan;49(1):130-3.
• Broderick P, Sellick G, Fielding S, Catovsky D, Houlston R.Lack of a relationship between the common 18q24 variant rs12953717 and risk of chronic lymphocytic leukemiaLeuk Lymphoma. 2008 Feb;49(2):271-2.
• Sellick GS, Broderick P, Fielding S, Catovsky D, Houlston RS.Lack of a relationship between the common 8q24 variant rs6983267 and risk of chronic lymphocytic leukemiaLeukemia. 2008 Feb;22(2):438-9. Epub 2007 Aug 23.
• Sellick GS, Wade R, Richards S, Oscier DG, Catovsky D, Houlston RS.Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosisBlood. 2008 Feb 1;111(3):1625-33. Epub 2007 Nov 15.
• Dearden C, Wade R, Else M, Richards S, Milligan D, Hamblin T, Catovsky D.The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemiaBlood. 2008 Feb 15;111(4):1820-6. Epub 2007 Nov 30.
• Dungarwalla M, Evans SO, Riley U, Catovsky D, Dearden CE, Matutes E.High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapyHaematologica. 2008 Mar;93(3):475-6.
• Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ.Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesBlood. 2008 Jun 15;111(12):5446-56. Epub 2008 Jan 23.
• Crowther-Swanepoel D, Wild R, Sellick G, Dyer MJ, Mauro FR, Cuthbert RJ, Jonsson V, Matutes E, Dearden C, Wiley J, Fuller S, Catovsky D, Houlston RS.Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLLBlood. 2008 Jun 15;111(12):5691-3. Epub 2008 Apr 18.
• Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R, Sullivan K, Vijayakrishnan J, Wang Y, Pittman AM, Sunter NJ, Hall AG, Dyer MJ, Matutes E, Dearden C, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Hillmen P, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Allan JM, Catovsky D, Houlston RS.A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2008 Oct;40(10):1204-10. Epub 2008 Aug 31.
• Dungarwalla M, Appiah-Cubi S, Kulkarni S, Saso R, Wotherspoon A, Osuji N, Swansbury J, Cunningham DC, Catovsky D, Dearden CE, Matutes E.High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosisBr J Haematol. 2008 Oct;143(1):71-4. Epub 2008 Jul 30.
• Houlston RS, Catovsky D. Familial chronic lymphocytic leukemia. Curr Hematol Malig Rep. 2008 Oct;3(4):221-5.
• Rudenko HC, Else M, Dearden C, Brito-Babapulle V, Jones C, Dexter T, Fenwick K, Mackay A, Ashworth A, Matutes E, Gonzalez D, Catovsky D, Morgan GJ.Characterising the TP53-deleted subgroup of chronic lymphocytic leukemia: an analysis of additional cytogenetic abnormalities detected by interphase fluorescence in situ hybridisation and array-based comparative genomic hybridisationLeuk Lymphoma. 2008 Oct;49(10):1879-86.
• Watson L, Wyld P, Catovsky D. Disease burden of chronic lymphocytic leukaemia within the European Union. Eur J Haematol. 2008 Oct;81(4):253-8. Epub 2008 Jul 8.
• Morilla A, Gonzalez de Castro D, Del Giudice I, Osuji N, Else M, Morilla R, Brito Babapulle V, Rudenko H, Matutes E, Dearden C, Catovsky D, Morgan GJ.Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL. Leuk Lymphoma. 2008 Nov;49(11):2108-15.
• Else M, Smith AG, Cocks K, Richards SM, Crofts S, Wade R, Catovsky D; UK NCRI CLL Trials Group.Patients’ experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trialBr J Haematol. 2008 Dec;143(5):690-7. Epub 2008 Oct 18.

2009

• Foucar K, Osuji N, Matutes E, Dearden C, Catovsky D. T-cell chronic lymphocytic leukaemia. In Armitage JO, Mauch PM, Harris NL, Coiffier B, Dalla-Favera R, Eds. Non-Hodgkin Lymphomas. 2nd Edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:393-403.
• Else M, Dearden CE, Matutes E, Garcia-Talavera J, Rohatiner AZ, Johnson SA, O’Connor NT, Haynes A, Osuji N, Forconi F, Lauria F, Catovsky D.Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosisBr J Haematol. 2009 Jun;145(6):733-40. Epub 2009 Mar 29.
• Bosanquet AG, Richards SM, Wade R, Else M, Matutes E, Dyer MJS, Rassam SMB, Durant J, Scadding SM, Raper SL, Dearden CE, Catovsky D.Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testingBr J Haematol. 2009 Aug;146(4):384-95. Epub 2009 Jun 22.
• Del Giudice I, Osuji N, Dexter T, Brito-Babapulle V, Parry-Jones N, Chiaretti S, Messina M, Morgan G, Catovsky D, Matutes E.B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signaturesLeukemia. 2009 Nov;23(11):2160-7. Epub 2009 Jul 30.
• Crowther-Swanepoel D, Qureshi M, Dyer MJ, Matutes E, Dearden C, Catovsky D, Houlston RS.Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia. Blood. 2009 Nov 26;114(23):4843-6. Epub 2009 Oct 7.

2010

• Catovsky D. Established and emerging prognostic markers in chronic lymphocytic leukaemia: a journey through time. In Stamatopoulos K, Ghia P, Rosenquist R, Eds. New Biological Prognostic markers in Chronic Lymphocytic Leukemia. Milan, Italy: Wolters Kluwer Health; 2010:XVII-XXII.
• Catovsky D, Montserrat E.Chronic lymphocytic leukaemia and other B-cell disorders. In Hoffbrand AV, Catovsky D, Tuddenham EGD, Green AR, EdsPostgraduate Haematology. Sixth edition. Oxford, UK: Wiley-Blackwell; 2010: 530-557.
• Catovsky D, Else M, Dearden C, Matutes E.Interferon as an alternative to purine analogues in the treatment of hairy cell leukaemia – response to Benz et alBr J Haematol. 2010 Feb;148(4):665-6.
• Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, Mansouri M, Ruiz-Ponte C, Enjuanes A, Rosenquist R, Carracedo A, Jurlander J, Campo E, Juliusson G, Montserrat E, Smedby KE, Dyer MJ, Matutes E, Dearden C, Sunter NJ, Hall AG, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Parker A, Oscier D, Allan JM, Catovsky D, Houlston RS.Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet. 2010 Feb;42(2):132-6. Epub 2010 Jan 10.
• Matutes E, Attygalle A, Wotherspoon A, Catovsky D. Diagnostic issues in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol. 2010 Mar;23(1):3-20.
• Hockley SL, Morilla A, Else M, Dearden C, Catovsky D, Morgan GJ, Matutes E, Gonzalez D.Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphomaLeukemia. 2010 May;24(5):1084-6. Epub 2010 Mar 18.
• Crowther-Swanepoel D, Broderick P, Ma Y, Robertson L, Pittman AM, Price A, Twiss P, Vijayakrishnan J, Qureshi M, Dyer MJ, Matutes E, Dearden C, Catovsky D, Houlston RS.Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus. Hum Mol Genet. 2010 May 1;19(9):1840-5. Epub 2010 Feb 1.
• Krishnan B, Else M, Tjonnfjord GE, Cazin B, Carney D, Carter J, Ketterer N, Catovsky D, Ethell M, Matutes E, Dearden CE.Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective studyBr J Haematol. 2010 Jun;149(6):907-10. Epub 2010 Mar 1.
• Crowther-Swanepoel D, Mansouri M, Enjuanes A, Vega A, Smedby KE, Ruiz-Ponte C, Jurlander J, Juliusson G, Montserrat E, Catovsky D, Campo E, Carracedo A, Rosenquist R, Houlston RS.Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia riskBr J Haematol. 2010 Aug;150(4):473-9. Epub 2010 Jun 10.
• Oscier D, Wade R, Davis Z, Morilla A, Best G, Richards S, Else M, Matutes E, and Catovsky D, Chronic Lymphocytic Leukaemia Working Group, UK National Cancer Research Institute.Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocationHaematologica. 2010 Oct;95(10):1705-12. Epub 2010 May 29.
• Martin P, Attygalle AD, Swansbury J, Min T, Morilla A, Hockley SL, Wotherspoon A, Morgan GJ, Catovsky D, Dearden CE, Matutes E.p53 protein overexpression in bone marrow biopsies from chronic lymphocytic leukaemia is associated with TP53 deletion and resistance to fludarabineJ Hematop. 2010 Oct 5; 3(2-3):61-8.
• Crowther-Swanepoel D, Corre T, Lloyd A, Gaidano G, Olver B, Bennett FL, Doughty C, Toniolo D, Caligaris-Cappio F, Ghia P, Rossi D, Rawstron AC, Catovsky D, Houlston RS.Inherited genetic susceptibility to monoclonal B-cell lymphocytosis. Blood. 2010 Dec 23;116(26):5957-60. Epub 2010 Sep 20.

2011

• Michallet M, Dreger P, Sutton L, Brand R, Richards S, van Os M, Sobh M, Choquet S, Corront B, Dearden C, Gratwohl A, Herr W, Catovsky D, Hallek M, de Witte T, Niederwieser D, Leporrier M, Milligan D; EBMT Chronic Leukemia Working Party.Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observationBlood. 2011 Feb 3;117(5):1516-21. Epub 2010 Nov 24.
• Catovsky D, Else M, Richards S. Chlorambucil–still not bad: a reappraisal. Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S2-6. Epub 2011 May 6.
• Dearden CE, Else M, Catovsky D.Long-term results for pentostatin and cladribine treatment of hairy cell leukemia. Leuk Lymphoma. 2011 Jun;52(Suppl 2):21-4.
• Else M, Dearden CE, Matutes E, Forconi F, Lauria F, Ahmad H, Kelly S, Liyanage A, Ratnayake V, Shankari J, Whalley I, Catovsky D.Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrenceLeuk Lymphoma. 2011 Jun;52(Suppl 2):75-8. Epub 2011 Apr 19.
• Dearden C, Richards S, Else M, Catovsky D, Hillmen P.A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trialCancer. 2011 Jun 1;117(11):2452-60. Epub 2010 Dec 14.
• Gonzalez D, Martinez P, Wade R, Hockley S, Oscier D, Matutes E, Dearden CE, Richards SM, Catovsky D, Morgan GJ.Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trialJ Clin Oncol. 2011 Jun 1;29(16):2223-9. Epub 2011 Apr 11.
• Crowther-Swanepoel D, Di Bernardo MC, Jamroziak K, Karabon L, Frydecka I, Deaglio S, D’Arena G, Rossi D, Gaidano G, Olver B, Lloyd A, Broderick P, Laurenti L, Szemraj-Rogucka Z, Robak T, Catovsky D, Houlston RS. Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk. Br J Haematol. 2011 Jul;154(2):229-33. Epub 2011 May 9.
• Hockley SL, Morgan GJ, Leone PE, Walker BA, Morilla A, Else M, Wotherspoon A, Dearden C, Catovsky D, Gonzalez D, Matutes E.High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemiaLeukemia. 2011 Jul;25(7):1189-92. Epub 2011 Mar 25.
• Wade R, Di Bernardo MC, Richards S, Rossi D, Crowther-Swanepoel D, Gaidano G, Oscier DG, Catovsky D, Houlston RS.Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trialHaematologica. 2011 Oct;96(10):1496-503. Epub 2011 Jun 9.
• Dearden CE, Khot A, Else M, Hamblin M, Grand E, Roy A, Hewamana S, Matutes E, Catovsky D.Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous routeBlood. 2011 Nov 24;118(22):5799-802. Epub 2011 Sep 26.

2012

• Jones G, Parry-Jones N, Wilkins B, Else M, Catovsky D.Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variantBr J Haematol. 2012 Jan;156(2):186-95. Epub 2011 Nov 24.
• CLL Trialists’ Collaborative Group.Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trialsHaematologica. 2012 Mar;97(3):428-36. Epub 2011 Dec 1.
• Pettitt AR, Jackson R, Carruthers S, Dodd J, Dodd S, Oates M, Johnson GG, Schuh A, Matutes E, Dearden CE, Catovsky D, Radford JA, Bloor A, Follows GA, Devereux S, Kruger A, Blundell J, Agrawal S, Allsup D, Proctor S, Heartin E, Oscier D, Hamblin TJ, Rawstron A, Hillmen P.Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trialJ Clin Oncol. 2012 May 10;30(14):1647-55. Epub 2012 Apr 9.
• Else M, Cocks K, Crofts S, Wade R, Richards SM, Catovsky D, Smith AG.Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trialLeuk Lymphoma. 2012 Jul;53(7):1289-98. Epub 2012 Mar 1.
• Slager SL, Skibola CF, Di Bernardo MC, Conde L, Broderick P, McDonnell SK, Goldin LR, Croft N, Holroyd A, Harris S, Riby J, Serie DJ, Kay NE, Call TG, Bracci PM, Halperin E, Lanasa MC, Cunningham JM, Leis JF, Morrison VA, Spector LG, Vachon CM, Shanafelt TD, Strom SS, Camp NJ, Weinberg JB, Matutes E, Caporaso NE, Wade R, Dyer MJ, Dearden C, Cerhan JR, Catovsky D, Houlston RS.Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood. 2012 Jul 26;120(4):843-6. Epub 2012 Jun 13.
• Hockley SL, Else M, Morilla A, Wotherspoon A, Dearden C, Catovsky D, Gonzalez D, Matutes E.The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.Br J Haematol. 2012 Aug;158(3):347-54. Epub 2012 May 18.
• Lin K, Adamson J, Johnson GG, Carter A, Oates M, Wade R, Richards S, Gonzalez D, Matutes E, Dearden C, Oscier DG, Catovsky D, Pettitt AR.Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response durationClin Cancer Res. 2012 Aug 1;18(15):4191-200. Epub 2012 Jun 6.
• Else M, Marín-Niebla A, de la Cruz F, Batty P, Ríos E, Dearden CE, Catovsky D, Matutes E.Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphomaBr J Haematol. 2012 Nov;159(3):322-8. Epub 2012 Sep 27.

2013

• Crowther-Swanepoel D, Catovsky D, Houlston RS. Etiology and epidemiology of CLL.In Wiernik PH, Goldman JM, Dutcher JP, Kyle RA, Eds. Neoplastic Diseases of the Blood. Fifth Edition. New York, NY: Springer; 2013: 63-9.
• Di Bernardo MC, Broderick P, Harris S, Dyer MJ, Matutes E, Dearden C, Catovsky D, Houlston RS. Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation. Leukemia. 2013 Jan;27(1):255-8. Epub 2012 Jul 2.
• Oscier DG, Rose-Zerilli MJ, Winkelmann N, Gonzalez de Castro D, Gomez B, Forster J, Parker H, Parker A, Gardiner A, Collins A, Else M, Cross NC, Catovsky D, Strefford JC.The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood. 2013 Jan 17;121(3):468-75. Epub 2012 Oct 18.
• Gonzalez D, Else M, Wren D, Usai M, Buhl AM, Parker A, Oscier D, Morgan G, Catovsky D.CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genesHaematologica. 2013 Feb;98(2):274-8. Epub 2012 Aug 16.
• Matutes E, Bosanquet AG, Wade R, Richards SM, Else M, Catovsky D.The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entryLeukemia. 2013 Feb;27(2):507-10. Epub 2012 Jul 19.
• Di Bernardo MC, Broderick P, Catovsky D, Houlston RS.Common genetic variation contributes significantly to the risk of developing chronic lymphocytic leukemiaHaematologica. 2013 Mar;98(3):e23-4. Epub 2012 Aug 16.
• Sava GP, Speedy HE, Di Bernardo MC, Deaglio S, Karabon L, Frydecka I, Woszczyk D, Rossi D, Gaidano G, Mansouri L, Smedby KE, Juliusson G, Rosenquist R, Catovsky D, Houlston RS.rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia? Br J Haematol. 2013 Jul;162(2):221-8. Epub 2013 May 14.
• Johnson GG, Lin K, Cox TF, Oates M, Sibson DR, Eccles R, Lloyd B, Gardiner LJ, Carr DF, Pirmohamed M, Strefford JC, Oscier DG, Gonzalez de Castro D, Else M, Catovsky D, Pettitt AR.CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia.Blood. 2013 Dec 19;122(26):4253-8. Epub 2013 Oct 15.

2014

• Speedy HE, Di Bernardo MC, Sava GP, Dyer MJ, Holroyd A, Wang Y, Sunter NJ, Mansouri L, Juliusson G, Smedby KE, Roos G, Jayne S, Majid A, Dearden C, Hall AG, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Rosenquist R, Catovsky D, Allan JM, Houlston RS.A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2014 Jan;46(1):56-60. Epub 2013 Dec 1.
• Rose-Zerilli MJ, Forster J, Parker H, Parker A, Rodríguez AE, Chaplin T, Gardiner A, Steele AJ, Collins A, Young BD, Skowronska A, Catovsky D, Stankovic T, Oscier DG, Strefford JC.ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trialHaematologica. 2014 Apr;99(4):736-42. Epub 2014 Feb 28.
• Catovsky D, Wade R, Else M. The clinical significance of patients’ sex in chronic lymphocytic leukemia. Haematologica. 2014 Jun;99(6):1088-94. Epub 2014 Mar 21.

2015

• Sava GP, Speedy HE, Di Bernardo MC, Dyer MJ, Holroyd A, Sunter NJ, Marr H, Mansouri L, Deaglio S, Karabon L, Frydecka I, Jamroziak K, Woszczyk D, Juliusson G, Smedby KE, Jayne S, Majid A, Wang Y, Dearden C, Hall AG, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Rosenquist R, Catovsky D, Allan JM, Houlston RS. Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk. Leukemia. 2015 Mar;29(3):748-51. Epub 2014 Nov 3.
• Robak T, Matutes E, Catovsky D, Zinzani PL, Buske C; ESMO Guidelines Committee.Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015 Sep;26(Suppl 5):v100-7. Epub 2015 Aug 12.
• Else M, Dearden CE, Catovsky D. Long-term follow-up after purine analogue therapy in hairy cell leukaemiaBest Pract Res Clin Haematol. 2015 Dec;28(4):217-29. Epub 2015 Oct 9.
• Sarid N, Ahmad HN, Wotherspoon A, Dearden CE, Else M, Catovsky D.An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapyBr J Haematol. 2015 Dec;171(5):784-7. Epub 2015 Sep 25.
• Strefford JC, Kadalayil L, Forster J, Rose-Zerilli MJ, Parker A, Lin TT, Heppel N, Norris K, Gardiner A, Davies Z, Gonzalez de Castro D, Else M, Steele AJ, Parker H, Stankovic T, Pepper C, Fegan C, Baird D, Collins A, Catovsky D, Oscier DG.Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trialLeukemia. 2015 Dec;29(12):2411-4. Epub 2015 Aug 10.

2016

• Else M, Wade R, Oscier D, Catovsky D.The long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 yearsBr J Haematol. 2016 Jan;172(2):228-37. Epub 2015 Oct 12.
• Johnson N, De Ieso P, Migliorini G, Orr N, Broderick P, Catovsky D, Matakidou A, Eisen T, Goldsmith C, Dudbridge F, Peto J, Dos-Santos-Silva I, Ashworth A, Ross G, Houlston RS, Fletcher O.Cytochrome P450 allele CYP3A7*1C associates with adverse outcomes in chronic lymphocytic leukemia, breast, and lung cancerCancer Res. 2016 Mar 15;76(6):1485-1493.
• Davis Z, Forconi F, Parker A, Gardiner A, Thomas P, Catovsky D, Rose-Zerilli M, Strefford JC, Oscier D.The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identityBr J Haematol. 2016 Apr;173(1):127-36. Epub 2016 Feb 5.
• Kandaswamy R, Sava GP, Speedy HE, Beà S, Martín-Subero JI, Studd JB, Migliorini G, Law PJ, Puente XS, Martín-García D, Salaverria I, Gutiérrez-Abril J, López-Otín C, Catovsky D, Allan JM, Campo E, Houlston RS.Genetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphismCell Rep. 2016 Aug 23;16(8):2061-2067. Epub 2016 Aug 11.
• Oscier D, Else M, Matutes E, Morilla R, Strefford JC, Catovsky D.The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trialBr J Haematol. 2016 Sep;174(5):767-75. Epub 2016 May 6.
• Pratt G, Thomas P, Marden N, Alexander D, Davis Z, Hussey D, Parry H, Harding S, Catovsky D, Begley J, Oscier D.Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survivalLeuk Lymphoma. 2016 Oct;57(10):2342-50. Epub 2016 Feb 8.
• Speedy HE, Kinnersley B, Chubb D, Broderick P, Law PJ, Litchfield K, Jayne S, Dyer MJS, Dearden C, Follows GA, Catovsky D, Houlston RS.Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemiaBlood. 2016 Nov 10;128(19):2319-2326. Epub 2016 Aug 15.

2017

• Law PJ, Sud A, Mitchell JS, Henrion M, Orlando G, Lenive O, Broderick P, Speedy HE, Johnson DC, Kaiser M, Weinhold N, Cooke R, Sunter NJ, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Carmichael J, Bailey JR, Pratt G, Rahman T, Pepper C, Fegan C, von Strandmann EP, Engert A, Försti A, Chen B, Filho MI, Thomsen H, Hoffmann P, Noethen MM, Eisele L, Jöckel KH, Allan JM, Swerdlow AJ, Goldschmidt H, Catovsky D, Morgan GJ, Hemminki K, Houlston RS.Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk lociSci Rep. 2017 Jan 23;7:41071.
• Larrayoz M, Rose-Zerilli MJ, Kadalayil L, Parker H, Blakemore S, Forster J, Davis Z, Steele AJ, Collins A, Else M, Catovsky D, Oscier DG, Strefford JC.Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trialLeukemia. 2017 Feb;31(2):510-514. Epub 2016 Oct 26.
• Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, Call TG, Catovsky D, Dearden C, Demeter J, Else M, Forconi F, Gozzetti A, Ho AD, Johnston JB, Jones J, Juliusson G, Kraut E, Kreitman RJ, Larratt L, Lauria F, Lozanski G, Montserrat E, Parikh SA, Park JH, Polliack A, Quest GR, Rai KR, Ravandi F, Robak T, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam C, Tiacci E, Troussard X, Zent CS, Zenz T, Zinzani PL, Falini B.Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood. 2017 Feb 2;129(5):553-560. Epub 2016 Nov 30.
• Law PJ, Berndt SI, Speedy HE, Camp NJ, Sava GP, Skibola CF, Holroyd A, Joseph V, Sunter NJ, Nieters A, Bea S, Monnereau A, Martin-Garcia D, Goldin LR, Clot G, Teras LR, Quintela I, Birmann BM, Jayne S, Cozen W, Majid A, Smedby KE, Lan Q, Dearden C, Brooks-Wilson AR, Hall AG, Purdue MP, Mainou-Fowler T, Vajdic CM, Jackson GH, Cocco P, Marr H, Zhang Y, Zheng T, Giles GG, Lawrence C, Call TG, Liebow M, Melbye M, Glimelius B, Mansouri L, Glenn M, Curtin K, Diver WR, Link BK, Conde L, Bracci PM, Holly EA, Jackson RD, Tinker LF, Benavente Y, Boffetta P, Brennan P, Maynadie M, McKay J, Albanes D, Weinstein S, Wang Z, Caporaso NE, Morton LM, Severson RK, Riboli E, Vineis P, Vermeulen RC, Southey MC, Milne RL, Clavel J, Topka S, Spinelli JJ, Kraft P, Ennas MG, Summerfield G, Ferri GM, Harris RJ, Miligi L, Pettitt AR, North KE, Allsup DJ, Fraumeni JF, Bailey JR, Offit K, Pratt G, Hjalgrim H, Pepper C, Chanock SJ, Fegan C, Rosenquist R, de Sanjose S, Carracedo A, Dyer MJ, Catovsky D, Campo E, Cerhan JR, Allan JM, Rothman N, Houlston R, Slager S.Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemiaNat Commun. 2017 Feb 6;8:14175.

2018

• Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating M, Montserrat E, Chiorazzi N, Stilgenbauer S, Rai KR, Byrd JC, Eichhorst B, O’Brien S, Robak T, Seymour JF, Kipps TJ.iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLLBlood. 2018 Jun 21;131(25):2745-2760. Epub 2018 Mar 14.
• Went M, Sud A, Speedy H, Sunter NJ, Försti A, Law PJ, Johnson DC, Mirabella F, Holroyd A, Li N, Orlando G, Weinhold N, van Duin M, Chen B, Mitchell JS, Mansouri L, Juliusson G, Smedby KE, Jayne S, Majid A, Dearden C, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Rosenquist R, Kuiper R, Stephens OW, Bertsch U, Broderick P, Einsele H, Gregory WM, Hillengass J, Hoffmann P, Jackson GH, Jöckel KH, Nickel J, Nöthen MM, da Silva Filho MI, Thomsen H, Walker BA, Broyl A, Davies FE, Hansson M, Goldschmidt H, Dyer MJS, Kaiser M, Sonneveld P, Morgan GJ, Hemminki K, Nilsson B, Catovsky D, Allan JM, Houlston RS.Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiologyBlood Cancer J. 2018 Dec 21;9(1):1.

2019

• Catovsky D, Else M, Oscier D. The clinical presentation of CLL. In Hallek M, Eichhorst B, Catovsky D, Eds. Chronic Lymphocytic Leukemia. Hematologic Malignancies. Cham, Switzerland: Springer; 2019:39-50.
• Speedy HE, Beekman R, Chapaprieta V, Orlando G, Law PJ, Martín-García D, Gutiérrez-Abril J, Catovsky D, Beà S, Clot G, Puiggròs M, Torrents D, Puente XS, Allan JM, López-Otín C, Campo E, Houlston RS, Martín-Subero JI. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics. Nat Commun. 2019 Aug 9;10(1):3615.
• Wojdacz TK, Amarasinghe HE, Kadalayil L, Beattie A, Forster J, Blakemore SJ, Parker H, Bryant D, Larrayoz M, Clifford R, Robbe P, Davis ZA, Else M, Howard DR, Stamatopoulos B, Steele AJ, Rosenquist R, Collins A, Pettitt AR, Hillmen P, Plass C, Schuh A, Catovsky D, Oscier DG, Rose-Zerilli MJJ, Oakes CC, Strefford JC.Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trialsBlood Adv. 2019 Aug 27;3(16):2474-2481.

2020

• Blakemore SJ, Clifford R, Parker H, Antoniou P, Stec-Dziedzic E, Larrayoz M, Davis Z, Kadalyayil L, Colins A, Robbe P, Vavoulis D, Forster J, Carr L, Morilla R, Else M, Bryant D, McCarthy H, Walewska RJ, Steele AJ, Chan J, Speight G, Stankovic T, Cragg MS, Catovsky D, Oscier DG, Rose-Zerilli MJJ, Schuh A, Strefford JC. Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trialLeukemia. 2020 Jul;34(7):1760-1774. Epub 2020 Feb 3.

2021

• Catovsky D, Else M. Early clinical trials in chronic lymphocytic leukaemia in the UK. Br J Haematol. 2020 Nov;191(4):535-541.
• Else M, Blakemore SJ, Strefford JC, Catovsky D.The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trialLeukemia. 2021 Feb 12:1–7. [Epub ahead of print]
• Pepper AGS, Zucchetto A, Norris K, Tissino E, Polesel J, Soe Z, Allsup D, Hockaday A, Ow PL, Hillmen P, Rawstron A, Catovsky D, Bulian P, Bomben R, Baird DM, Fegan CD, Gattei V, Pepper C.Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapiesLeukemia. 2021 Jun 19. [Epub ahead of print].